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Abstract 
 
 
This thesis describes the fabrication, characterisation and validation of two novel 
immunosensors for the detection of the inflammation markers nerve growth factor-β 
(NGF) and psoriasin (S100-A7). 
 
The initial phase of sensor construction involves the electrodeposition of polyaniline onto 
commercial screen-printed carbon electrodes.  A classical avidin-biotin link was then 
used to immobilise biotinylated antibodies.   Fully fabricated immunosensors were 
incubated with their target antigen and interrogated with AC impedance to observe the 
change in real (Z‘) impedance (Ohms) with respect to antigen exposure.  The Z‘ 
impedance was found to increase over physiologically significant concentration ranges of 
the target antigen.  The effects of non-specific antigen binding were accounted for via 
controls using a non-specific antigen analogue for each immunosensor.  The sensors 
reported here, after optimisation of the fabrication procedure using the BioDot AD3200 
automatic dispensing system, are capable of detecting the presence and concentration of 
target antigen in a commercial sample within 35 minutes with a lower limit of detection 
(LLD) (a response observed that is more than three times the standard deviation of the 
immunosensors baseline impedance measurement) of 50pg ml
-1
 for NGF and 250pg ml
-1
 
for psoriasin. 
 
An evaluation is also presented of the competitive advantage gained by companies such 
as Unilever by undertaking research projects in conjunction with universities and forming 
other such strategic networks. 
 
As part of this EngD project, a review paper concerning antibody based sensors in the 
past decade was written and is now submitted ready for publishing in the peer reviewed 
journal ‗Biosensors and Bioelectronics‘.  A further two papers describing the 
development, characterisation and validation of the NGF and psoriasin immunosensors 
described within this thesis have also been submitted for publishing in ‗Biosensors and 
Bioelectronics‘. 
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AC Alternating current 
Ag/AgCl A silver / silver chloride reference electrode 
anti-FITC  Antibodies targeted towards Fluorescein protein 
anti-NGF  Antibodies targeted towards nerve growth factor protein 
anti-psoriasin  Antibodies targeted towards psoriasin protein 
AuNP Gold nanoparticles 
BAC-sulpho-NHS Biotinamidohexanoic acid sulpho-N-hydroxysuccinimide 
BSA Bovine serum albumin 
C Capacitance 
Cdl The double layer capacitance 
CDR Complimentarity determining region 
CDK2 Cyclin dependant kinase 2 
CE Counter / auxiliary electrode 
CNT Carbon nanotubes 
CTR Charge transfer resistance 
EIS    Electrochemical impedance spectroscopy 
ELISA   Enzyme linked immunosorbent assay 
EngD   Engineering Doctorate 
Ee Equilibrium potential of an electrode 
Ep Potential peaks on a voltammogram 
EU European union 
E
ө
 Standard electrode potential 
F Faraday constant (96 485 C mol
-1
) 
Fab   Antigen binding domain or fragment of an antibody 
Fc The constant region or fragment of an antibody 
FET Field effect transistor 
Fe
2+
/Fe
3+
 The iron redox couple present in ferri-ferrocyanide 
FITC   The fluorophore Fluorescein 
FOS Fibre-optic sensors 
Fv Variable fragment of an antibody 
GC-MS  Gas chromatography – mass spectrometry 
hCG Human chorionic gonadotrophin 
HCV Hepatitis C virus 
Hz Hertz – a measure of frequency 
H2O2 Hydrogen peroxide 
IHP Inner Helmholtz plane 
IgG Immunoglobulin G 
IgM Immunoglobulin M antibody subclass 
ip Current peaks on a voltammogram 
ISFET  Ion-sensitive field effect transistor 
IUPAC The international union of pure and applied chemistry 
Jm Migratory flux 
KB Boltzmann constant 
Kd The dissociation constant, giving a measure of the strength of a 
molecular bond 
kDa   The size of a protein moiety as measured in kilo Daltons 
LDL Low density lipoprotein 
LH Luteinising hormone 
LLD   The lower limit of detection – three times the standard deviation of  
LoC Lab on a Chip 
the mean of the baseline value 
M Molar concentration 
mg ml
-1
 Milligrams per millilitre 
MIP Molecularly imprinted polymer 
MOSFET Metal oxide silicon field effect transistor 
MWNT  Multi-walled nanotubes (carbon) 
ng ml
-1
 Nanograms per millilitre 
NGF   Nerve growth factor – β 
NHE Normal hydrogen electrode 
OHP Outer Helmholtz plane 
 [O] The molar concentration of an oxidised redox ion 
PBS Phosphate buffered saline 
pg ml
-1
 Picograms per millilitre 
pH A measure of the concentration of H
+
 ions 
Plc   Public limited company 
PoC Point of care, whereby a sensor can be used at the sample source 
PSA Prostate specific antigen 
QCM  Quartz crystal microbalance 
QD Quantum dot 
R Universal gas constant (8.3145 J K
-1
 mol
-1
) 
RBV   The resource based view of a firm 
Rct Charge transfer resistance 
RE Reference electrode 
RIFTS Reflective inferometric fourier transform spectroscopy 
[R] The molar concentration of a reduced redox ion 
R
2
   The linear correlation coefficient 
R&D   Research and development 
scFv   Single chain variable fragment of an antibody molecule 
SPR Surface plasmon resonance 
SWNT   Single walled nanotubes (carbon) 
S100A7  An alternative name for psoriasin 
T Absolute temperature 
TNT   Tri-nitro-toluene 
μg ml-1 Micrograms per millilitre 
V Volts 
VSC   Volatile sulphur compounds 
WE Working electrode 
Xc Capacitance reactance 
z Ionic charge 
Zf Faradaic impedance (Zw + Rct) 
Zw Warburg impedance 
Z‘ Real component of impedance 
Z‘‘ Imaginary component of impedance 
φ Phase angle in rad s-1 = 2πf 
ω Frequency 
Ω   Ohms – a measure of resistance to current 
°C   Degrees centigrade – a measure of temperature 
ρq   The density of a quartz crystal 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Chapter 1: 
 Research Rationale 
  
T.R.J. Holford          Cranfield University 
1. Research Rationale 
1.1. Introduction 
Electrochemical impedance spectroscopy (EIS) is a technique used to characterise the 
changes in the movement of charge across a conductive surface and, in the case of 
immunosensors, how this relates to the formation of an antibody-antigen complex.  The 
following research aims to develop, characterise and validate immunosensors as a novel 
approach to detect the presence of the inflammation markers nerve growth factor-β 
(NGF) and psoriasin (S100A7) in treated skin samples during clinical trials for new and 
existing personal care products at the projects industrial sponsor (Unilever Plc). 
 
Existing techniques for clinical safety trials within the sponsoring company for personal 
care products include the Enzyme-Linked Immunosorbent Assay (ELISA) (described in 
more detail in chapter 2, section 2.1) (Yalow and Berson, 1959) and radio-immunological 
methods.  However there is a drive within both industry and academia towards the 
development and use of new analytical tests with increased rapidity of response times, 
enhanced sensitivity to the specific analyte, high throughput of samples and simplified 
analytical approaches at a lower cost. 
 
The first step of the investigation was to find a proof of principle (results presented in 
chapter 4, section 4.2.2).  This involved testing for any change in impedance upon the 
incubation of an immunosensor with its given target, regardless of sensitivity or standard 
error.  The research could then continue to focus on the optimisation of the 
immunosensors in terms of reproducibility and sensitivity to the target analyte. 
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1.2. Business Focused Rationale 
Unilever is a multinational company that owns an array of brands within the food, health, 
hygiene and beauty sectors as well as possessing a large research and development 
capability focused towards the delivery of quality products.  The formation of strategic 
alliances such as that between Unilever and smaller research facilities like Cranfield 
Health at Cranfield University (in the case of this project) allow them to maintain a 
competitive edge in the market in addition to creating new opportunities through ‗blue 
skies research‘ or ‗curiosity-driven science‘.  By outsourcing core research activities, 
Unilever benefit from the tacit knowledge, skills and competencies to innovate that is 
otherwise difficult to obtain within a single company.  Some aspects of Unilevers‘ 
ongoing research can in this instance be furthered by the use of immunosensors for the 
detection of biochemical markers linked to a number of skin conditions and particularly 
the allergic reactions in response to the topical application of personal care products.  The 
immunosensors developed in this project will be used in key clinical tests to help ensure 
new skincare products are safe to use via a faster and more economical method than the 
presently used ELISA.  As a benchmark, ELISA assays for both NGF and psoriasin can 
be commercially purchased with a sensitivity of <1pg ml
-1 
and 120pg ml
-1
 with lead times 
of 4.5 hours and 3 hours respectively.  ELISA assays for NGF typically cost $6 per well 
on a 96-well plate and $7 per well for a psoriasin ELISA. 
 
It is important to any public company such as Unilever that the products they distribute 
throughout the country and the world are in line with their mission statement.  For 
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Unilever that means that all products present some kind of healthy benefit and are 
entirely safe to the user (Figure 1. 1). 
Figure 1. 1: Unilever mission statement (www.unilever.co.uk, 2011). 
 
 
Products are rigorously tested to fulfil this mission promise.  In many cases using the 
methods developed in this project, Unilevers‘ marketing campaign and that of its many 
brands can help to reflect the quality, safety and benefit of the products to the customers, 
ultimately to increase sales. 
 
Another benefit of this project to Unilever is decreasing the cost and time taken for 
bringing newly developed skincare products to market.  Existing methods, including 
ELISA, used to ensure new products interact with the skin in a non-harmful manner are 
often slow to provide results, extending time to market.  Electrochemical immunosensors 
could, in this context, provide a quick and less expensive alternative, thereby providing 
Unilever with an operational competitive advantage. 
 
 
 
The four pillars of our vision:  
 We work to create a better future every day 
 We help people feel good, look good and get more out of life with brands and 
services that are good for them and good for others 
 We will inspire people to take small everyday actions that can add up to a big 
difference for the world 
 We will develop new ways of doing business with the aim of doubling the size 
of our company while reducing our environmental impact 
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To summarise, the research presented in this EngD thesis aims to: 
 
1. Fabricate, characterise and optimise a novel EIS immunosensor to target the 
inflammation biomarkers to their stipulated (by sponsor) physiological levels: 
 NGF (50 – 200pg ml-1) 
 Psoriasin (5 – 20ng ml-1) 
 
2. Validate the immunosensors developed to ensure specificity 
 
3. Consider and critically evaluate the business benefits of the use of the EIS 
immunosensor developed here in addition to discussing strategic network 
formation to gain competitive edge. 
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2. Introduction and Literature review 
2.1. Introduction to Immunosensors 
The concept of using immunological components as sensing agents was first established 
in 1959 by Yalow and Berson who described an immunoassay for plasma insulin in 
human subjects.  The high dissociation constants (Kd) and specificity with which 
antibodies bind to their target antigen has continued to be exploited ever since, with the 
most well-known immunoassay being the enzyme linked immunosorbent assay (ELISA) 
developed in 1971 (Engvall and Perlmann, 1971).  The ELISA test has since been seen as 
a ‗gold-standard‘ for immunoassays for comparison against all newly developed 
immunoassays and immunosensors.  Briefly, ELISAs involve the immobilisation of a 
reactant (an antibody or antigen) onto a solid surface - and enzymes are used as markers 
for the presence and abundance of a specific antibody-antigen (antibody-antigen) 
interaction (Butler, 2000). 
 
Immunoassays have the ability to make specific and sensitive measurement of the target 
analyte by harnessing the high specificity of the antibody-antigen interaction - and this 
phenomena was used to develop what would lead to the first commercially available 
immunoassay – the home pregnancy test (measuring human chorionic gonadotrophin 
(hCG)).  Immunoassays for detecting hCG were first described in the 1960s, with 
radioimmunoassays following in the 1970s, however issues arose concerning the 
specificity of these immunoassays towards hCG until 1972 when the first lateral-flow 
immunoassay measuring the hCG-β subunit was first developed which could distinguish 
between hCG and luteinising hormone (LH) (Vaitukaitis et al., (1972).   
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Later in the late 1980‘s the first pregnancy tests (targeting hCG-β) were made available to 
the public for home use, and ever since, the technology has been applied to a diverse 
range of uses.  Independent work by Clark and Lyons (1962), described development of 
the first biosensor, which coupled the biological specificity of enzymes with an electrode 
and transducer.  Immunosensors, by definition, also incorporate this transduction stage to 
link the specific antibody-antigen interaction with a signal generation. 
 
Presently, immunosensor technology is a multidisciplinary area of research being 
advanced by biologists, chemists and physicists alike.  Several methods exist to transduce 
a signal created by the binding reaction of antibody and antigen, each one with their own 
associated advantages and disadvantages, which will be discussed further in the following 
subsections within this chapter.  The previous decade has seen a wealth of research and 
fabrication of working immunosensors and immunoassays, with a particular focus 
towards point of care (PoC) systems, reusable and portable devices, miniaturisation, 
fabrication of more reliable platforms and the use of aptamers, molecularly imprinted 
polymers (MIPs), nanoparticles and other relevant molecules.  It is now possible to 
produce antibody fragments with a high specificity for their target analyte and for a much 
wider range of uses than is available with naturally formed antibodies (Nassef et al., 
2009; Lu et al., 2007). 
 
The future of this area of research seems set towards developing more sensors with the 
characteristics described above, with particular emphasis towards PoC applications and 
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greater capabilities for simultaneous multiple analyte analysis (multiplexing) and 
high-throughput screening. 
 
2.1.1 Immunosensors: Present day status 
There is a diverse population of immunoassays and sensors presently developed and 
operational with many more in the process of being developed.  Many of these types of 
sensors and assays will be discussed within this review along with some relevant 
examples. 
 
The home pregnancy test was first established as a lateral flow-cell immunoassay to 
measure levels of hCG in urine (Vaitukaitis et al., 1972).  Lateral-flow immunoassays 
generally consist of an absorbent strip along which sample flows on a single axis from 
the sampling pad until the analyte reaches its specific antibody conjugated to a coloured 
marker (Marino et al., 2009).  There are many variations of the lateral flow-cell 
immunoassay for pregnancy available on the market but in general they share the same 
principles of operation.  The target (hCG), bound to its monoclonal antibody (a coloured 
anti-α-hCG), will progress along a wick to a capture site where antibodies (polyclonal 
anti-hCG immobilised along a line) bind the Antibody-antigen complex.  As long as hCG 
is present in the urine, the Antibody-antigen complex will bind with the polyclonal 
anti-hCG and this will gather at the collection site to form a coloured line to indicate the 
presence of hCG.  Urine then continues to flow up the strip until it passes a pH sensitive 
control area in which a second line becomes visible to indicate that the sample has 
progressed all the way along the test strip.  The appearance therefore of two solid lines on 
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the strip indicates a positive result.  If the test is negative, then only one line is shown.  
Today many lateral-flow tests include a transducer which generates a digital readout of 
the result by determining the intensity of the coloured antibody-antigen complex 
(Fumière et al., 2009) (Figure 2. 1). 
 
 
Figure 2. 1: a) The lateral-flow immunoassay format (marker shows if positive or negative for hCG) 
and b) the present day digital readout which displays in written format whether the user is pregnant 
or not, and if pregnant then for how long. 
 
PoC testing is an ‗on site‘ test carried out at the location where the patient may be.  PoC 
is covered by a large proportion of contemporary front-line research, with devices being 
numerous and diverse in terms of analytical targets, yet none offer a complete set of the 
necessary characteristics for a good PoC sensor including full automation, portability, 
precision, accuracy and sensitivity, low cost and ease of use (Von Lode, 2005; Warsinke, 
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2009).  For example, in recent years some PoC devices have become available for the 
detection and monitoring of cancer development (Rusling, 2009; Mani et al., 2009; Yu, 
2006).  However, further work in lowering the limits of detection on presently existing 
sensors and development of new tests for other targets is needed. 
 
Non-invasiveness is another important characteristic when considering PoC sensor design 
whereby the method of sample extraction is non-invasive to the patient - or samples other 
than blood are used, such as urine, sweat or saliva.  One method proven to minimise the 
pain associated with blood spot sampling, as used in some blood glucose sampling 
systems, is to lower the sample size; with devices utilising samples of 0.3µl blood now on 
the market (Warsinke, 2009) for blood glucose monitoring, however when sampling for 
proteins, larger sample sizes of 1µl are typically, at the time of writing, needed 
(Warsinke, 2009).  Therefore the miniaturisation of devices could help with using 
lowered sample sizes, since they operate on a smaller scale, and minimise pain upon 
sample collection as well as lowering unit costs for tests.   
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2.2. Electrochemical Methods and Electrochemistry 
2.2.1. Introduction 
This chapter will give a brief account of the important aspects of electrochemistry 
relating to analytical electrochemistry which is related to the work done within this thesis 
whereby electrochemistry is used to both fabricate and characterise the immunosensors. 
 
Electrochemistry describes the relationship between chemical and electrical effects.  
Electrochemistry as a whole covers phenomena such as electrophoresis and corrosion, the 
study of devices in the form of electrochromic displays, electroanalytical sensors, 
batteries and fuel cells, and various technologies including the electroplating of metals 
and the large-scale production of aluminium and chlorine.  There is an abundance of texts 
detailing the many phenomena involved in electrochemistry.   
 
The electrochemical focus of this thesis concerns the charge transfer occurring to or from 
an electrode in the presence of a chemical process.  The electrode can be metallic, carbon 
or a semiconductor.  Through these charge transfer reactions, chemical species, either on 
or surrounding the electrode can be either be oxidised or reduced by the transfer of 
electrons in order to generate an electrical signal.  The core of any electrochemical sensor 
is built upon this phenomenon. 
 
Electrochemical reactions occurring within the confines of a cell involve both a cathode 
and an anode.  The cell is made up from a solid phase i.e. the electrode and a mobile 
phase i.e. the conductive media in which the electrode sits.  Charge will transfer through 
  
T.R.J. Holford          Cranfield University 
the solid phase in the form of electrons, and through the mobile phase carried through 
ionic species. 
 
It is necessary to include both an oxidising and reducing element within an 
electrochemical cell in order to allow electrons to pass freely from one electrode to the 
other, preventing an accumulation of charge somewhere within the cell.  A schematic 
example of a simple electrochemical cell is displayed below in Figure 2. 2: 
 
Figure 2. 2: Schematic diagram depicting a simple electrochemical cell with three electrodes: 
working electrode, reference electrode and counter (auxiliary) electrode (adapted from Higson, 
2003). 
 
The electrochemical cell in Figure 2. 2, as displayed above, includes a typical 
three-electrode arrangement with a working electrode, a reference electrode and a counter 
electrode.  The counter electrode is typically double the size of the working electrode to 
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guarantee that it is not the limiting factor in the transfer of electrical charge from the 
working electrode. 
 
Reference electrodes are important to provide a stable reference potential against which 
the potential of the working electrode can be compared – and therein obtain a potential 
difference.  Other electrode potentials can be measured in relation to the reference 
electrode potential.  Each type of reference electrode will be chosen for the stable 
qualities its double layer possesses.  The electrical double layer (described in further 
detail in section 2.2.3) consists of a layer of charge on the surface of the electrode and a 
second layer of charge consisting of ions of opposite charge to the first layer.  The perfect 
reference electrode is also entirely non-polarisable, meaning current cannot flow between 
the reference electrode/electrolyte interface.  The most frequently used reference 
electrodes include the silver/silver chloride (Ag/AgCl) electrode, the normal hydrogen 
electrode (NHE) and the saturated calomel electrode (SCE).    
 
The rate at which the electrons travel i.e. the electrical current (i) can be used to measure 
the rate of chemical reactions and ultimately the total chemical change occurring within 
the cell.  Typically, within an electrochemical cell, an electrolyte (ionic conductor) is 
used.  In general, these ionic conductors will consist of a liquid media containing ionic 
species such as, for example, H
+
, Na
+
 or Cl
+
 in order to remain conductive and allow the 
flow of electrons between the cathode and anode.  Less commonly, electrolytes can 
consist of fused salts, conductive polymers including Nafion and polyethylene 
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oxide-LiClO4 and solids such as, for example, sodium β-alumina in which the charge 
transfers via mobile sodium ions moving between aluminium oxide sheets.   
 
The transfer of charges between electrodes in an electrochemical cell creates a potential 
difference which can be measured using a high impedance voltmeter.  The overall cell 
potential is measured in volts (V), where 1V = 1 J C
-1
 (1 Joule per Coulomb).  The 
voltage gives a measure of the energy present to push charge through the mobile phase 
between electrodes.  This driving power is generally influenced by effects occurring at 
the electrode/electrolyte interface.  The potential difference present at this interface is 
proportional to the relative energies carried within the ionic species; therefore the 
potential difference controls both the direction and the rate of charge transfer within the 
cell.  This fact leads to the conclusion that controlling and monitoring the cell potential is 
important to analytical and experimental electrochemistry. 
 
The electrode potential can also be determined, at equilibrium, using the Nernst equation.  
This equation explains that the electrode potential at equilibrium is dependant on the 
standard electrode potential of the reaction and the concentration of ions in the solution.  
An inert electrode, for example, a platinum electrode encased in glass and attached to a 
platinum rod, immersed in a redox solution, like ferri-ferrocyanide (containing Fe
2+
 and 
Fe
3+
 ions), will eventually form an equilibrium by the direct exchange of electrons 
between the solution and the electrode phases.  A standard electrode potential will be 
reached at equilibrium, after which point a change in ion concentration will alter the 
electrode potential.  This relationship is explained using the Nernst equation below: 
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Where Ee: Equilibrium potential, E
ө
: Standard electrode potential of the reaction, R: 
Universal gas constant (8.3145 J K
-1
 mol
-1
), T: Temperature, n: Number of electrons 
transferred in the redox half-equation, F: Faraday constant (96 485 C mol
-1
), [O]: 
Concentration of the oxidised ion (Fe
2+
) and [R]: Concentration of the reduced ion (Fe
3+
). 
 
There are several factors capable of affecting the electrochemical dynamics of an 
electrode cell.  The electrode potential, mass transport, reactivity of the chemical species, 
the electrode surface topography and the properties at the electrode/solution interface can 
all exert changes onto the rate of charge transfer 
 
2.2.2. Faradaic and Non-Faradaic Processes 
At the electrode/electrolyte interface, two types of process can occur to initiate a change 
that is measurable through the electrode.   
 
As previously described, faradaic processes, which follow Faraday‘s law (the chemical 
reaction caused by the flow of current is proportional to the electricity that has passed 
through the system), explain the transfer of electrical charges across the 
electrode/electrolyte interface, causing oxidation or reduction of chemical species. 
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Non-faradaic processes describe when a range of potential changes are evident where no 
actual charge transfer reactions occur.  They may not occur due to being either 
thermodynamically or kinetically unfavourable.  Instead, a number of processes such as 
adsorption or desorption may occur at the electrode surface, altering the structure of the 
electrode/electrolyte interface and ultimately affecting the surface potential and/or 
solution composition. 
2.2.3. Mass Transport 
There are four factors which can determine the rate of the reaction and current flow 
within an electrochemical cell.  These are 1) Mass transport, 2) Charge transfer at the 
electrode/electrolyte interface, 3) Chemical reactions occurring before or after the 
transfer of charge and 4) adsorption and desorption at the electrode surface. 
 
Within an electrochemical cell, once a steady state current has been established, only the 
rate limiting factor or step will affect the current rate.  The way in which mass transport 
influences charge transfer at the electrode/electrolyte interface is discussed in detail 
below. 
 
The term mass transport describes the movement of electroactive chemical species, as 
reactants of a chemical reaction, towards the electrode surface and the products of the 
chemical reaction away from the electrode surface.  If the rate of mass transport is slower 
than the rate at which the chemical reaction and charge transfer occurs, i.e. the reactants 
are being supplied to the electrode surface slower than they are being used up, and the 
products are being removed from the surface slower than they are being made, then mass 
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transport is the rate limiting factor.  Three modes of mass transport exist namely, 
diffusion, migration and convection. 
 
2.2.4. Diffusion 
In the presence of a concentration gradient; ions, molecules or particles will move from a 
high to low concentration through diffusion, holding to the laws of entropy, effectively 
depleting the concentration difference (Figure 2. 3).   
 
 
Figure 2. 3: A graph describing the diffusion of ions down their concentration gradient. 
 
 
 
Ficks‘ first law of diffusion states that the extent of the concentration gradient will 
directly affect the diffusional flux of the reactant (O).  Flux can be described as the 
number of moles passing through a unit area within a unit time.  Ficks‘ first law is 
illustrated in the equation below: 
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Flux = Diffusion Coefficient x Concentration gradient 
 
Or, in mathematical form: 
 
j = 
-
DO ∂[O] 
        ∂χ 
 
where j denotes the diffusional flux and DO is the diffusion coefficient relating to O. 
 
This process of diffusion down the concentration gradient will occur continuously 
between the electrode surface and the bulk solution as reactant O is converted to product 
R.  The reaction O → R creates a diffusion layer at the interfacial region where [O] will 
be lower than that in the bulk solution, as it is consumed through the electrochemical 
reaction.  In contrast, [R] will be higher at the electrode surface than in the bulk solution 
as it is being generated through the redox chemistry occurring.  As a diffusion gradient 
develops between Osolution → Oelectrode and Relectrode → Rsolution, if the rate of diffusion for 
either is slower than the rate of reaction at the electrode, diffusion becomes the rate 
limiting step. 
 
An ions diffusion coefficient can be directly related to its molar conductivity via the 
Nernst equation: 
 
Di = Λi  KBT 
             z
2
e
2 
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where Di is the diffusion coefficient, Λi is the molar conductivity, KB denotes the 
Boltzmann Constant, T represents the absolute temperature, z is the ionic charge of the 
ion and e is the electron charge on the species. 
 
The concentration of a chemical species within a fixed region (x to x + dx) close to the 
electrode, over a time period can be determined as described by Ficks‘ second law of 
diffusion: 
 
∂[O]  =  DO  ∂
2
[O] 
∂t                  ∂x2 
 
2.2.5. Migration   
All charged species contribute to the transfer of current, and in the bulk solution, where 
there is little concentration gradient, the current generally travels via migration.  
Additionally, an electrical circuit is completed through the solution via ions at the 
electrode/solution interface as an external circuit.  Due to electrostatic forces acting on 
ions both in the bulk solution and at the electrode surface, ions are able to migrate from 
one electrode to another, thereby being a part of the electrochemical reactions taking 
place at the electrode surface. 
 
The migration of an ion over a measurable distance in a certain time (i.e. the migratory 
flux (jm)) is proportional to the concentration of the reactant ion [O], the electric field and 
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the mobility of the ion (u).  The ionic mobility may be affected by ionic charge and size 
and the viscosity of the solution. 
 
jm  
-
u [O] ∂Ø 
                   ∂x 
 
Effects from migration on the rate of reaction can be minimised through the presence of a 
background or buffer electrolyte at a concentration of at least a hundred times that of the 
electroactive species.   
 
2.2.6. Convection 
Convection is the term used to describe a physical or mechanical drive acting upon 
particles within a solution.  Two forms of convection exist; natural convection and forced 
convection. 
 
Natural convection originates from the presence of thermal gradients and regions of 
inconsistent density within the solution.  Thermal gradients may be formed through 
energy being consumed or liberated during the development of an electrochemical 
reaction within the solution or at the electrode/solution interfacial region.  The depletion 
of reactant O and the production of the product R at the electrode induces the differences 
in density that ultimately lead to convection events taking place.  
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It is a challenge to estimate the effects of natural convection on the processes being 
measured at an electrode surface.  The effects of convection on an electrode of a 
millimetre or larger size conventionally take hold after 10-20 seconds or longer. 
 
Forced convection is a function caused by external forces, such as, for example, gas 
permeating through the solution and pumping or stirring of the solution.  Forced 
convection can purposefully be established in an electrochemical cell so as to maintain a 
homogeneous hydrodynamic behaviour and induce reproducibility over a range of 
experiments and so negate the unpredictable effects from natural convection. 
 
Changes in concentration due to convection within a solution can be solved 
mathematically by: 
 
∂[O] = -Vx  ∂[O] 
∂t               ∂x 
 
2.2.7. The Electrical Double-Layer Theory 
The nature of the electrode-solution (solid-liquid) interface is highly sophisticated and 
attempts have been made throughout recent history to establish this nature though the 
hypothesis of various models representing the interfacial region and the electrochemical 
phenomena occurring there.  Each model describes the complex interfacial region that 
exists when placing a charged surface into an ionic solution. 
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The Helmholtz model – 1853 
The electrode surface displays a particular charge density, dependant on either the excess 
or deficiency of electrons.  The interfacial region, according to the laws of entropy, will 
strive to maintain electrical neutrality and therefore charges in the bulk solution will act 
to counter the charge present on the electrode surface.  This is achieved through the 
electrostatic rearrangement of ions in the interfacial region and alteration of molecular 
dipoles.  This generates a potential difference across the interfacial region, resulting in 
the formation of an electric field gradient, attracting or repelling ions – and this in turn 
creates an excess of positive or negative ions. 
 
A schematic of the Helmholtz model, proposed in 1853, is displayed below (Figure 2. 4) 
along with a plot of the potential drop across the interfacial region. 
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Figure 2. 4: Schematic illustration of the Helmholtz model for the electrical double-layer (adapted 
from Fisher, 1998 pg 52) 
 
As can be seen in Figure 2. 4, an ion attracted to the charged electrode surface may 
approach up to the distance equal to that of its salvation molecule, a monolayer of 
salvation is therefore present, separating the ion from the electrode surface.  The Outer 
Helmholtz Plane (OHP) illustrates the point at which ions balancing excess charges at the 
electrode surface exist.  A linear drop in potential difference then occurs between the 
electrode surface and the OHP boundaries.  Hence, the electrical double-layer is 
comprised of a region at the electrode/solution interface that separates two layers of 
charge. 
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The Gouy and Chapman Model 
Gouy and Chapman independently evolved the Helmholtz model, establishing that the 
build-up of excess charge density is not bound to the OHP alone and, owing to Brownian 
motion; many ions are dispersed back towards the bulk solution.  This theory leads to the 
hypothesis that a three-dimensional diffuse layer of charge density exists close to the 
electrode surface.  The thickness of the diffuse layer is dependant upon the ionic 
concentration of the solution.  For example, the thickness will be under approximately 
100Å providing that ionic concentrations are above 10
-2
 M.  The charge density within 
this layer in minimised in correlation with distance away from the electrode surface, 
meaning the potential drop exists beyond the OHP. 
 
A schematic representation of the Gouy and Chapman electrical double-layer model is 
shown below (Figure 2. 5), along with the accompanying potential drop. 
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Figure 2. 5: A representative illustration of the Gouy-Chapman double-layer model, consisting of a 
diffuse layer of charges dispersed via Brownian motion (adapted from Fisher, 1998 pg 53) 
 
 
The Stern Model – 1924 
It was later accepted that both earlier models had proposed valid hypotheses regarding 
the electrical double layer and whilst accepting the Gouy and Chapman idea that 
Brownian motion acts upon excess charged particles and forms a diffuse layer, the 
presence of a minimum distance of approach of the ions was also accepted, termed the 
OHP.  This resulted in the model below (Figure 2. 6) which includes a sharp potential 
drop between the electrode and the OHP, followed by a more gradual potential drop into 
the diffuse layer further out into the bulk solution. 
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Figure 2. 6: Schematic of the Stern modification of the double-layer model, with a diffuse layer and a 
minimum distance of approach for solvated ions called the OHP.  A plot of the potential drop with 
distance away from the electrode surface is also illustrated (adapted from Fisher, 1998 pg54) 
 
 
The Grahame Model – 1947 
More than two decades after Sterns model, Grahame put forward the idea of an Inner 
Helmholtz Plane (IHP).  The IHP is formed due to the presence of ionic or uncharged and 
non-solvated species at the electrode surface, whilst solvated species can only approach 
the electrode surface to the distance of their salvation particle shells.  These species in 
question may not have a salvation shell and therefore the ion is ‗specifically adsorbed‘ in 
direct contact with the electrode surface.  This occurrence is uniquely in contrast to the 
rest of the interfacial region in that the specific adsorption of these ions in question is 
independent of charge, and positive ions are able to adsorb to the cathodic electrode 
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surface.  The IHP therefore represents this new, closer plane of minimum approach.  As a 
result of this specific adsorption phenomenon, a lower charge density is necessary in the 
double-layer to compensate for the electrode charge and form electrical neutrality.  The 
Grahame model is represented below (Figure 2. 7).  This most recent model of the 
electrical double-layer has been illustrated differently to the previous models.  It has been 
shown in such a way as to display the detailed structures involved and provide a clear 
view of what is happening at this level. 
 
 
Figure 2. 7: Schematic of the Grahame model of the electrical double-layer widely accepted in the 
present day.  Solvated ions approach to a minimum of the OHP and non-solvated ions may approach 
up to a minimum distance of the IHP as ‘specifically adsorbed’ ions.  A plot of the potential drop in 
correlation with distance away from the electrode surface is shown (adapted from Fisher, 1998, pg54 
and Bard and Faulkner, 2001, pg13). 
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In light of the double-layer structure, it can be predicted how the specific double-layer 
arrangement will affect the rate of the electrochemical reaction of the analyte being 
interrogated.  If the analyte is an electroactive, solvated species, then it may only 
approach the electrode surface up to the OHP, where it will experience a different 
potential, equal to the potential drop across the diffuse layer, compared to what it would 
experience in bulk solution. 
 
Although the double-layers effects can be neglected in some cases, it is general practice 
to consider the double-layer in most analytical experiments, particularly when the analyte 
concentration is low. 
 
2.2.8. Voltammetry 
Voltammetry provides a method of analysing reactions within an electrochemical cell 
with great detail.  The basic principle consists of the measurement of electrode currents in 
relation to a varying, applied, polarizing potential.  The current can then be measured in 
relation to either the applied potential or over a particular time period. 
 
A standard two-electrode system uses a working electrode (WE), at which the reaction 
occurs, and a reference electrode (RE) against which to reference the change in potential 
of the WE.  This allows the current to potential relationship to be interrogated.  
 
Testing that utilises larger electrodes requires the use of a three-electrode system which 
includes an additional counter or auxiliary electrode (AE) exclusively to which the 
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current flows directly from the WE.  The AE must be at least ten times larger than the 
WE, preventing it from acting as a rate limiting factor of the electrochemical reaction at 
the WE.  When larger currents are applied, through larger electrodes, the voltage drop in 
solution is significant as the current flow is subject to change.  In addition, reference 
electrode potential can be altered slightly from their fixed potential when presented with 
the passage of large currents.  It is therefore common practice for the latter types of 
analysis to include the three-electrode system.   
 
Utilising the three-electrode system additionally means that the current does not pass 
through the reference electrode; instead the WE potential can be electronically 
maintained relative to the RE with a potentiostat.  A potentiostat maintains the potential 
across the electrodes independently of the current flowing through the circuit.  Most 
potentiostats are linked to a computer, allowing simple storage, plotting and manipulation 
of the data procured. 
 
There are two commonly exploited fields of voltammetry, linear sweep and cyclic 
voltammetry.  Consider that in each case, a potentiostat controlled three-electrode system 
is in place, and the analyte ‗O‘ is present in the electrolyte media.  The electrochemical 
process that occurs at the WE, coinciding with the application of a potential is a 
one-electron redox reaction forming the product ‗R‘: 
 
                reduction 
O(aq) + e
- 
(m) ↔ R(aq) 
                  Oxidation 
 
  
T.R.J. Holford          Cranfield University 
2.2.9. Linear Voltammetry 
Initially used as an analytical technique that is simple and rapid to obtain useful data 
regarding the electroactive species / reaction under investigation.  There is no mechanical 
convection applied to the system, which remains stationary throughout the experiment.  
The applied potential is elevated from a low to high potential called a potential sweep, 
during which the current can be continuously monitored.  The rate of each potential 
sweep can range from a minimum of a few millivolts per second up to a maximum of 
hundreds of volts per second.  A plot of the resulting current to potential relationship is 
then produced and termed as a voltammogram. 
 
Figure 2. 8 represents a single linear sweep with increased potential over time from 
–
E1 to 
+
E2, through E0. 
 
Figure 2. 8: A plot of a single linear sweep representing a ramped potential against time (t) 
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At potential 
-
E1, O cannot be reduced until it reaches 
+
E2, where electron-transfer then 
rapidly occurs.  Figure 2. 9 below displays an ideal example of the current (i) response in 
relation to the change in applied potential for a): an irreversible reaction and b): a 
reversible reaction. 
 
 
Figure 2. 9: a) The relationship between potential and current for an irreversible redox reaction.  b) 
The relationship between potential and current for a reversible redox reaction.  In both cases the 
potential is ramped from E1 to E2.  The current peaks (ip) and potential peaks (Ep) are shown. 
 
 
Figure 2. 9 a): shows an irreversible electron transfer.  As the applied potentials become 
more reducing, O is induced to form R through the addition of an electron, therefore 
initiating the flow of current exponentially increasing proportionally to the potential.  
Once higher potentials are reached, a peak current (ip) is observed whereby the 
concentration of R ([R]) at the electrode surface is at a maximum, and the concentration 
of O ([O]) is negligible.  At ip, the current flow can only be maintained from O being 
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transported from the bulk solution to the electrode surface.  A drop in current is then 
subsequently observed due to the thickness of the region of depleted [O] surrounding the 
electrode surface increases, meaning fresh O must travel further from the bulk solution to 
the electrode surface and ultimately be reduced to R.  Therefore the drop in current, 
post-ip, provides important information regarding the rate of mass transport of the 
particular species, whereas the rate in current change preceding ip represents the specific 
electrode kinetics. 
 
Figure 2. 9 b) shows the current changes observed during a reversible reaction.  The most 
significant difference being observed is that current increases are present once a reduction 
becomes thermodynamically viable.  An important contrast between reversible and 
irreversible redox reactions is that the peak current observed for the former are unaffected 
by the potential sweep rate.  Irreversible redox reactions display an ip sooner and at 
higher potential sweep rates. 
 
Another stark determinant, contrasting the two types of reaction is that the ip for the 
reversible redox is larger, owing to the differing electrode kinetics in both types of 
system.  In either reaction type, the concentration of O directly affects the ip as the higher 
[O] means that a higher concentration gradient is established between the electrode 
surface and the bulk solution, in turn providing a more rapid rate of diffusion of O to the 
electrode surface, giving a large ip.  The same is true with increasing scan rate, which 
effectively allows a smaller time frame for the electron transfer reaction to occur and O to 
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deplete per cycle, consequently decreasing the diffuse layer thickness and a steeper 
concentration gradient as shown in Figure 2. 10 below. 
 
 
Figure 2. 10: Plot showing the relationship between current and potential over a range of increasing 
voltage scan rates. 
 
2.2.10. Cyclic Voltammetry 
Cyclic voltammetry extends from linear-sweep voltammetry in that the potential ramp 
can be reversed until it once again reaches the original starting potential (Figure 2. 11).  
This cycle can subsequently be repeated ‗n‘ times.   
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Figure 2. 11: A plot of a linear sweep representing a ramped potential against time (t), and a 
following reverse, oxidative potential. 
 
This technique can allow a more in-depth interrogation of the electrochemical system.  A 
typical and ideal cyclic voltammogram is plotted below in Figure 2. 12. 
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Figure 2. 12: A plot showing an idealised cyclic voltammogram (adapted from Higson, 2003) 
 
 
Concerning reversible redox reactions, the Nernst equation dictates that the forward and 
reverse current peaks should be separated by 59/n mV (n = number of electrons per 
molecule involved in the electron transfer). 
 
In order to elucidate upon the shape of the plot in Figure 2. 12, a simple one electron 
transfer reaction involving the ferri-ferrocyanide redox couple, as used as the electrolyte 
media in the impedance interrogations in this project. 
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[Fe
(III)
(CN)6]
3-
 + e
-
 ↔ [Fe(II)(CN)6]
4-
 
 
To set the scene, the potential is ramped from +0.8 to -0.2 V versus a silver / silver 
chloride (Ag/AgCl) RE.  The constituent steps of the cyclic voltammogram are described 
and explained below in a similar way to the linear voltammogram. 
 
A – As with linear-sweep voltammetry, potentials +0.7 to +0.4 V are not sufficient to 
induce an electron transfer, hence no current flow as visible. 
 
B – At approximately +0.4 V, electron transfer is initiated, producing a sharp rise in 
current. 
 
C – As the rate of electron transfer increases so does the rate at which the current rises. 
 
D – As [Fe(CN)6]
3-
 is being reduced at the electrode surface, its concentration also 
decreases at the electrode surface until it reaches near zero and the cathodic current 
comes to a peak (ip). 
 
E – The diffuse region of low [Fe(CN)6]
3-
 then extends further into the solution, meaning 
fresh reactant must travel further from the bulk solution to reach the electrode surface. 
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F – The rate of diffusion of [FeCN)6]
3- 
from the bulk solution now becomes the rate 
limiting factor and depends purely on the concentration of the reactant in bulk solution.  
A new equilibrium is reached until the potential sweep is reversed at F. 
 
G / H – Reduction continues and the current decreases until the same potential at which ip 
was previously observed is reached, and the current briefly passes zero. 
 
I / J – The reverse, oxidation of [Fe(CN)6]
4-
 now begins, resulting in an oxidative current, 
rising until the surface concentration of [Fe(CN)6]
4-
 reaches near zero, where a second, 
oxidative ip is reached at J. 
 
K – The potential is then moved past +0.4 V and electron transfer cannot occur, resulting 
in the decrease in current back to zero. 
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Adsorptive reactions and voltammetry 
Voltammetry can also be utilised as a fabricative method, as well as an analytical 
technique.  Some electrochemical reactions such as, for example, the oxidation of aniline 
and subsequent polymerisation to a carbon surface (Figure 2. 13), results in an adsorptive 
effect to the electrode surface. 
 
 
Figure 2. 13: A typical voltammogram for adsorptive voltammetry techniques 
 
Figure 2. 13  shows a voltammogram produced during the electropolymerisation of 
aniline to a screen-printed carbon electrode using up to 20 voltametric cycles.  The 
anodic and cathodic peaks observed in Figure 2. 12  are not replicated in adsorptive 
reactions (Figure 2. 13) in addition to an increase in peak height from one cycle to the 
next.  The increased peak heights are caused by an increase in the thickness of the 
polyaniline layer on the electrode surface.  This thicker layer means that there is a larger 
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surface area across which a larger current is able to travel.  The potentials at which peaks 
are observed in Figure 2. 13 are the potentials at which aniline is reduced and oxidised.  
These peaks are always specific to the nature of the chemicals present in the solution in 
contact with the electrode. 
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2.3. AC Impedance and Electrochemical Impedance 
Spectroscopy 
2.3.1. Impedance Definition 
The impedance (Z) of a circuit is the measure of force against an alternating current 
through a given electrical circuit.  When a circuit or electrochemical system is 
interrogated by impedance a voltage is applied, in a cyclic, sinusoidal fashion, at a 
varying range of frequencies (measured in Hz).  This forms an alternating current (ac).  
The current (i) is dependant on the frequency (ω) and will be out of ‗phase‘ by a given 
time factor (θ). 
 
Impedance is split in to a real (Z‘) resistive component, and an imaginary (Z‘‘) capacitive 
component.  Resistance is described as the opposition of a circuit or system to the 
passage of current, whereas capacitance is the ability of the electrode-solution interface to 
hold or store charge, as described in more detail in section 2.2.7, which explains the 
electrical double-layer theory. 
 
The applied oscillating sinusoidal potential in an impedimetric system can be calculated 
by: 
 
 
where E: Instantaneous potential value, ΔE: Maximum amplitude, ω: Angular frequency 
equal to 2πf (f is measured in Hz). 
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The above equation can be represented on a polar diagram as show below (Figure 2. 14), 
whereby E: Rotating vector: 
 
Figure 2. 14: A schematic diagram of the sinusoidal potential in an impedance interrogated system in 
a complex plane. 
 
 
The current resulting from the applied potential will be either lagging or leading and 
therefore have different amplitude as determined by: 
 
 
The current (i) and the potential (E) can then be related through ohms law: 
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Ohms law can again be represented in the complex plane.  (Figure 2. 15) shows the 
relationship between the current and the applied potential, separated by a phase angle (φ) 
which is in this case 0. 
 
Figure 2. 15: The complex plane showing the relationship between the current and potential of a 
system, which can be interpreted as the resistive component of impedance. 
 
 
The relationship between current and applied potential are different when considering the 
capacitive component of impedance.  This relationship is described in the equation 
below: 
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whereby C: Capacitance as calculated by the stored charge, divided by the applied 
potential.   
 
If 1 / ωC is then substituted by the capacitance reactance (Xc) then: 
 
 
 
This current, with the phase angle π / 2, leads the voltage.  If the sinusoidal response of a 
system is then taken in to account, the equation becomes: 
 
 
 
Another way to represent E when in a series circuit, is the sum of every voltage drop 
across an impedimetric system, as shown below (Z: Impedance): 
 
 
 
From the above equation, the phase angle is then determined as: 
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The relationship between the Z‘ and the Z‘‘ components are illustrated in (Figure 2. 16) 
below: 
 
Figure 2. 16: Diagram showing how Z’ and Z’’ components of impedance are related. 
 
The impedance of a parallel circuit can be calculated as the reciprocal of the sum of 
reciprocal impedance (1 / Z) of each parallel circuit component.  1 / Z can also be defined 
as admittance (Y). 
 
2.3.2. Measuring Impedance 
Large frequency ranges are often used for impedimetric interrogation of systems for 
analytical and diagnostic applications.  For the impedance interrogation of the 
immunosensors for NGF and psoriasin developed in this EngD, a frequency range of 1 to 
10,000 Hz is used.  Another factor to be considered during impedance investigation is 
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that both working and auxiliary electrodes must be symmetrical in order to give 
consistent current distribution.  Additionally, the size of the auxiliary electrode should be 
larger than the working electrode and be as low resistance as possible so as it is not 
considered a limiting factor in the flow of current. 
 
Impedance can be further represented using Randles Circuit (Figure 2. 17) where RE: The 
electrolyte resistance between the working electrode and the reference electrode, Cdl: 
Double layer capacitance, Rct: Charge transfer resistance, Zw: Warburg impedance 
which reflects the effect of mass transport of the electroactive species on the system and 
Zf: A combination of Rct and Zw, forming the Faradaic impedance: 
 
 
Figure 2. 17: Randles circuit, representing impedance in a circuit diagram format.  
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The faradaic impedance reflects the charge transfer across the electrode-solution 
interface. 
 
When diffusion is the limiting factor, Zw dominates, whereas in systems where charge 
transfer is the limiting step, Rct is the dominant factor. 
 
Z‘ and Z‘‘ components of impedance can be plotted against each other on a Nyquist plot 
(Figure 2. 18). 
 
Figure 2. 18: A typical Nyquist plot of the relationship between Z’ and Z’’ impedance components 
observed over a range of frequencies. 
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At higher frequencies, diffusion limited processes dictate that electrolysis does not occur.  
At lower frequencies, charge transfer dominates and the faradaic impedance shows a 
semicircular trend and above (Figure 2. 18). 
 
2.3.3. Applications and Prospectives 
The use of AC impedance for diagnostic and analytical applications holds benefits over 
Amperometric and Potentiometric methods.  Firstly, impedance measurements detect 
changes to the opposition of a flow of current, and therefore do not affect electrode 
surface integrity.  Additionally, impedance analytical techniques do not require the use of 
any additional labels for analysis, thereby minimising costs and making impedance 
studies simple and easier to interpret.  Further discussion on the use of impedance 
interrogations for analytical and diagnostic purposes is presented in section 2.6.3 of this 
chapter. 
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2.4. Antibodies and Immobilisation Techniques 
2.4.1. Antibody Structure and Function 
Antibodies are binding structures that are targeted specifically towards a particular 
antigen or analyte.  They are developed as part of the biological immune system in 
response to the presence of foreign antigens in the body. 
 
Figure 2. 19 illustrates the structure of a typical antibody molecule in the 
immunoglobulin G (IgG) antibody subclass. 
 
 
Figure 2. 19: Typical structure of an immunoglobulin G (IgG) antibody molecule (adapted from 
Edelman, 1973). 
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While different subclasses of antibody exist, the most commonly found being used in 
immunosensor and immunoassay technology is the IgG subclass.  A typical IgG is 
composed of four polypeptide chains in total, with two heavy and two light chains.  
Theses chains are linked through disulphide bridges.  Each antibody molecule can be 
divided into two sections, the upper, Y shaped section being the variable (Fv), antigen 
specific binding domain (containing the complementarity determining regions (CDRs)), 
and the lower section being the constant (Fc) region, which is further split into three parts 
– CH3, CH2 and CH1.  The disulphide bridge between CH1 and CH2 provides a flexible 
‗hinge‘ region, allowing the variable binding regions to make slight conformational 
changes upon antigen binding. 
 
Killard et al (1995) suggested that the presence of the hypervariable loops containing the 
CDRs present 10
8
 possible different antibody species with different specific target 
antigens. 
 
Antibodies can exist as polyclonal or monoclonal mixes.  Polyclonal antibodies are born 
from B Lymphocyte cells in response to an antigen.  Many slightly different antibodies 
are produced in this case in order to recognise a different epitope or amino-acid sequence 
on the target antigen and are not as useful as monoclonal antibodies for analytical and 
diagnostic applications, which require antibodies that target specific, know antigen 
epitopes. 
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To develop monoclonal antibodies, B Lymphocytes are fused to tumorigenic myeloma, 
allowing for longer in vitro storage and subsequent periodical harvesting of antibodies.   
Animals, generally mice, rats, goats and rabbits are injected with the target antigen, 
initiating the production of monoclonal antibodies (Killard et al., 1995).  The animal 
spleen can then be removed and the spleenocytes harvested and fused with myeloma cells 
using polyethylene glycol prior to storage.  Over time, the myeloma fused spleenocytes 
continue to produce the antibody, confirmed by immunoassay of a sample of the 
population. 
 
A comprehensive review of how antibodies are utilised in sensing technology is provided 
in this chapter, sections 2.5 – 2.10. 
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2.5. Principles of Immunosensors 
2.5.1. Definition of Immunosensors 
The International Union of Pure and Applied Chemistry (IUPAC) defines a biosensor as 
an: ‘…analytical device incorporating a biological material, a biologically derived 
material, or a biomimic, intimately associated with or integrated within a 
physicochemical transducer or transducing microsystem…’. Biosensors can incorporate 
many different biological sensing agents e.g. enzymes, cell receptors, nucleic acids, 
microorganisms and, in the case of immunosensors, antibodies or antibody fragments. 
Immunosensors employ the high antibody-antigen specificity to detect the presence of its 
analyte as shown schematically in Figure 2. 20. 
 
 
Figure 2. 20: A schematic illustration of the mechanism of a standard immunosensor. a) The 
antibody-antigen complex is formed, b) this then creates a change and thereby a signal. c) the signal 
is then transduced either electrochemically, thermometrically, optically or piezoelectrically and d) an 
electrical signal is formed which can be displayed on a digital readout. 
 
 
Immunosensors can be either direct or indirect, meaning that the detection mechanism 
operates either directly via the antibody-antigen interaction, or a further label, such as an 
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enzyme or fluorescent molecule, is used in order to detect whether a binding event has 
occurred. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
T.R.J. Holford          Cranfield University 
2.6. Electrochemical immunosensors 
Electrochemical sensors can be based on potentiometric, amperometric or impedimetric 
transduction principles. Inherent benefits of electrochemical sensors include selectivity, 
ease of use, low limits of detection and scope for miniaturisation. 
 
2.6.1. Potentiometric immunosensors 
Devices based on this principle use potential changes which are logarithmically 
proportional to a particular ion activity and reactants are neither destroyed nor consumed 
during the measurement process. Therefore no concentration gradients are formed and 
stir independent responses are observed, facilitating ease of use. A sensor design which 
transduces the potential across a membrane into a digitised signal - or field effect 
transistors (FETs) whose semi-conductive surface potential changes upon a change in 
analyte concentration (Luppa et al., 2001) are examples of potentiometric sensors.  
 
A FET consists of a ‗source‘ and a ‗drain‘ of electrical current flowing through a silicon 
channel, which can be controlled by a transverse electric field created by a charged 
metallic gate controlling the flow of charge. ISFETs (Ion-Sensitive Field-Effect 
Transistors) are similar to metal oxide silicon field effect transistors (MOSFET) whereby 
there is a substitution of the gate electrode with a chemically sensitive membrane, 
solution and a reference electrode (Figure 2. 21) (Yuqing et al., 2003). ISFETs are 
micrometer sized integrated circuits which have led towards the ‗lab on a chip‘ (LoC) 
concept being introduced into a patient, offering for instance, and continuous monitoring 
of blood glucose levels or a cardiac marker in patients at risk of heart attack (McKinley, 
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2008). ISFETs are utilised as potentiometric immunosensors due to their high sensitivity, 
potential for miniaturisation and multichannel testing as well as short sample times and 
low sample volumes (making them useful for PoC and forensic applications) (Yuqing et 
al., 2003).  
 
 
Figure 2. 21: a) A schematic representation of a MOSFET b) a schematic representation of an ISFET 
c) a schematic of the electrical circuit (this applies to both a and b) the letters represent the following: 
Vgs – Voltage for gate to source; G gate; D Drain; S Source; Vds Voltage for drain to source 
(reprinted from Biosensors (Bergveld, 1986), with permission from Elsevier). 
 
When antibodies are bound to the surface of the gate on an ISFET, the conductivity at the 
electrode surface can be higher than in the surrounding buffer. This change in local 
conductivity to the gate metal can be monitored utilising alternating current (ac) 
impedance and may be related to the concentration of the analyte in the sample (Bergveld 
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1986, Schasfoort et al., 1990). Other workers (Estrela et al., 2010) immobilised peptide 
aptamers on a MOSFET gate which recognise CDK2 (cyclin-dependant kinase 2) with an 
LLD of 5pg ml
-1
, a clinically significant concentration. Very low analyte concentrations 
can be reliably detected (Selvanayagam et al., 2002) and background noise significantly 
minimised. Other workers reported using two monolithically integrated sensors 
connected in a serial flow configuration, the streaming potential was measured with low 
noise due to a differential sensor arrangement (Koch et al., 1999). 
 
Other immunopotentiometric sensors include enzyme labelled antibody sensors (indirect) 
which utilise a shift in potential upon activation of the enzyme reaction as a measurement 
of the analyte (Ghindilis et al., 1992, Purvis et al., 2003), the principle advantage being 
that measurements can be taken in real-time. Sensitivity and reproducibility of these 
potentiometric sensors can be improved by modifying the layers supporting the sensor 
construct. For example (Purvis et al., 2003) electrodeposition of polypyrrole onto 
electrodes for sensing hepatitis B surface antigen, troponin 1, digoxin and tumor necrosis 
factor, could be improved by increasing the potential range to a more anodic (positive) 
range, thereby increasing the sensitivity and stability of the sensor. Other workers (Tang 
et al., 2005) reported development of a potentiometric sensor containing layer-by-layer 
assembled polymers to produce a stable and ordered platform on which to immobilise 
antibodies.  
 
Stable three dimensional sol-gels or chitosan membranes were found (Tang et al., 2006, 
Liang et al., 2008) to improve reaction efficiency and offer the possibility of creating 
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template polymer layers for immunosensorss with improved measurement of a wide 
range of analytes (Liang et al., 2008). Challenges to the use of these devices are lack of 
sensitivity to distinguish between concentrations within the same order of magnitude (i.e. 
within a small concentration range) and often a high occurrence of non-specific binding 
effects in comparison to their amperometric counterparts, due to their logarithmic signal 
response characteristics. 
 
2.6.2. Amperometric immunosensors 
Amperometric immunosensor designs measure changes in current in response to an 
electrochemical reaction at a set voltage and are generally favoured over potentiometric 
designs in research and sensor development. They consume a small percentage of 
analytes during measurement, requiring either the analyte to be redox active or use of a 
redox label and creates concentration gradients, so responses are stir-dependant;. 
 
Workers successfully increased the sensitivity of amperometric immunosensors, 
including using a layer-by-layer construction approach utilising gold nanoparticles 
(AuNPs) and methylene blue to form a uniform and stable base for a hCG sensor. 
Increasing the surface area onto which capture agents were immobilised increased 
binding events and sensitivity (Chai et al., 2008). A multi-enzyme immunosensor 
targeting prostate specific antigen (PSA) was fabricated with carbon nanotubes (CNTs), 
enhancing sensitivity by decreasing particle size and increasing the number of labels in 
the system (Jensen et al., 2009). Other workers used AuNPs to enhance the surface area 
and sensitivity of sensors (Chai et al., 2008, Zhuo et al., 2008, Liang et al., 2009, Kim et 
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al., 2009) and platinum nanoparticles have been used in an operational design for the 
detection of H2O2 electroreduction (Fu et al., 2009).  
 
Stabilisation of sensor constructs was achieved by using polylysine films into which 
anti-biotin molecules were immobilised (Cataldo et al., 2008). Cross-linking prevents 
conformational change and unfolding of the antibodies allowing markedly enhanced 
sensitivity when compared with similar constructs, longer storage times and higher 
resistance to extremes of pH and temperature.  
 
Usually amperometric sensors require a redox reagent to allow electron flow. However a 
miniaturised, reagentless immunosensor design for the cancer marker carcinoembryonic 
antigen (CEA) has been constructed (Zhuo et al., 2008), incorporating AuNPs and a 
ferrocenyl substituted 3,4,9,10-perylenetetracarboxylic dianhydride derivative to give a 
nanostructured material which forms a stable redox-active film. Another reagentless 
amperometric immunosensor incorporated AuNPs in a α-fetoprotein immunoassay 
displaying long term maintenance of bioactivity and heightened sensitivity (Liang et al., 
2009). 
 
An amperometric reversible immunosensor has been developed (Gooding et al., 2004) 
incorporating rabbit IgG antibodies in an electrodeposited polypyrrole layer on an 
electrode. Reversibility of the immunoreaction is attributed to a 200 millisecond pulse at 
each potential during measurement through a flow cell, which is too short to allow the 
stronger hydrogen bonds and hydrophobic forces to take effect in the binding event, but 
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long enough to allow for a specific binding event to occur and a measurement to be made 
(Gooding et al., 2004). However; if sensors can be produced at low cost, there is little 
need for reversibility, since sensitivity may dissipate upon each use (Piehler et al., 1997). 
The main advantage of reusable systems is the ability to continuously monitor analytes in 
real-time, allowing prompt counter-action to be taken. However Antibody-antigen 
interactions have high affinities (Kd‘s generally lie between 105 – 1011 M), making 
reversing this strong interaction without rendering the device unusable by removing or 
denaturing the biological recognition element challenging. 
 
2.6.3 Impedimetric immunosensors 
The use of impedance/capacitance to detect Antibody-antigen complex formation was 
first reported when upon formation of this complex on the surface of the electrode, the 
increase in dielectric layer thickness caused changes in capacitance proportional to the 
size and the concentration of antibodies (Bataillard et al., 1988). 
 
Pulsed potential waveforms were used to measure current transients during electrical 
relaxation of conducting polymer surfaces incorporating anti-HSA antibodies (Sadik and 
Wallace, 1993). Pulses were applied and current transients measured after 520 
milliseconds using a Dionex-PAD II. Another group utilised a repeating polarising 
waveform and by recording the current transient using computerised software, produced a 
labeless, reversible immunosensor for bovine serum albumin (BSA) with a range of 0-50 
mg l
-1 
(Grant et al., 2003). Further work (Grant et al., 2005) used AC impedance for 
continual perturbation of the polymer, as opposed to exciting the surface and recording 
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the relaxation profile for the current transient. The current with respect to the polarising 
potential was monitored with the capacitive (imaginary (Z‘‘)) and faradaic (real (Z‘)) 
components of impedance being identified, quantified and displayed as Nyquist plots. 
 
Impedance changes between electrode surfaces and a surrounding solution upon a 
binding event can be transduced into an electrical signal using a frequency response 
analyser. There are several theories as to how this binding event affects changes in real 
and imaginary components of the system, although it is difficult to identify the origin of 
these changes. One theory hypothesises that binding of larger antigens forms a resistive 
barrier, causing the impedance to increase whilst binding of smaller antigens can 
facilitate a charge transfer and lower impedance (Tully et al., 2008). Another theory is 
that when the antibody-antigen complex is formed, the binding events between the 
hyper-variable loop regions mean that conformational changes occur and potential 
changes are introduced into the system. Future work must establish the origin of this 
impedance change, whether from increases in surface density or conformational changes 
that modify charge transfer across the sensor interface. 
 
Some groups (Balkenhohl and Lisdat 2007, Vig et al., 2009, Escamilla-Gomez et al., 
2009) have reported determining charge transfer resistance (CTR) as opposed to the real 
or imaginary components of impedance. CTR is a direct measurement of the ability for 
charge transfer to occur between electrodes and surrounding electrolyte and is directly 
affected by the concentration of reaction products in the system, allowing their 
determination. Impedimetric immunosensors can be used as reagentless alternatives to 
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indirect sensors, for example electrochemical impedance spectroscopy (EIS) was used in 
an immunoassay for the detection of luteinising hormone (LH) entrapped within a 
conductive polypyrrole polymer matrix (Farace et al., 2002). Responses were observed in 
phase angle after exposure to LH, demonstrating that immunosensors can undertake 
reagentless transduction of specific signals related to the antibody-antigen complex 
formation. 
 
Recent examples include capacitative immunosensors for measurement of 
transglutaminase in human serum (Balkenhohl and Lisdat, 2007) which amplify the 
signal using secondary antibodies; direct sensors for Salmonella typhimurium in milk 
without sample pre-treatment (Pournaras et al., 2008); direct, labeless sensors for 
Escherichia coli in river and tap water with thiolated antibodies immobilised to a gold 
SPE (Escamilla-Gomez et al., 2009); another label-free sensor for the detection of the 
antibiotic enrofloxacin (Wu et al., 2009); a highly sensitive (LLD down to pg ml
-1
) 
labeless sensor for digoxin based on microarrays, sonochemically ablated into an 
insulating poly-1,2-diaminobenzene polymer into which conducting polymer (containing 
the specific antibody) is deposited (Barton et al., 2009); and labeless sensors that directly 
detect atrazine in wine, to limits significantly lower than the EU maximum residue level 
of 50 µg l
-1
  (Ramon-Azcon et al., 2007). 
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2.7. Optical immunosensors 
Optical immunosensors operate under the principle that the manner and extent to which 
the sensor responce to light is modified upon binding of a specific antigen. As with other 
immunosensors, optical sensor research has seen a trend towards development of label-
free, simple to construct and use, inexpensive and highly sensitive devices (González-
Martínez et al., 2007).  
 
An optical sensor uses light as a stimulus and is able to detect alterations in the intensity 
of light as it passes through or refracts from a sampling system in relation to Antibody-
antigen binding. Popular examples of optical immunosensors include surface plasmon 
resonance (SPR) based sensors, fibre-optic sensors (FOS) and various fluorescence based 
sensors. 
 
Several papers have reported the benefits of using nanoparticles in their immunosensor 
design to improve performance (Seydack, 2005). Nanoparticles have in general lowered 
detection limits, allowed for multiplexing and signal amplification due to increased 
surface areas and enhanced ability to control the system they provide, such as, for 
example through the use of magnetic nanoparticles, which can be electromagnetically 
manipulated, allowing higher levels of control. Measuring samples in a label-free manner 
means that the device can operate on a real-time basis; examples include an 
immunosensor based on Reflective Interferometric Fourier Transform Spectroscopy 
(RIFTS)  to detect BSA via a self-correcting double layer of porous silicon (Pacholski et 
al., 2006); the detection of antinuclear antibodies using an optical immunosensor 
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modified with colloidal gold (Lai et al., 2007); and the use of optical waveguide 
light-mode spectroscopy for environmental monitoring of trifluralin (a herbicide), a 
Fursarium mycotoxin zearalenone and vitellogenin, an egg yolk protein. (Szekacs et al., 
2008). 
 
2.7.1. Surface Plasmon Resonance Immunosensors 
Surface Plasmon resonance (SPR) harnesses refractive index changes caused by the 
formation of the Antibody-antigen complex on a metal surface being related to the 
concentration of the antigen in the sample being measured (González-Martínez et al., 
2007). A typical SPR system (Figure 2. 22) uses microfluidics to pass controlled amounts 
of analyte across the sensor surface to which the antibody is immobilised. Measurements 
are made by reflecting a beam of polarised light off of the back surface of the metal film, 
through a prism. When the beam of light passes through the glass prism and hits the 
noble metal surface, not all the light is reflected. Some of the energy from the light 
photons is absorbed into the metal, exciting surface plasmons (electron oscillations at an 
interface of two materials) on the other side of the surface. Binding events cause changes 
in refractive index close to the surface which affect the reflected light intensity, angle and 
wavelength, measured as resonance units (RU). 1 RU is generally equal to a 
concentration of 1 pg mm
-2
 of analyte (Varki, 1999). Passing antigen and then washing 
solutions over the sensor surface, allows the analyte concentration and association and 
dissociation constants of antibody-antigen complexes to be determined. 
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Figure 2. 22: Illustration of surface plasmon resonance (SPR) 
 
 
Recent developments utilise the high specificity and real-time measuring abilities that 
SPR offers. For example (Prieto-Simon et al., 2009) the theoretical lowest limit of 
detection for a analyte when considering the affinity of the antibody – anti- Okadaic acid 
(IC70 = 0.03 ug l
-1
), was achieved using a flow-based kinetic exclusion assay (KinExA), a 
fluorimetric method which provides rapid and continuous screening. The added precision 
and reliability this method brings in comparison to an indirect assay, is most likely 
accredited to the absence of the non-specific adsorption of avidin. Other work described 
successful operation of reusable and portable devices, for example, an ‗all-in-one‘ 
multi-microchannel sensor, designed to detect low molecular weight analytes (Kim et al., 
2007). The use of biotin-avidin interactions enhance the sensor signal, allowed 
miniaturisation and increased storage times. Additionally the ‗all-in-one‘ sensor is a 
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multichannel device and able to make many highly sensitive measurements (LLD ~ 8ppt) 
enough to produce a calibration curve every 4 minutes (Kim et al., 2007). Other 
examples that have utilised and enhanced the high sensitivity and adaptability of SPR 
include a sensor for the trace (1 ppt - 1 ppb) detection of 2,4-dinitrophenol (Aizawa et al., 
2007), the combination of Fourier Transform – Surface Plasmon Resonance (FT-SPR) in 
a sensor targeted to rabbit IgG (Boujday et al., 2009), a sensor for the labeless, 
multiplexed detection of antibiotics in milk (Rebe Raz et al., 2009), the detection of 
dengue virus in serum (Kumbhat et al., 2010) and low density lipoprotein (LDL) 
detection (Matharu et al., 2009). 
 
2.7.2. Fibre-Optic Immunosensors 
The use of fibre-optics for use in sensors started in the late 1970s (Lubbers et al., 1977, 
Lubbers and Opitz 1975, Peterson et al., 1980, Goldstein et al., 1980). Due to their 
reliability and small size they are easily integrated into other technologies. Chemical and 
immunochemical reagents can be immobilised at or close to the tip of an optical fibre 
with measurements being taken of absorbance and or fluorescence. In adsorbance 
fibre-optic sensors (FOS), binding of antigen leads to a colorimetric change (McKinley, 
2008). Fluorescence based FOS relyon the quenching or build-up of fluorescence 
(measured as fluorescence intensity) in a fluorescent molecule which can then be related 
to the amount of antigen present. Absorbance/fluorescence of the antigen can be either 
inherent or due to a suitable label. 
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Benefits inherent to FOS are adaptability to operating over long distances and the 
potential for less common forms of interrogation to be performed, such as evanescent 
wave spectroscopy. Additionally they are easy to manufacture, and are unaffected by 
electrostatic or electromagnetic interference. They have good stability in most sample 
matrices and the promise for targeting multiple analytes (Lubbers, 1995). 
 
Recent research has improved the sensitivity, reproducibility, simplicity of manufacture, 
operation and maintenance and many fibre-optic immunosensors have been developed for 
a variety of applications due to their small size and therefore simple integration into 
sensor devices. One example is an optical fibre covered with a photoactivatable 
polypyrrole-benzophenone polymer film upon which specific binding reagents are 
immobilized through ultra-violet  light stimulation of the polymer (Konry et al., 2005). 
The immunosensor targets antibodies to viral antigens (which are covalently bound to the 
conductive polymer surface) in order to detect the presence of hepatitis C virus (HCV) 
and could replace the present immunoassay for HCV which can give false negatives in 
patients under dialysis (Konry et al., 2005). 
 
A fibre-optic based fluorescence immunosensor which targets auto-antibodies to ovarian 
and breast cancer associated antigens (Salama et al., 2007) was developed for early 
detection of cancer biomarkers in ovarian and breast serum and increase the chances of 
early and successful patient treatment. The sensor was a reliable and sensitive device with 
a limit of detection for 27.B1 IgM (an antibody against the G-protein GIPC-1), of 30 pg 
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ml
-1
 (50 times lower than chemiluminescent ELISA, 500 times lower than colorimetric 
ELISA) with lowered detection time and smaller sample volumes. 
 
A portable, reusable immunosensor was developed (Long et al., 2009) with an optical 
fibre based sensor targeted towards microcystin-LR (MC-LR) in water samples, a source 
of contamination from cyanobacteria which can be responsible for conditions such as 
liver cancer. MC-LR-ovalbumin was covalently immobilized to the fibre-optic surface, to 
give a highly sensitive sensor, with a LLD of 0.03 µg l
-1
, resistant to non-specific 
interactions and response times <8 minutes (Long et al., 2009).  
 
2.7.3. Fluorescence based immunosensors 
Fluorescence is a phenomenon by which certain molecules emit light energy of certain 
wavelengths. Fluorescence based immunosensors utilise fluorescent molecules which 
bind either directly to the target molecule or as an indirect label to measure, via 
spectrometry, the fluorescence intensity and therefore the concentration of the analyte to 
which the molecule is bound. 
 
Recent advances include capillary waveguide fluoroimmunosensors which utilised 
polydimethylsiloxane coated glass capillaries to improve reproducibility, sensitivity and 
rapidity of measurement of detection of rabbit IgG (Niotis et al., 2009). Black drawing 
ink was used to block bulk fluorescence in capillary waveguide fluoroimmunosensor  to 
improve detection of the analyte in these devices (Mastichiadis et al., 2009). Improving 
the immobilisation of Brucella-killed organisms to the surface of a chemiluminescent 
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sensor with silane-benzophenone derivatives improved performance compared to other 
methods (Liebes et al., 2009). 
 
Fluorescence spectroscopy has also been used in unison with SPR (Wang et al., 2009) 
with excitation of surface plasmons inducing an increase in the fluorescence signal and 
an enhanced intensity of electromagnetic field, allowing quantification of down to 0.6 pg 
ml
-1
 aflatoxin M1 in milk, much lower than the maximum residue level quoted by EC 
legislation. 
 
Fluorescent nanocrystals (quantum dots (QD‘s)) are inorganic fluorophores (Zhou et al., 
2010) usually containing a 2-10 nm diameter crystalline core of CdSe or CdTe. They are 
generally fabricated in >200ºC temperatures using toxic and costly organic solvents and 
then bound to a biological linker. A more efficient and less toxic ‗single-pot‘ synthesis 
has been developed using dually functional fusion proteins as nanocrystal mineralisers to 
make ZnSe immuno-quantum dots linked to an IgG antibody (Zhou et al., 2010). QDs are 
highly sensitive and specific when paired with a biological ligand and often aid in the 
reducing detection time (Wang et al., 2009). They have photophysical properties 
including broad absorption and narrow emission spectra, long fluorescence lifetimes and 
size-tuneable emissions. Improvements in QD design include minimisation, stability 
enhancement and adressing long and short-term toxicity issues (Sukhanova and Nabiev, 
2008) - the optimisation of QD ‗anatomy‘. Using multiple QDs could allow development 
of multi-analyte detection systems to allow higher throughput of samples at lower cost. 
 
  
T.R.J. Holford          Cranfield University 
2.8. Piezoelectric immunosensors 
Piezoelectric devices convert a physical or mechanical change into electrical energy and 
visa versa. The commonest piezoelectric sensor is the quartz crystal microbalance 
(QCM), which exploits the change in the resonance of quartz crystals upon changes in 
their mass, allowing binding of antigen to antibody (when one of these is immobilised on 
the crystal surface) to be measured electrically. Recently multiple QCMs were immersed 
in a flow channel and connected by two line-antenna wires which are used to both 
generate and detect vibrations (Ogi et al., 2010) to give a multichannel, wireless and 
electrode-less QCM immunosensor. Various IgGs were used to confirm the specific 
operation of the immunosensor. Another group (Ghosh et al., 2010) utilised the 
anharmonic interactions of polystyrene microbeads on a quartz crystal platform. 
Anharmonics are based on how different interactions on the surface of the sensor affect 
the harmonic resonance frequencies in different manners, thereby allowing identification 
of an analyte. 
 
Microcantilever based devices were developed utilising rotating resonance 
microcantilevers which measured the frequency-shift of the microcantilever motion with 
respect to the specific-adsorbed mass, to give sensors capable of measuring α-fetoprotein 
to less than 2 ng ml
-1
 for the label-free, PoC early detection of heptocellular carcinoma 
(Liu et al., 2009). Also a microring resonator immunosensor has been recently described 
which can detect multiple analytes (PSA, α-fetoprotein, CEA, tumour necrosis factor-α 
and interleukin-8) concurrently, without loss of sensitivity or measurement precision 
when compared to single-parameter analysis (Washburn et al., 2010). 
  
T.R.J. Holford          Cranfield University 
2.9. Magnetic immunosensors 
Incorporating magnetic beads into immunosensors allows a higher level of control. 
Electromagnets can pull immuno-substituted beads towards a binding site and then 
weakly bound species can be removed by an oppositely located electromagnet. An 
optomagnetic immunosensor for detection of cardiac markers (Bruls et al., 2009) utilises 
antibody-bound super-paramagnetic nanoparticles and two separately operated 
electromagnets, on either side of a plastic casing (Figure 2. 23). One electromagnet pulls 
the substituted nanoparticles through the media to the optical sensor surface, then the 
upper electromagnet is switched on to remove loosely bound or unbound particles from 
the sensor surface. An optical determination of binding can be taken. There are no extra 
wash stages, giving a simple one-step measurement once the sample fluid has been 
added, allowing simplicity and rapid procurement of results necessary for PoC. 
 
 
Figure 2. 23: a: the microchamber is filled with analyte in solution and the antibodies are redispersed 
into the solution, some bind with the analyte. b: magnetic particles are attracted to the lower surface. 
c: The free and weakly bound immunosensors which are not bound to analyte are removed from the 
lower surface when the upper magnet is switched on (Bruls et al., 2009, reproduced by permission of 
The Royal Society of Chemistry). 
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Immunomolecular-magnetic beads have been incorporated into a technique which both 
separates and then tests for, particular analytes; for example, the separation of 
Staphylococcus aureas and G. Streptococcus to allow both detection and quantification 
(Xiao et al., 2007). Other workers developed a magnetic relaxation switching device that 
can detect different enantiomeric molecules, similar in structure but pharmacologically 
different (Tsourkas et al., 2004). The principle is that magnetic nanoparticles affect the 
magnetic resonance of the different enantiomers; this can be detected by the 
immunosensor as the nanoparticles compete for the active site of the antibody. 
 
The embodiment of magnetic beads produces stable devices that are inexpensive to 
fabricate, easy to operate and rapidly measure their specific analytes. The greatest 
challenge is constructing the device, although once fabricated operation is simple 
(Palecek and Fojta, 2007). 
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2.10. Thermal Immunosensors 
The preliminary pioneering work was carried out by Danielsson et al (1976) into the 
development of calorimetric or thermal based sensors.  These thermistor based biosensors 
can be used to detect heat or thermal absorption and or evolution that can originate from a 
substrate or enzyme reaction, or the attachment of a specific target and transduce this 
information into a readable signal (Ramanathan and Danielsson, 2001).  The thermal 
changes of a reaction or system are related to molar enthalpy of the reaction and the 
number of molecules produced in the reaction.  The heat change can therefore be used as 
a study in direct correlation with the reaction kinetics.  Additionally, enhancements to 
thermal sensor operation can be achieved through the use of organic solvents in which the 
thermal interrogation occurs.  Organic solvents tend to have a lower heat capacity than 
alternative aqueous solvents and therefore present a greater sensitivity to thermal 
evolution or absorption.  Thermal changes are then compared to a control thermistor on 
which no specific antigen or interaction occurs, thereby acting as a reference point. 
 
Most thermistor nodes are fabricated from a ceramic semiconductor with a high negative 
temperature resistance coefficient.  Any changes in resistance of current through the 
thermistor is then interpreted as a change in heat (Ramanathan and Danielsson, 2001) 
 
Thermal sensors are reported to have been used in recent years for a wide array of 
applications including the monitoring of enzyme activity, clinical monitoring, process 
and reaction studies and multiple analyte determination (Ramanathan and Danielsson, 
(2001).  One such thermally based immunosensor targeted toward the detection of 
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catalase enzyme activity using a fiber-optic inferometry has been developed (Choquette 
and Locascio-Brown, 1994) 
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2.11. Polymers in Sensing 
2.11.1. Introduction 
Polymers are versatile materials used in sensor technology not only for the 
immobilisation of chemical and biological components, but they can also provide 
valuable electrical and chemical characteristics to the sensor surface (Adhikari and 
Majumdar, 2004).  For example, once coated onto the sensor electrode surface, polymers 
can either insulate the electrode or provide improved electroconductivity. 
 
Structural properties of electrodes are shown to have been enhanced by the use of 
polymer deposition, in addition to the use of polymer as the sensing element itself, 
namely in pH sensors (Korostynska et al., 2007).   
 
A favourable technique with which to coat electrode surfaces with polymer is via 
electropolymerisation.  The electropolymerisation of aniline to a carbon electrode is 
discussed in more detail in chapter 3, section 3.4.1. 
 
Electropolymerisation is favourable to other chemical absorptive methods as it allows 
greater control over the process and layer thickness can be a more reproducible factor 
(Yuqing et al., 2004).  Polymer thickness must be consistent on an electrode surface to 
maximise reproducibility of the readout.  Since the thickness of the sensor construct 
dictates the distance across which current must travel in electrochemical investigations, 
the greater the reproducibility in the polymer thickness, the greater the reproducibility of 
results obtained.  
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Several methods exist whereby biomolecules can be immobilised either on or entrapped 
within the polymer, which can later be exposed or liberated using sonochemical ablation, 
as discussed in further detail in section 2.13. 
 
2.11.1. Conducting Polymers 
Conducting polymers (developed in the 1970s), possess electrical properties comparable 
to those observed with metals and semiconductors.  The existence of this conductive 
property of some polymers was established in 1977 when a significant increase in 
conductivity of iodine after being doped with an acetylene polymer, was observed.  
However, further studies revealed that non-cyclic polymers such as polyacetylene are 
unstable in air and a decade later, hetero-cyclic polymers, including polyaniline used for 
the nerve growth factor and psoriasin immunosensors developed in this research, were 
discovered.  Hetero-cyclic polymers are stable in air. 
 
In the present day, a vast choice of conducting polymers are selected for use in sensing 
applications with several different physical and chemical properties providing a flexible 
base on which to construct various sensor technologies.  Monomers can be mixed into 
aqueous solutions and polymerised under neutral pH conditions.  This means that these 
monomers are compatible with the entrapment of biological sensing agents without being 
detrimental to the biomolecule.  One such example of this type of polymer is polypyrrole, 
which has been extensively used and reported in the literature because of this property.  
Other polymers exist that need acidic conditions, for example polyaniline, to form a film 
  
T.R.J. Holford          Cranfield University 
on an electrode.  Until recently these were not useful for sensor technology as entrapment 
of the biological molecule without harm was difficult, however due to the development of 
several methods of immobilising biomolecules and sensing agents onto pre-polymerised 
films on the electrode meant that the use of these polymers was no longer a limitation. 
 
Saxena and Malhotra (2003) determined that it is the π-electron backbone of conducting 
polymers that enables them to accommodate the passage of electrons and gives them their 
conductive properties. 
 
2.11.2. Insulating Polymers 
Insulating polymers present several benefits over the use of conducting polymers for 
sensing technologies.  A main advantage is that unlike conductive polymers, insulating 
polymers, by their very nature, are not affected by factors other than the specific sensor 
target, thereby enhancing sensor selectivity.  Conducting polymers, for example, can 
often be influenced by the presence of ions in the electrolyte media, a phenomenon 
discussed in more detail in chapter 4, section 4.7 and chapter 6, section 6.4. 
 
Insulating polymers provide a challenge to electropolymerise onto an electrode surface, 
as they are insulating materials (Law and Higson, 2005) resulting in the deposition of a 
near perfect, thin film of polymer.  This however provides another benefit to sensor 
applications, as a thinner, more reproducible polymer film provides a base on which to 
immobilise sensing reagents through which the flow of current is rapid.  This acts to 
rapidly provide more reliable results than a sensor with a thicker polymer film. 
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Examples of commonly utilised insulating polymers for sensor development include 
phenol and phenylenediamine derivatives.  One example describes the use of 
poly-o-phenylenediamine electropolymerised onto a platinum electrode to immobilise 
glucose oxidase in an amperometric based sensor targeting glucose (Malitesta et al., 
1990).  Polyphenol is another insulating polymer that was electropolymerised onto a 
platinum electrode for the immobilisation of glucose oxidase along with an Os-polymer 
that were based on the detection of hydrogen peroxide (H2O2) (Pravda et al., 1995).  The 
use of insulating polymers for the development of microelectrodes is presented in section 
2.13. 
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2.12. Immunosensor Components and Their Benefits / 
Characteristics 
2.12.1. Carbon Nanotubes 
Carbon nanotubes (CNT's), first reported in 1991 (IIjima 1991) which can be 
single-walled (SWNT‘s) and multi-walled (MWNT‘s), offer promise for 
immunochemical devices. The benefits of using carbon nanotubes are that they display 
enhanced detection sensitivity compared to sensors incorporating other carbon platforms 
(possibly due to increased surface area, they have electrocatalytic effects, benefit from 
lower levels of fouling, are mechanically strong and flexible and have excellent electrical 
and thermal conductivity (Dumitrescu et al., 2009, Huang et al., 2010). CNTs can be 
incorporated into screen-printed electrodes (as well as almost any other format of 
electrode) allowing large scale, cost effective production of these sensors. For example, 
polysulphone screen-printed sensors containing CNTs could be integrated with 
microfluidics in a continuous flow format to measure Botrytis cinerea in apple tissues for 
food (Pumera et al., 2007) or environmental monitoring purposes (Fernandez-Baldo et 
al., 2009). A nanohybrid system of CNTs and AuNPs doped into chitosan films 
containing antigen were utilised in the development of an immunosensor for 
α-fetoprotein synergising the benefits of both nanostructures (Lin et al., 2009). 
Alternatively carbon nanohorns could be utilised within an immunosensor for quantifying 
microcystin-LR in the range 0.05 to 20 ng ml
-1
.  
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2.12.2. Nanoparticles 
The inherent benefit that the use of nanoparticles, in particularly gold nanoparticles 
(AuNPs), brings is their ability to significantly enhance sensitivity and lower detection 
limits of sensors, possibly due to the increased surface area onto which antibodies can be 
immobilised, or affecting the refraction of light in an SPR based sensor. Recent work 
includes an immunosensor based on organic semiconductors with nanogold-labelled 
antibodies (Li et al., 2008); a sensor with anti-CEA-modified magnetic nanoparticles to 
detect CEA down to 0.5 ng ml
-1
 (Chen and Tang, 2007); a sensor which utilises AuNPs 
for the detection of interleukin-6 (Liang and Mu, 2006); SPR and EIS based 
immunosensors using AuNPs for the detection of Salmonella spp. (Ko et al., 2009, Yang 
et al., 2009) and an electrochemical immunosensor for the detection of α-fetoprotein with 
improved sensitivity over previously developed immunosensors for clinical use (Liang et 
al., 2009). There is a natural limit of detection depending on the antibodies used simply 
because they each have their own cross-reactivities and non-specific binding, meaning 
eventually the difference cannot be established between specific and non-specific 
interactions (Seydack, 2005). 
 
Gold nanoshells have been synthesised consisting of a dielectric core surrounded by a 
metal shell, where the optical resonance is related to the relative size of their constituents 
and were utilised to detect analytes in whole blood (Figure 2. 24). Antibody conjugated 
nanoshells aggregate upon binding the analyte and the resonance spectra measured, 
giving a simple, purification free measurement system applicable to PoC usage (Hirsch et 
al., 2003). 
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Figure 2. 24: Representation of the aggregation immunotest for antibodies within whole blood 
samples using gold nanoparticles (reprinted from Biosensors and Bioelectronics (Seydack, 2005), with 
permission from Elsevier). 
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2.13. Microelectrodes 
Microelectrode arrays, formed by the sonochemical ablation of insulating polymer 
encapsulating a bio-recognition molecule (Figure 2. 25), offer many advantages over 
standard planar electrodes. Microelectrodes provide stir independence sensor responses 
and although each separate microelectrode environment is far smaller than that of a 
planar electrode as a whole, collectively in an array, they frequently permit lower limits 
of detection for an analyte (Barton et al., 2009).  
 
 
Figure 2. 25: A microelectrode, displaying hemispherical diffusion profiles leading to stir 
independence. 
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2.14. Antibody Fragments 
Antibodies can be lysed into different constitutive fragments using the proteolytic 
enzymes pepsin or papain. They can be split into the Fab region which is the specific 
binding part of the molecule targeted to the antigen and the Fc region, which is 
unnecessary for immunosensors. It can be necessary to reduce the disulphide bridge in 
the Fab region and using dithiothreitol to prevent any non-specific interactions (Lee et 
al., 2005). It is possible to digest the Fab regions further into single chain variable 
fragments (scFv) in which the variable regions of the heavy and light chains are fused 
together, they are smaller than the Fab fragment, yet display similar specificity (Torrance 
et al., 2006). An extensive library of antibody fragments targeted towards a diverse array 
of antigen targets has been created (Nissim et al., 1994, Vaughan et al., 1996,. Toth et al., 
1999, Charlton et al., 2001).  
 
Immunoglobulin macromolecules are prone to asymmetrical binding to sensor platforms 
on which they operate, meaning many of the macromolecules are in an unsuitable binding 
orientation, lowering the specificity and reproducibility of a sensor (Lee et al., 2005). 
Antibody fragments still retain the required biological specificity but are small and 
symmetrical in shape, allowing for reliable immobilisation and higher specificity towards 
the analyte due to lower steric hindrance. For example a immunosensor was fabricated 
utilising the Fab fragment from a monoclonal antibody against bovine insulin on a gold 
surface as the basis of an SPR sensor which displays a working concentration range of 
between 100 ng ml
-1
 – 10 µg ml-1 insulin (Lee et al., 2005).  Another group used scFv 
selection and cloning techniques to fuse the scFv section of an antibody to the light chain 
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cysteine residue on the C-terminal to aid uniform immobilisation of the fragments to the 
surface of an SPR chip to give an immunosensor (Torrance et al., 2006). Labeless EIS 
immunosensors were developed incorporating antibodies and antibody fragments 
immobilised onto a polyaniline surface (Tully et al., 2008). By relating the redox state of 
the polymer to the charge transfers occurring upon Antibody-antigen complex formation 
via impedance changes, antigen concentrations with a LLD for Internalin B (as a marker 
for Listeria monocytogenes, a food pathogen) of 4.1 pg ml
-1
 could be determined. 
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2.15. Immunosensor applications 
2.15.1. Commercially Viable Sensors 
The first commercially available immunoassay was the hCG hormone pregnancy test, a 
breakthrough for PoC sensing as it was used in the home, by the patient, without any 
need for specialised training; this meant the sensor had to be robust, inexpensive and 
simple to both operate and interpret. Later immunosensors which give an indication of 
the duration of the pregnancy on a digital display by means of a transducer can be 
classified as true immunosensors. 
 
Target Method Reference 
Glucose Potentiometric (Ghindilis et al., 1996)  
Human chorionic 
gonadotrophin (hCG) 
Optical fluorescence (Deacon et al., 1991) 
Folic acid in food Microfluidic ELISA (Hoegger et al., 2007) 
Marine Algae;CO2;Toxic 
blooms 
Salmonella 
spp.;Campylobactor spp. 
Biomarkers for colorectal 
cancer 
Cocaine  
Optical fluorescence (Ruano-López et al., 2009) 
Table 1: Various sensor types are listed along with their target, method of detection and the relevant 
reference 
 
Immunoassays are presently available for a more diverse range of analytes than 
immunosensors. These immunoassays, for example ELISA, can be highly labour 
intensive, time consuming and expensive. Development of immunosensors for analytical 
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applications, particularly in commercial markets, is important for cost minimisation. Also 
immunoassay development is paramount for integrating analytical capabilities into a 
portable, disposable and robust device, useful in many scenarios such as hospitals, 
general practitioners, airport, roadside police control and environmental measuerments 
(Ruano-Lopez et al., 2009). 
 
Recent work developed template platforms that can be used and fabricated as 
immunosensors for many targets where antibody can be immobilised onto an 
immunostrip with a reading being taken very specifically and rapidly and with 
sensitivities superior to equivalent ELISA tests. Sensors were developed capable of label 
free electrochemical detection of myelin basic protein (Tsekenis et al., 2008) and 
ciprofloxacin (Garifallou et al., 2007), non-specific binding effects were minimised using 
a dual electrode system.  
 
The Philips SmartBioPhone
TM
 is a portable, disposable LoC device developed with 
objectives of low cost and simplicity of operation and interpretation by being able, owing 
to its dry film lamination, of being integrated with any smartphone by either connecting 
with a USB or SDIO. The optical fluorescence device ‗LABONFOIL‘ is fully automated 
and deals with the whole process from sample preparation to interpretation of the results. 
LABONFOIL has been used for the measurement of a): marine algae to study climate 
change, CO2 sequestration and toxic blooms b): Salmonella spp. and Campylobacter spp. 
c): biomarkers for colorectal cancer and d): detection of cocaine in professional drivers 
(Ruano-Lopez et al., 2009). Other workers (Hoegger et al., 2007) developed a disposable 
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microfluidic ELISA device capable of measuring of folic acid in infant formula in five 
minutes with eight simultaneously operated microchannels in a highly automated 
microfluidic system. Commercial immunosensors must be robust and suitable for use by 
un-skilled operators. Due to these requirements, they pose a challenge in design and 
fabrication. 
 
The major research drive in the development of implantable sensors comprises research 
into implantable glucose sensors (Ghindlilis et al., 1996) to help treat diabetes without 
the trauma of taking drops of blood for glucose measurement. Challenges to this 
approach exist such as the risks associated with tissue destruction and infection or 
toxicological effects of new nanotechnologies such as QDs and CNTs, for example 
because of their long, straight shape, CNTs are thought to be possibly as dangerous as 
asbestos and capable of causing cancer in cells lining the lungs (Poland et al., 2008).  
 
The 2007-2009 recession has had an impact on PoC in all sectors, which is particularly 
evident in blood glucose testing; however, not considering the blood glucose sensors, the 
rest of the PoC market is predicted to grow by 8 – 9% between the time of writing and 
2015 with many companies developing some innovative PoC technologies (Stephans et 
al., 2009). For commercial viability, sensors must operate under various conditions or 
measure multiple targets, be inexpensive and be stable for more than one month‘s 
shelf-life (Luong et al., 2008). Commercial sensors are being developed at lower rates 
than those made for research purposes, mainly due to additional stringent requirements 
such as damage resitance, lower cost and being non-invasive. Successful biosensor 
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designs must also incorporate characteristics such as biorecognition agent 
interchangeability, the prospect for miniaturisation and ideally be comparable to existing 
protocols to facilitate approval by relevant regulatory agencies. These objectives are 
difficult to achieve concurrently, making it difficult to enter the market without a 
reasonable volume niche product as a market driver. For example, within the food 
production industry, the market potential for the detection of bacterial and viral 
pathogens in food has been estimated to be $150 million (worldwide) (Alocijia and 
Radke, 2003). Another significant market driver has been for detection of biological 
weapons following the increased perceived risk of terrorist activity. 
  
2.15.2. Medical Diagnostics 
Medical applications for immunosensors include for example hCG-β (Kassanos et al., 
2008), Escherichia coli (Lin et al., 2004), myoglobin related to post-myocardial 
infarction (Billah et al., 2008), anti-cholera toxin antibody (Haddour et al., 2006) and 
fatty acid-binding proteins related to tissue injury (Chan et al., 2005).  
 
Detection, diagnosis and subsequent treatment of cancer is challenging medical 
diagnostics and much research has been conducted into sensors capable of detecting 
exceptionally low quantities of cancer markers, with the requirement of operating with 
the small sample sizes available from tissue or bone when concerning cancer diagnosis. 
With small sample sizes, particularly at the early stages of development, it is far more 
likely that the cancer can be detected if multiple cancer biomarkers are tested for (Rusling 
et al., 2009). 
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Benefits from such devices are early detection of serious diseases and increased 
possibility of successful treatment. Contrarily, so much is to be expected of these devices 
that they are often complex to fabricate compared to existing techniques and devices, 
such as, for example liquid chromatography-mass spectrometry (LC-MS) which can 
provide reliable results in the diagnosis of diseases such as cancer (Stevens et al., 2003). 
However, although presently difficult to fabricate, immunosensors offer a financial 
advantage over techniques such as LC-MS and are far more suitable for PoC applications 
due to their operational simplicity. 
 
2.15.3. Sensors for Environmental Applications 
Sampling large areas such as fields, rivers or lakes requires high sample throughputs to 
cover the entire sample area. This requires portable equipment capable of rapid 
measurement at low cost with great sensitivity. Precision and accuracy are important 
since, for environmental and public safety purposes, routine sampling is commonplace, 
so the reliability of any results is highly important if contamination is slowly increasing. 
 
A fluorescent reporter yeast biosensor was fabricated that could both detect and 
biodegrade organophosphate pesticide paraoxon (Schofield et al., 2007). This self-
sustaining detection and solution system represents a significant advance because it 
allows a continuous and toxic contamination minimisation solution to the environmental 
damage that chemical and biological agents can exert. A challenge however is acquiring 
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all the necessary, specific antibodies towards the diverse range of toxins which can affect 
the environment (Goryacheva et al., 2007).  
 
2.15.4. Public Health and Safety Applications 
Following recent terrorist attacks, significant efforts have been focused towards 
homeland security for example, the detection of explosives and other agents that might 
pose a public. Other uses include de-mining, forensics, monitoring of health risks posed 
to military personnel and the demilitarisation of weapons. This had led to development of 
new and improved ways of detecting materials used for terror (Singh, 2007). Examples 
include a TNT sensor with multiplexed liquid arrays with aid of a flow-cytometer 
(Anderson et al., 2006); a sensor capable of detecting trace amounts of TNT in aquatic 
environments (Bromage et al., 2007) and an SPR based immunosensor comparing 
polyclonal and monoclonal antibodies for the detection of TNT (Shankaran et al., 2006).  
These examples mostly target TNT and there is a marked lack of research into the 
detection of other explosive devices. Nitroaromatic explosives have low vapour pressures 
and concentrations in air at ambient temperatures making detection of these vapours more 
problematic (Singh, 2007) especially since the window within which to detect a suspect 
explosive or dangerous material is a few seconds as the carrier walks by the detector, 
unless they have been selected for individual screening. Presently, ELISA, GC-MS, 
HPLC and electrochemical sensing are used for the detecting explosives and dangerous 
materials, but they can be time consuming and laborious, leaving a gap for 
immunosensors with increased speed and simplicity of detection (Anderson et al., 2006). 
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Analytical performance in these sensors is, at the moment, insufficient. One challenge for 
the use of immunosensors in airport security is they use antibodies which, once bound to 
their constituent antigen, are generally not reusable. There are many working 
immunosensors available being used for the detection of explosives in situations such as 
contamination in the environment and on military personnel (Singh, 2007).  
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2.16. Skin Inflammation in Response to Chemical Treatment 
2.16.1. The Stratum Corneum 
The stratum corneum (Figure 2. 26) forms the outer most layer of the epidermis and is 
considered to function as a sensory, excretory and protective organ with the ability to 
regulate skin and body temperature.  In order to satisfy these roles, the skin must not 
simply act as an inert barrier but contain highly specialised functional cells and 
intercellular fluid (Harding, 2004).  The main relevant function of the stratum corneum is 
its ability to act as a barrier that can retain water while acting as a permeable layer, a 
characteristic in which ceramide 1 plays an important role (Imokawa, 1990).  Since this 
property is so central to the hydration of the skin, any damage to the stratum corneum can 
result in - or worsen skin conditions such as Atopic Dermatitis, Psoriasis and varying 
degrees of inflammation for example (Farwanah, 2005).  The hydration level of this outer 
epidermal layer is also highly important for regulation of desquamation, which, if 
defective can cause excessive flaking and dryness of the skin. 
 
Figure 2. 26: The schematic ‘bricks and mortar’ structure of the stratum corneum 
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The stratum corneum is the site where many skin conditions can be caused or further 
aggrevated by chemicals in skincare products.  It is also therefore the site that gives rise 
to many biochemical markers indicative of these conditions.  These include, for example, 
Nerve Growth Factor in inflamed and reddened skin, the volatile sulphur compounds 
(VSCs) and bacterial secretions present in malodour disorder and ceramide 1 / cholesterol 
/ free fatty acids within the stratum corneum, which are exposed in dry, flaky skin 
conditions such as eczema and atopic dermatitis.  The increasing knowledge of how these 
indicative factors relate to particular skin conditions and how these can be quickly 
measured, brings forward the ability and efficiency of refining the quality and safety of 
skincare products. 
 
2.16.2. Nerve Growth Factor 
Nerve growth factor - β (NGF-β), in humans and mice, is responsible for nerve cell 
differentiation, regeneration and survival (Hoffman, 1970) and is found at the site of 
inflamed or sensitive skin.  The ability to measure the concentration of NGF in areas near 
the skins surface will allow adverse effects on the skin to be detected and will also help 
towards development of products that do not harm the skin. 
 
Analytical approaches for the detection and measurement of NGF include the gold 
standard ELISA, various in vitro bioassays (Robinson and Stammers, 1994) and a fiber-
optics based immunosensor (Tang et al, 2006), which detects NGF levels in human blood 
plasma as opposed to skin samples as targeted in this research.  Electrochemical sensors 
inherently offer the benefit of a faster experimental procedure and in this case the ease of 
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label-free technique over ELISA.  In addition, electrochemical sensors offer approaches 
that can be less expensive than alternatives such as fibre optic sensors and often produce 
more reliable readings; in the case of microelectrode sensors, stir independence of 
responses may be offered, which greatly benefits the end user (Higson, 2003). 
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2.16.4. Psoriasin (S100A7) 
Psoriasin (S100A7) is a calcium binding protein isolated from psoriatic scales that 
exhibits antimicrobial protection responsible for the unexpectedly low incident of 
infection of psoriatic legions in sufferers (Harder and Schroder, 2005).  These legions are 
evident as reddening and swelling of the skin (Watson et al, 1998).  Psoriasin functions 
as a chemotactic agent by inducing neutrophil and CD4
+
 T lymphocyte production and 
entry into the epidermis (Jinquan et al, 1996). 
 
Immunosensors capable of determining the concentration of Psoriasin as a marker in a 
sample would be useful in situations where new skincare products may aggravate 
symptoms of Psoriasis.   
 
2.16.5. Existing Technology for Psoriasin Measurement 
 
To date there is no published evidence that sensors have been successfully been 
developed for detection of S100A7 and so the development of an immunosensor that 
electrochemically measures the concentration of S100A7 would enable significant in 
depth analysis of how the skin of a psoriasis sufferer reacts to products presently in 
clinical trials. 
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2.17. Conclusions and Future Prospects 
Immunosensor research is focussed towards development of PoC devices to allow prompt 
management of a particular issue whether commercial, medical, environmental or 
security by non-trained personnel. The future will see more of these devices being 
developed with these improved characteristics. Immunosensing devices are becoming 
miniaturised into LoCs to carry out all testing in one device in one place, thereby 
improving their suitability as PoC tools. Micro-fluidics aid this characteristic and allow 
for continuous sampling. Recent research into microelectrode technology has led the way 
to obtaining stable, stir-independent responses using a variety of robust platforms for 
immobilisation of various sensing elements. Finally, the ability of immunosensor arrays 
to detect multiple analytes within one device is an area receiving much attention within 
the research community. 
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Chapter 3: 
 Materials and Methods 
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3. Materials and Methods 
3.1. Introduction 
This chapter provides a comprehensive overview of all the materials, apparatus and 
methods used to undertake the research towards this four year EngD project.  A 
description of the materials and apparatus used is given explaining the chemical, 
biological, mechanical and electrical components that were used, where they were 
purchased from and in what conditions they were used.  The chapter then goes on to give 
details of the techniques and methods used to obtain results, which are then presented in 
chapters 4, 5, 6 and 7). 
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3.2. Materials 
3.2.1. Immunosensor Fabrication and Impedance Interrogation 
Aniline hydrochloride (97%), potassium ferrocyanide (ACS), IgG (from human serum), 
psoriasin (S100A7), nerve growth factor β (NGF-β), albumin serum bovine (BSA), biotin 
3-sulfo-N-hydroxysuccinimide ester sodium salt, potassium ferricyanide(III), potassium 
chloride,  Immunoprobe™ biotinylation kits containing 0.1M sodium phosphate buffer, 
0.01M phosphate buffered saline (NaCl 138mM; KCl 27mM; pH 7.4), 
biotinamidohexanoic acid sulfo-N-hydroxysuccinimde (BAC-sulfo-NHS), pronase, 
affinity purified avidin, dimethylsulfoxide and 10mM 2-(4-hydroxyphenylazo) benzoic 
acid (HABA) in 10mM NaOH - were all purchased from Sigma-Aldrich (Gillingham, 
Dorset, UK).   
 
Di-sodium hydrogen orthophosphate 12-hydrate and sodium dihydrogen orthophosphate 
1-hydrate were purchased from BDH lab supplies (Poole, Dorset, UK).  Hydrochloric 
acid (analytical grade), potassium dihydrogen orthophosphate and sodium chloride were 
all purchased from Fisher Scientific (Loughborough, Leicester, UK).  Potassium 
phosphate (monobasic) was purchased from Acros organics (Geel, Belgium).  
Anti-human nerve growth factor (biotinylated) and anti-psoriasin were purchased from 
Abcam plc (Cambridgeshire, UK).  Commercial screen-printed carbon electrodes (Figure 
3. 1) with carbon working and counter electrodes and an Ag/AgCl reference electrode 
were purchased from Microarray Ltd, (Manchester) and used as the substrate to 
immobilise the immunosensor construct and for carrying out further electrochemical 
interrogations. 
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Figure 3. 1: Microarray dual carbon screen-printed electrode, used for the fabrication of the NGF 
and psoriasin immunosensors developed in this project. 
  
YM-30 Microcon
® 
centrifugal filtration devices used for the concentration of 
anti-psoriasin protein was purchased from Millipore (Watford, UK). 
 
3.2.2. Buffers and Solutions 
Unless stated otherwise, all buffers and solutions were prepared in deionised water, with 
a resistivity of ≥18 MΩ cm-1, dispensed from an Elga Purelab UHQ-II Water System 
(Vivendi Water Systems, High Wycombe, Buckinghamshire, UK).  Phosphate buffered 
saline (PBS), pH7.4, was prepared with 52.8mM disodium hydrogen orthophosphate 
12-hydrate, 13mM sodium dihydrogen orthophosphate 1-hydrate and 5.1mM sodium 
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chloride for the dilution of antibody and antigen solutions in addition to 1 x 10
-6
 M 
ferri-ferrocyanide for electrochemical interrogation of sensors.  Aniline buffer (pH1) was 
made with 0.5M potassium chloride, 0.3M hydrogen chloride and 0.2M aniline 
hydrochloride (97%) for electrochemical deposition of polyaniline onto the surface of 
carbon printed electrodes as a conductive polymer base for the immunosensor construct.  
BSA blocking solutions were prepared to 1 x 10
-6
M for use to minimise background 
non-specific binding, thereby improving the reliability of the impedimetric data obtained.  
 
All solutions used for the biotinylation of antibodies and the determination of extent of 
biotinylation were prepared following the instructions provided with the Immunoprobe
TM
 
biotinylation kit.  Biotinylated psoriasin antibodies were stored frozen in aliquots of 50μl 
at a concentration of 100μg ml-1. Antigen solutions of 50ml for incubation with 
immunosensors were prepared at interval concentrations between 25pg ml
-1
 – 10ng ml-1 
in PBS (pH7.4) for psoriasin and 1pg ml
-1
 – 1ng ml-1 in PBS (pH7.4) for NGF.  
Ferri-ferrocyanide solutions of 1 x 10
-6 
M
 
were prepared for use as electrolytes for 
impedimetric analysis. 
 
All electrical consumables such as wires and crocodile clips were purchased from Maplin 
Electronics (Luton, Bedfordshire, UK).  
 
3.2.3. Immunosensor Construct Validation 
Gold sensor electrodes (100nm) were procured from Q-Sense (Gothenburg, Sweden) 
(part of Biolin Scientific) for the fabrication of NGF and psoriasin immunosensor 
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constructs within the quartz crystal microbalance system, described below in section 
3.3.3. 
 
For the conjugation of anti-NGF and anti-psoriasin to 
125
Iodine, Pierce Iodination Beads 
were used (Piercenet, Thermo Fischer Scientific, Northumberland, UK). 
125
Iodine, also 
purchased from Piercenet, part of Thermo Fischer Scientific. 
 
Anti-rabbit IgG (whole molecule) – Fluorescein (FITC) antibody (produced in Goat) for 
the confocal microscopy investigations, reported in chapter 5, section 5.4, were 
purchased from Sigma-Aldrich (Gillingham, Dorset, UK). 
 
 
 
 
 
 
 
 
 
 
  
T.R.J. Holford          Cranfield University 
3.3. Apparatus 
3.3.1. Electropolymerisation of Aniline 
A Sycopel analytical electrochemical workstation (AEW2-10) potentiostat (supplied by 
Sycopel Scientific Ltd, Tyne and Weir, UK) was used with a PC user interface package, 
ECProg3, for the deposition of polyaniline onto planar electrodes via cyclic voltammetry. 
 
Figure 3. 2: An AEW2–10 Sycopel analytical electrochemical workstation (potentiostat), as used to 
electropolymerise aniline onto the carbon screen-printed working electrode surface. 
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3.3.2. Immunosensor Fabrication 
A BioDot Ltd. AD3200™ dispensing platform in combination with a BioJet Plus™ 3000 
dispensing system (Figure 3. 3) (BioDot Ltd., Chichester, West Sussex, UK) and 
controlled by PC driven AxSys™ software was used to automatically dispense reagent 
droplets at the surfaces of sensors between 20nl - 4µl. 
 
Figure 3. 3: A BioDot Ltd AD3200
TM
 dispensing platform in conjunction with a BioJet Plus 3000
TM
 
dispensing system used to reproducibly deposit reagents onto the working electrode surface during 
fabrication. 
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3.3.3. Quartz Crystal Microbalance  
The Q-Sense E4-Auto Quartz Crystal Microbalance (Figure 3. 4) (with dissipation 
monitoring) (QCM-D) purchased from Q-Sense (Gothenburg, Sweden) by the Faculty of 
Biological Sciences at the University of Leeds was used in NGF and psoriasin 
immunosensor characterisation studies, as reported in chapter 5, section 5.2. 
 
Figure 3. 4: A Q-Sense quartz crystal microbalance and control apparatus. 
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3.3.4. 125Iodine Radio-Labelling  
A Packard Cobra II Gamma Counter
TM
 (D5005) (Figure 3. 5) (purchased from 
Perkin-Elmer, Cambridgeshire, UK by the Faculty of Biological Sciences, University of 
Leeds) was used to quantify the level of gamma radioactive material present on the 
sensor constructs after fabrication with 
125
Iodine radiolabelled anti-NGF and 
anti-psoriasin before and following washing stages in order to determine the proportion 
of radiolabelled antibody that was specifically bound to the surface of the 
immunosensors. 
 
Figure 3. 5: A Packard Cobra II Gamma Counter (D5005) as used to measure the level of 
radioactivity on the working electrode of immunosensors for characterisation purposes. 
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3.3.5. Fluorescence Labelling and Confocal Microscopy 
A Zeiss LSM510 META confocal imaging system (Figure 3. 6), with variable emission 
detectors in one channel, used to visualise immunosensor surface homogeneity and layer 
thickness was purchased from (Welwyn Garden City, Hertfordshire, UK). 
 
Figure 3. 6: A Zeiss LSM510 confocal microscope used to visualise the immunosensor constructs, 
fabricated with a fluorescent antibody (Anti-FITC/FITC). 
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3.3.6. Scanning Electron Microscopy 
An ISI ABT-55 scanning electron microscope (SEM) (Figure 3.7) (ISI, Korea) was used 
to visualise the immunosensor surface topography after each immunosensor fabrication 
step. 
 
 
Figure 3. 7: An ABT-55 scanning electron microscope as used to visualise the immunosensor 
constructs for NGF and psoriasin at each stage of fabrication. 
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3.3.7. Impedance Interrogation 
An ACM instruments (Grange-over-Sands, Cumbria, UK) Auto Gill AC DSP frequency 
response analyser (Figure 3. 8) (supplied by ACM, Grange-over-Sands, Cumbria, UK), 
linked to a PC with ACM software (version 4.10) was used to interrogate the 
immunosensors through ac impedance protocol (as described in more detail in section 
3.6.5). 
 
Figure 3. 8: The ACM Auto AC DSP frequency response analyser, use for immunosensor impedance 
interrogations. 
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3.3.8. Centrifugal Filtration – Antibody Concentration 
Anti-psoriasin was concentrated using Millipore Microcon centrifugal filtration devices 
and centrifuged in an Eppendorf 5417R Centrifuge (Figure 3.9) (purchased from 
Eppendorf UK Ltd, Histon, Cambridge, UK).  Anti-psoriasin protein concentration was 
then achieved following instructions provided with the centrifugal devices. 
 
 
Figure 3. 9: Eppendorf (5417R) centrifuge as used in conjunction to the Microcon centrifugal 
filtration devices to concentration the anti-psoriasin protein. 
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3.4. Methodology 
3.4.1. Cyclic Voltammetric Deposition of Polyaniline onto Screen          
Printed Carbon Electrode Surfaces 
Polyaniline is a conductive polymer used frequently for many analytical chemistry 
applications due to its relative ease of production, stability and availability of free amine 
groups (Bejan, 1998).  In this project, polyaniline is utilised for its amine (NH3
+
) groups 
to immobilise biotin molecules to the construct (see section 3.5.4). 
 
At different electrode potentials, the isoform of aniline is different due to altering amine 
to imine ratios.  It becomes protoemeraldine at 25% (0.15 V/S.C.E) (S.C.E – Saturated 
Calomel Electrode), emeraldine at 50% (+0.60 V/S.C.E) and nigraniline at 80% (+0.80 
V/S.C.E) oxidation (Bejan, 1998).  At 0.8V, another reduction peak is observed whereby 
emeraldine (the most conductive form of polyaniline) is produced.  The polymerisation 
reaction is stopped at 0.8V for the fabrication of the immunosensors developed in this 
project, leaving the polymer layer in its most conductive condition for optimal sensing. 
 
A screen-printed carbon electrode was immersed in aniline buffer (pH1) so that the 
working, reference and counter electrodes were covered.  The electrode was then 
connected to a Sycopel analytical electrochemical workstation (AEW2-10) potentiostat.  
Potentiodynamic scan parameters were set to; start [-0.2V], dwell [0], limit 1 [0.8V], 
cycles [20], limit 2 [-0.2V], stop [-0.2V], and scan rate [0.5V s
-1
] and the measurements 
were then recorded.  Subsequently, a single oxidative linear sweep was initiated and 
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halted at 0.8V, leaving the polyaniline in its most conductive oxidative (emeraldine) 
state.  Following deposition of polyaniline, the electrodes were gently rinsed in water. 
 
The cyclic voltammogram below (Figure 3. 10) illustrates the uniform 
electropolymerisation of polyaniline on the surface of a generic, commercially 
screen-printed carbon electrode.  With each new scan, a higher peak is observed between 
0.1 - 0.4V versus Ag/AgCl on the cathodic linear sweep and -0.1 to +0.1V Vs Ag/AgCl 
on the anodic linear sweep. 
 
 
 
Figure 3. 10: The deposition of polyaniline onto the surface of screen-printed electrodes by cyclic 
voltammetry. Sweeps are shown of cycles 1, 10 and 20. 
 
 
 
Aniline polymerisation is an irreversible reaction.  Oxidised aniline migrates to the 
surface of the working electrode, is reduced and is immobilised at the surface as the 
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monomer is polymerised.  The potential is reversed and the bound aniline molecule is 
oxidised, leaving a free amine group on which another aniline molecule can bind, 
forming an aniline oligomer.  The process repeats over multiple cycles, forming a layer of 
polyaniline on the sensor surface.  As the layer thickness of polyaniline on the working 
electrode increases, so does the current, resulting in the observed peaks at +0.2V and -
0.1V.  This increase in current peak height continues to a point at which the thickness of 
the polyaniline layer eventually becomes progressively resistive and insulating to current.  
When this occurs, the voltammogram will show diminishing current peak heights with 
each cycle (Lawrence, 2004).  However, this layer thickness is not reached in this 
experiment – and indeed it is necessary to form a conductive polymer layer to allow the 
passage of current through the immunosensor construct during impedance interrogations 
(chapter 4, sections 4.2 and 4.3) 
 
The aniline electropolymerisation reaction is normally implemented under acidic 
conditions of pH1-2 in order to provide sufficient H
+
 ions to shift the polymerisation 
reaction of aniline to favour the formation of polyaniline. 
 
The cyclic voltammogram displayed in Figure 3. 10 above, alongside information on the 
size of each aniline molecule, can be used to calculate the thickness of the deposited 
polyaniline layer. 
 
Figure 3. 11 represents a schematic illustration of the chemical pathway in the 
polymerisation mechanism of aniline to form polyaniline. 
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Figure 3. 11: The chemical mechanism of aniline polymerisation. 
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3.5. Reagent Deposition on NGF and Psoriasin Immunosensor 
Surfaces 
3.5.1. Introduction 
Following the electropolymerisation of polyaniline to the carbon working electrode 
surface, both the NGF and psoriasin immunosensors were fabricated in order as described 
in the sections below (sections 3.5.2 – 3.5.7).   
 
These reagents where always deposited in the same order and with the same incubation 
times as specified, however two dispensing approaches were used as explained in the 
subsequent two sub-sections (sections 3.5.2 and 3.5.3). 
 
3.5.2. Reagent Deposition by Hand 
Prior to the immunosensor enhancement stages of the project (described in chapter 4, 
sections 4.3 - 4.7), both the NGF and psoriasin targeted immunosensors were fabricated 
by dispensing each reagent by hand using a standardised Gilson 10µl dispensing pipette.   
 
The main issue concerning this method of fabrication relates to the reproducibility of the 
approach due to both the reproducibility of the reagent volume and also the ability to 
reproducibly sterically dispense the reagent on to the working electrode. 
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3.5.3. Reagent Deposition Using an Automatic Dispensing System 
A BioDot AD3200
TM
 automatic dispensing system was used as part of the sensor 
enhancement stage of this project (chapter 4, sections 4.3 - 4.7).  This auto-dispensing 
system uses robotics and a computer operating program to control a mounted precision 
dispensing pipette tip, capable of dispensing reagent with 100µm resolution to a 
minimum volume (for this particular BioDot AD3200
TM
 model) of 20nl. 
 
Due to the high reproducibility of this method of reagent deposition, each sensor can be 
fabricated to a high level of reproducibility with relative ease.  Each reagent is dispensed 
at a precise volume on each carbon working electrode and with accurate resolution. 
 
3.5.4. Biotin Deposition 
Biotin is a small protein (13 kDa) (Figure 3. 12) that can be specifically and covalently 
attached with high affinity to an avidin molecule or tethered to a vast array of biologicals 
to act as a biological linking bridge between two entities.   
 
Figure 3. 12: Molecular structure of a biotin molecule. 
 
Attachment to biotin can be achieved via amine groups as shown in Figure 3. 13, 
whereby biotin has been attached to an avidin molecule. 
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Figure 3. 13: Structural representation displaying the chemical interactions between avidin (black) 
and biotin (blue – Centre).  There are several hydrogen bond interactions which forms a basis for the 
high affinity with which these two molecules bind. 
 
The sensors described within this project utilise the binding of biotin to avidin to 
covalently attach antibodies to the polymerised surface of the sensor in a uniformed layer 
in an effort to maximise the sensitivity of the sensor.  The initial layer of biotin is in its 
N-hydroxysuccinimide ester form (biotin-NHS ester), allowing the molecule to attach to 
the polyaniline surface whilst acting as a molecular docking station for the following 
avidin layer as illustrated within section 3.5.7, and the schematic of Figure 3. 14. 
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10µl biotin-sulpho-NHS was deposited on the surface of each polyaniline covered 
working electrode and incubated at room temperature overnight; care was taken not to 
allow the biotin-sulpho-NHS to come into contact with either the reference or counter 
electrodes.  The electrode was then washed exhaustively and dried with compressed air or 
nitrogen.   
3.5.5. Avidin Deposition 
Avidin, streptavidin and neutravidin are the three forms of avidin that are used as a 
connecting bridge between two biotin molecules - and in the case of the sensors in 
question, these tether the biotinylated sensor surface to the biotinylated antibody.   
 
Avidin is a homo-tetramer able to bind up to four biotin molecules at any one time with a 
high affinity of KD 10
-15
M.  It is stable in a variety of harsh conditions and remains intact 
at temperatures below 70°C, at which point the protein begins to denature.  It is sourced 
from the egg whites of birds, reptiles and amphibians and ranges between 66-69 kDa in 
size. 
 
Streptavidin is produced from certain strains of Streptomyces as an inhibitor of its 
competitive bacterial strains. 
 
Neutravidin is a de-glycosylated form of avidin with modified arginine groups, 
displaying minimised non-specific binding properties.  For this reason neutravidin has 
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been used throughout the project for the fabrication of both the NGF and psoriasin 
immunosensors. 
 
10µl neutravidin was dispensed onto the working electrode and incubated at room 
temperature for 1hr, again ensuring neutravidin did not come into contact with either the 
reference or counter electrodes.  The electrode was then washed with copious water and 
dried with compressed air or nitrogen.   
 
3.5.6. Biotinylated Antibody Deposition 
Both NGF and psoriasin were covalently attached to biotin, which then completes the 
sensor construction through binding the antibody specifically, with high affinity, and with 
a uniform distance from the surface sensor, to the avidin layer bound in the previous step.  
Although it is possible to deposit and bind biotinylated antibodies to the polyaniline 
surface directly without an additional biotin and avidin layer, it is postulated that the use 
of a biotin-avidin bridge forms a uniform layer in which a much higher proportion of 
antibody molecules are bound in the correct orientation, with their antigen binding site 
facing outwards (investigated and discussed in more detail in chapters 6 and 7, sections 
6.3 and 7.2 respectively) 
 
10μl biotinylated anti-psoriasin or anti-NGF was deposited onto the electrode, which was 
then incubated at 4 ºC for 10 minutes before rinsing with water and drying in compressed 
air or nitrogen.   
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3.5.7. Bovine Serum Albumin Deposition 
As a final preparatory stage, it is necessary to incubate the sensor for five minutes in a 
solution of 1 x 10
-6
 M bovine serum albumin (BSA) which acts a blocker for non-specific 
adsorption of the antigen onto the non-antigen binding site regions of the sensor surface.   
 
10µl BSA (10
-6
M) blocking agent for 5mins at room temperature before rinsing with 
water and drying as usual.  The sensor constructs can, at this point, be kept at 4 ºC.  
Sensors of this type must be used within 24 hours. 
 
Following deposition of BSA and a final washing stage, the fully fabricated sensors are 
formed as illustrated in the schematic diagram below (Figure 3. 14). 
 
 
Figure 3. 14: Schematic representation of an immunosensor as described within this thesis.  The 
construct is the basis for both the NGF and psoriasin sensors.  BSA – Bovine Serum Albumin 
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Although many other methods exist for the fabrication of immunosensors as explained, 
compared and contrasted in chapter two of this thesis, the construct selected has shown to 
aid in overcoming several issues.  The use of the biotin-avidin bridge creates a uniform 
and structurally sound sensor, oriented in an optimum manner for specific antigen 
sensing. 
 
It is postulated that the construct is designed to create a layer thickness necessary to 
observe an appropriate base impedance for optimal detection of antigen via impedance 
interrogation. 
 
Various factors concerning the fabrication of the NGF and psoriasin immunosensors are 
discussed in more detail in the results chapters 4, 5, 6 and 7 of this thesis.  Chapter 4 goes 
on to describe and present optimisation approaches and impedance interrogation results 
concerning the immunosensors for both NGF and psoriasin. 
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3.6. Immunosensor Fabrication and Validation of its Molecular 
Building Block Approach 
3.6.1. Quartz Crystal Microbalance 
Gold coated quartz crystal electrode sensors first had aniline electropolymerised onto 
their surface using a Sycopel AEW2-10 potentiostat.  This was performed separately to 
the QCM measurements due to the unavailability of the electrochemical module of the 
QCM instrument.  Electropolymerisation was achieved using the following parameters 
for cyclic voltammetry: Start potential [1V], dwell [0], limit 1 [-0.2V], limit 2 [1V], stop 
[1V], cycles [10] and a scan rate of [0.5V s
-1
].  Aniline polymerisation on the gold 
electrodes was started at 1V as opposed to -0.2V with the carbon working electrodes 
since a higher potential was necessary to initiate the polymerisation process. 
 
QCM electrodes with aniline polymerised on the surface were then mounted into the 
QCM measurement module and the initial resonance frequency of the electrode measured 
and recorded.  PBS was then injected into the flow module, which passes any reagent or 
buffer across the electrode surface.  Fluctuations in the frequency of the electrode were 
observed as the measurements began and then stabilised as a baseline frequency was 
reached.  Biotin (1mg ml
-1
) was then introduced into the flow-through module, binding to 
the polyaniline on the surface of the QCM electrode, altering the resonance frequency of 
the quartz crystal and therefore adding mass to the electrode surface (as described by the 
Sauerbrey equation).  A washing step was then initiated, pumping PBS across the surface 
of the electrode until a stable frequency was achieved.  Avidin (10mg ml
-1
) was then 
exposed to the electrode surface, followed by another PBS washing step.  Frequency 
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changes were again monitored and recorded using the QCM device.  1mg ml
-1
 anti-NGF 
or anti-psoriasin was then added to the electrode surface using the QCM flow-through 
module and the frequency monitored.  Another PBS washing step followed, prior to 
injection of 0.06mg ml
-1
 Bovine Serum Albumin (BSA) into the QCM flow-through 
module.  NGF or psoriasin antigen was then exposed to the sensor surface, again 
followed by a final PBS washing step after which the change in frequency monitored and 
recorded. 
3.6.2. 125Iodine Radio-Labelling 
125
Iodine radiolabelled anti-NGF and anti-psoriasin were used to fabricate 
immunosensors (as described above in section 3.5.3).  The level of radioactivity on the 
working electrode surface was monitored using a gamma counter prior to any washing 
steps to establish the initial level of radioactivity on the surface which could be directly 
related to the concentration of radiolabelled antibody on the surface.  Surfaces were then 
washed with 2M NaCl, and the washing buffer was collected so that the gamma radiation 
in counts per minute (cpm) could be measured.  By subtracting the radioactivity in a 
washing buffer from the initial level of radioactivity measured on the electrode surface, 
the proportion of antigen actually binding to the surface in a specific manner can be 
determined. 
 
3.6.3. Fluorescence Labelling and Confocal Microscopy 
Anti-FITC bound to FITC was used to fabricate sensors in place of anti-NGF and 
anti-psoriasin.  These fluorescently active sensors were then viewed under a confocal 
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microscope with a wavelength of 483nm via an argon laser.  The laser is able to pierce 
the immunosensor construct and take cross sections through the layers, allowing 
determination of both layer homogeneity and layer thickness. 
 
3.6.4. Scanning Electron Microscopy 
Immunosensors for both anti-NGF and anti-psoriasin were fabricated and halted at each 
step of fabrication.  Steps include starting with a bare carbon electrode, then a carbon 
electrode with aniline polymerised onto the surface, an electrode with polyaniline and the 
biotin layer, an electrode with the polymer, biotin and avidin layers deposited, an 
electrode with the polymer, biotin, avidin and biotinylated anti-NGF immobilised and a 
final electrode with polymer, biotin, avidin and biotinylated anti-psoriasin all 
immobilised.  Each sensor was then coated in silver dag to enable imaging through the 
scanning electron microscope (SEM).  Images were taken with a magnification of 1000 
times and at an operating potential of 15kV. 
 
3.6.5. Impedance Interrogation 
The fabricated immunosensor electrodes were connected to the Auto AC DSP frequency 
response analyser (ACM) and immersed in 1 x 10
-6
 M ferri-ferrocyanide solution.  Gill 
AC settings were as follows: DC offset [+0.4V], offset to rest potential [0.032V] and area 
[2.178E
-1
cm
2
].  The immunosensors were then interrogated over a range of frequencies 
between 1 – 10,000Hz and the impedance measurements obtained from the Gill AC 
impedance software, after incubation in a range of frequencies of their target analyte.  
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Anti-NGF immunosensors were incubated with NGF antigen concentrations between 1pg 
ml
-1 
and 1ng ml
-1
.  Anti-psoriasin immunosensors were incubated with psoriasin 
concentrations between 25pg ml
-1
 and 10ng ml
-1
.  As a control to measure the impedance 
change due to non-specific interactions on the electrode surface, the impedance of the 
NGF immunosensor was interrogated after incubation with psoriasin antigen, and the 
impedance of the psoriasin targeted immunosensor was interrogated after exposure to 
NGF antigen.  NGF and psoriasin have similar molecular weights of 13kDa and 11kDa 
and therefore can be used as analogs of each other for control experiments. 
 
Calibration curves could then be plotted after subtraction of the impedance changes 
observed due to non-specific interactions on the immunosensor surface from the 
impedance changes observed with the specific sensor.  Changes in impedance values 
from the Z‘ (Ohms) were used at a frequency of 1Hz to plot each data-point on the 
calibration curves. 
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Chapter 4: 
 Immunosensor Interrogation and 
Optimisation 
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4. Immunosensor Interrogation and Optimisation 
4.1. Introduction 
The interrogation and optimisation of the lower limit of detection and reproducibility of 
both the NGF and psoriasin immunosensors is described in this chapter.  This was 
achieved through the improvement of immobilisation and fabrication techniques as well 
as interrogation regimes. 
 
Each optimisation technique is briefly introduced, followed by a detailed description of 
how it was developed to enhance the performance of the sensors.  The resulting sensor 
improvements made in each case are then discussed. 
 
The purpose of this sensor enhancement is to ensure that each sensor performs reliably 
and to a high standard in line with the requirements laid out in chapter 1.  These 
immunosensors will play a key role in Unilevers‘ research and development into the 
safety of its products – so allowing them to undertake research and development in a 
more efficient way than at present.  It is therefore important that the sensors measure the 
given inflammation marker targets within the physiological concentration ranges (NGF: 
50 to 200pg ml
-1
 and Psoriasin: 5 to 20ng ml
-1
 and with a low level of standard error 
between measurements.  
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4.2. Immunosensor Fabrication by Hand 
4.2.1. Introduction 
Sensors were initially constructed by the deposition of reagents onto the sensor surface 
with a hand pipette as described in chapter 3, section 3.5.2; these were incubated for 30 
minutes at a time over a range of concentrations of specific antigen and then interrogated 
by electrochemical impedance after consecutive incubations.  Changes in impedance can 
then be related to the antigen concentrations to allow a calibration curve to be plotted. 
 
4.2.2. Results and Discussion 
Nerve Growth Factor (NGF) Immunosensor: 
NGF immunosensors, fabricated as described in chapter 3, section 3.5.2, were 
interrogated via ac impedance across a range of frequencies.  AC spectra in the form of a 
Nyquist plot (Figure 4. 1) and Bode plots are shown in Figure 4. 2. 
 
The Nyquist and Bode plots (Figure 4. 1 and Figure 4. 2) illustrate a trend in changing 
impedance values at 1Hz over a range of antigen concentrations.   
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Figure 4. 1: A Nyquist plot displaying impedimetric parameters Z’ and Z’’ (Ohms) for a range of 
concentrations of NGF antigen over a range of applied frequencies (Hz) 
 
The impedimetric spectra of these sensors consist of two components, namely real (Z‘) 
impedance and imaginary (Z‘‘) impedance.  The real component represents the specific 
antibody-antigen interactions, while the imaginary component represents the non-specific 
effects of physiosorption of reagents onto the sensor platform surface. 
 
The Bode plot (Figure 4. 2) shows the total impedance vs frequency of the measurement 
and as can be observed, the larger changes in impedance with varying concentration 
towards the lower frequencies within the ac spectrum.  The Z‘ impedance changes at 
1Hz, were for this reason, taken from the Nyquist plot, would be used to construct the 
calibration curve (Figure 4. 3) of this NGF sensor. 
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Figure 4. 2: Bode plot illustrating the relationship between the frequency (Hz) at which the 
measurement of total impedance is taking place and the total impedance itself, over a range of NGF 
antigen concentrations. 
 
Figure 4. 3a depicts the percentage change in impedance (Ohms) of the specific NGF 
immunosensor in response to incubation with a range of NGF antigen concentrations 
between 25pg ml
-1
 – 1ng ml-1.  The data points are displayed in a logarithmic scale in 
Figure 4. 3a and a linear scale in Figure 4. 3b for clarity. 
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Figure 4. 3a:  The percentage impedance change (Ohms) in response to a range of concentrations of 
NGF antigen (25 – 1000pg ml-1) on a specific NGF immunosensor.  Antigen concentrations are 
presented on a logarithmic scale. 
 
Figure 4. 3b:The percentage impedance change (Ohms) in response to a range of concentrations of 
NGF antigen (25 – 1000pg ml-1) on a specific NGF immunosensor. 
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Figure 4. 4a demonstrates the percentage impedance response observed over a range of 
concentrations of psoriasin antigen on an immunosensor fabricated with anti-NGF as a 
control investigation, which shows the increase in impedance that can be attributed to 
non-specific interactions on the sensor surface.  A further plot of this data is also 
presented in Figure 4. 4b, in which the antigen concentration is positioned along a linear 
scale axis. 
 
Figure 4. 4a:  The percentage impedance change (Ohms) in response to a range of concentrations of 
psoriasin antigen (25pg ml
-1– 1ng ml-1) on an immunosensor fabricated with anti-NGF. 
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Figure 4. 4b: The percentage impedance change (Ohms) in response to a range of concentrations of 
psoriasin antigen (25pg ml
-1
 – 1ng ml-1) on an immunosensor fabricated with anti-NGF. 
 
As can be observed from Figure 4. 5a below, although the calibration curve (obtained 
from Nyquist and Bode plots above - Figure 4. 1 and Figure 4. 2) for sensors fabricated in 
this manner do show an increase in impedance with increasing concentration the error 
bars are extensive and would prevent the sensors being used due to the large spread of 
data and associated unreliability of the data.  Figure 4. 5b has also been presented as a 
plot of the concentrations of NGF in a linear scale. 
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Figure 4. 5a:  Corrected calibration plot displaying the percentage changes in Z’ impedance over a 
range of NGF antigen concentrations (25pg ml
-1
 – 1ng ml-1). 
 
Figure 4. 5b: Corrected calibration plot displaying the percentage changes in Z’ impedance over a 
range of NGF antigen concentrations (25pg ml
-1
 – 1ng ml-1). 
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A range of concentrations (25pg ml
-1
 – 1ng ml-1) of NGF antigen were exposed to the 
specific NGF sensor and an increase in impedance (Z‘ – Ohms) was seen up to greater 
than 400%.  Taking into consideration that non-specific interactions have been accounted 
for using a sensor fabricated with an antibody that does not detect NGF, the gradient of 
the curve shows promise that a specific interaction is occurring between antibody and 
antigen and this can be directly monitored using impedance changes.  The sensor at this 
stage has a lower limit of detection (LLD) of 250pg ml
-1
.  The LLD can be defined as the 
lowest response that is more than three times the standard deviation of the baseline 
measurement.   
 
However, it is important that the results are reliable and therefore reproducible between 
sample tests, hence the error bars must be sufficiently small such that each data point can 
be distinguished from the next.  Therefore the LLD cannot be stated with any significant 
level of confidence.  Many factors relating to hand pipetting small volumes of reagent (as 
described in chapter 3, section 3.5.2) may be responsible for these large error bars, 
including inaccuracies in the volumes and the homogeneity of how the reagents are 
deposited at the surfaces of sensors. 
 
Psoriasin Immunosensor: 
The corrected calibration plot for the impedimetric response of a specific psoriasin sensor 
to a range of concentrations of psoriasin antigen (0.25, 0.5, 1, 2.5, 5 and 10ng ml
-1
) as 
shown in Figure 4. 8a.  These sensors were again fabricated by the deposition of each 
reagent using a hand pipette as described in chapter 3, section 3.5.2. 
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Percentage change in impedance in response over a range of concentrations of psoriasin 
antigen (250pg ml
-1
 – 10ng ml-1) for specific sensors interrogated against NGF antigen 
and non-specific psoriasin antigen are shown in Figure 4. 6a and Figure 4. 7a 
respectively.  Each Figure is then presented with the antigen concentration on a linear 
scale for clarity (Figure 4. 6b and Figure 4. 7b respectively). 
 
 
Figure 4. 6a:  The percentage impedance change (Ohms) in response to a range of concentrations of 
psoriasin antigen (250pg ml
-1
 – 10ng ml-1) on a specific psoriasin immunosensor. 
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Figure 4. 6b: The percentage impedance change (Ohms) in response to a range of concentrations of 
psoriasin antigen (250pg ml
-1
 – 10ng ml-1) on a specific psoriasin immunosensor. 
 
 
Figure 4. 7a:  The percentage impedance change (Ohms) in response to a range of concentrations of 
NGF antigen (250pg ml
-1
 – 10ng ml-1) on an immunosensor fabricated with anti-psoriasin. 
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Figure 4. 7b: The percentage impedance change (Ohms) in response to a range of concentrations of 
NGF antigen (250pg ml
-1
 – 10ng ml-1) on an immunosensor fabricated with anti-psoriasin. 
 
If impedimetric responses for each antigen for the non-specific immunosensor are 
subtracted from the responses for each antigen for the specific immunosensor, this allows 
the calibration profile of Figure 4. 8a to be plotted, which represents the impedance 
change responses that are solely caused by the psoriasin / anti-psoriasin binding event.  
Figure 4. 8b is a plot of the same data-set but presented on a linear scale. 
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Figure 4. 8a: Corrected calibration curve plotting the percentage changes in Z’ impedance (Ohms) 
over a range of concentrations of psoriasin antigen (pg ml
-1
).  This immunosensor was fabricated by 
hand. 
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Figure 4. 8b: Corrected calibration curve plotting the percentage changes in Z’ impedance (Ohms) 
over a range of concentrations of psoriasin antigen (pg ml
-1
).  This immunosensor was fabricated by 
hand. 
 
Although the psoriasin sensors display a 10-fold larger percentage change in impedance 
in comparison to the NGF sensor (Figure 4. 3), the error bars are still significant, making 
points between concentrations 250 – 1,000pg ml-1 and 2,500 – 10,000pg ml-1 
indistinguishable. 
 
Similarly to NGF sensors, the psoriasin immunosensor displayed a significant upwards 
trend in impedance (Z‘ – Ohms) in response to psoriasin antigen from 250pg ml-1 – 10ng 
ml
-1
) with a lower limit of detection of 1ng ml
-1
 (more than three times the standard 
deviation of the baseline measurement).  Additionally in line with the NGF sensor 
responses, psoriasin sensors display error bars that are significantly large to prevent 
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adjacent data points to be distinguished from one another.  Again, in comparison to the 
NGF immunosensors, the psoriasin sensor is fabricated by dispensing reagents by hand 
with a pipette, again leading to the same problems as discussed above. 
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4.3. Sensor Fabrication Using an Automatic Dispensing System 
4.3.1. Introduction 
 
Sensors for the detection of NGF and psoriasin were fabricated by depositing biotin, 
avidin, anti-NGF, anti-psoriasin and BSA using a BioDot micro-dispenser (Figure 4. 9) 
as described in chapter 3, section 3.5.3. 
 
Figure 4. 9: Photograph of the BioDot AD3200
TM
. 
 
As described in the previous section (section 4.2), the sensors were initially fabricated by 
dispensing reagents onto the electrode surface using a hand-held Gilson pipette.  
Although pipettes are able to dispense reagent with a reasonably high standard of 
accuracy, there are several aspects which can not be controlled and the reliance on a hand 
deposition approach can lead to irregulations and inconsistencies in the deposition of the 
reagents, which in turn leads to irreproducibility of the sensors. 
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In order to optimise the fabrication of the sensors, a BioDot Ltd AD3200
TM
 dispensing 
platform used in conjunction with a BioJet Plus 3000
TM
 system is able to dispense down 
to 20nl of fluid reagent with a point resolution of 100µm, which results in highly 
reproducible fabrication of the sensors. 
 
The standard operation of the BioDot dispensing system is based on a micro-needle, 
positioned on a robotic arm, which is able to pick up a pre-determined volume of reagent, 
remove bubbles by eluting the contents of the tip of the needle and clean the needle tip 
under vacuum before each reagent is picked up and dispensed. 
 
The BioDot was used to dispense 7.5μl reagent onto each working electrode of an NGF 
or psoriasin immunosensor starting with biotin-sulpho-NHS, then avidin, biotinylated 
anti-NGF or anti-psoriasin and bovine serum albumin (BSA) (described in further detail 
in chapter 3 section 3.5.3). Figure 4. 12 (section 4.3.2) depicts the impedance response 
calibration curves obtained for sensors developed using the automatic dispensing system 
(BioDot) and compares that to the sensors fabricated by hand (as described in chapter 3, 
section 3.5.2). 
 
As illustrated below, the impedimetric response with BioDot fabricated sensors give a 
much more reliable response curve with lower error bars and a more defined upwards 
trend for both the NGF and psoriasin immunosensors representing an increase in 
impedance as the antigen concentration is increased. 
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4.3.2. Results and Discussion 
Nerve Growth Factor (NGF) Immunosensor: 
Figure 4. 10a shows the percentage change in impedance (measured in Ohms at 1Hz) 
observed with an NGF immunosensor after incubation with a range of NGF antigen 
concentrations (10pg ml
-1 – 5ng ml-1).  The x-axis in Figure 4. 10a displays the logarithm 
of the NGF antigen concentrations and so for clarity, Figure 4. 10b has been presented 
showing the same data-set in linear format. 
 
Figure 4. 10a: The percentage impedance change (Ohms) over a range of concentrations of NGF 
antigen (10pg ml
-1
 – 5ng ml-1) on a specific NGF immunosensor fabricated with the BioDot 
AD3200
TM
.  NGF concentrations are presented on a logarithmic scale. 
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Figure 4. 10b: The percentage impedance change (Ohms) over a range of concentrations of NGF 
antigen (10pg ml
-1
 – 5ng ml-1) on a specific NGF immunosensor fabricated with the BioDot 
AD3200
TM
. 
 
 
In order to account for non-specific interactions between the antigen and the sensor, 
control sensors were fabricated with anti-NGF (as described in chapter 3, section 3.5.3).  
The sensor was then interrogated with AC impedance after incubation over a series of 
non-specific psoriasin antigen concentrations (Figure 4. 11a).  Psoriasin has a molecular 
weight of 11kDa which is similar in size to the 14kDa NGF antigen; therefore it can be 
used to measure the increase in impedance due to non-specific interaction on the 
immunosensor surface (i.e. non antigen-antibody binding events).  There is a much lower 
response observed for the non-specific sensor with NGF thus non-specific interactions 
only contribute to a minimal proportion of the total impedance change on a specific 
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sensor.  Again, for clarity, Figure 4. 11b is displayed to illustrate the data-set on a linear 
scale. 
 
 
Figure 4. 11a: The percentage impedance change (Ohms) in response to a range of concentrations of 
psoriasin antigen (10pg ml
-1
 – 5ng ml-1) on an immunosensor fabricated with anti-NGF using the 
BioDot auto-dispensing system.  Concentrations presented on a logarithmic scale. 
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Figure 4. 11b: The percentage impedance change (Ohms) in response to a range of concentrations of 
psoriasin antigen (10pg ml
-1
 – 5ng ml-1) on an immunosensor fabricated with anti-NGF using the 
BioDot auto-dispensing system. 
 
 
 
Figure 4.12 shows the percentage increase in the real impedance profile following 
exposure to a range of antigen concentrations comparing the results for NGF 
immunosensors fabricated using and automatic dispensing system (chapter 3, section 
3.5.3) and immunosensors fabricated by hand (chapter 3, section 3.5.2).  These results 
show a corrected calibration curve, in which the impedance responses for an NGF 
immunosensor with incubation with a range of non-specific antigen (psoriasin) 
concentrations (Figure 4. 11a) have been subtracted from the responses observed with an 
NGF immunosensor after incubation with a range of specific NGF antigen concentrations 
(Figure 4. 10a) for the BioDot fabricated immunosensor.  The impedance begins to trend 
towards a plateau after 1ng ml
-1
, and this might be explained by saturation of the 
anti-NGF active sites on the surface of the sensor.  There is a near linear correlation 
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(R
2
=0.92) between antigen concentrations 100pg ml
-1
 – 1ng ml-1 and the coefficient of 
variance has been lowered from 1715.77% (hand fabricated immunosensors) to 38.56% 
(automatic reagent dispensing system fabricated immunosensors). 
 
 
Figure 4. 12: Corrected calibration curve showing the percentage change in impedance (Ohms) over 
a range of NGF antigen concentrations (pg ml
-1
).   This immunosensor was fabricated using the 
BioDot AD3200
TM
. The corrected calibration curve for the results obtained with an immunosensor 
fabricated by hand (pink data points) are also shown on this graph to enable comparison between the 
two fabrication techniques. 
 
 
With the use of the BioDot AD3200
TM
, the error bars have been significantly minimised 
in comparison to the NGF immunosensor fabricated by hand.  Each point representing the 
impedimetric response to a higher NGF concentration is distinguishable from the 
previous between 10-250pg ml
-1
.  These results suggest that a major issue concerning the 
fabrication of such immunosensors and biosensors that require a deposition and 
incubation step is that deposition by hand can introduce a high level of standard error 
related to micro-litre fluctuations in deposited volume of reagent on one electrode 
compared to another. 
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Psoriasin Immunosensor: 
A BioDot fabricated psoriasin immunosensor was interrogated over a range of 
concentrations of psoriasin (100pg ml
-1
 – 10ng ml-1) and the percentage changes in 
impedance in response to this was recorded and illustrated below (Figure 4. 13a).  Figure 
4. 13b displays the same results as Figure 4. 13a, as with the data-sets above, the range of 
psoriasin concentrations are presented on a linear scale axis. 
 
 
Figure 4. 13 a: The percentage impedance change (Ohms) in response to a range of concentrations of 
psoriasin antigen (100pg ml
-1
 – 10ng ml-1) on a specific psoriasin immunosensor fabricated using the 
BioDot AD3200
TM
. 
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Figure 4. 13b: The percentage impedance change (Ohms) in response to a range of concentrations of 
psoriasin antigen (100pg ml
-1
 – 10ng ml-1) on a specific psoriasin immunosensor fabricated using the 
BioDot AD3200
TM
. 
 
 
Figure 4. 14a depicts the percentage change in impedance response observed over a range 
of non-specific NGF antigen concentrations, again to illustrate the level of change in 
impedance that non-specific interactions on the immunosensor surface are contributing.  
Figure 4. 14b again for clarity, shows the change in impedance due to non-specific 
psoriasin antigen on the NGF immunosensor with antigen concentrations displayed on a 
linear scale. 
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Figure 4. 14a: The percentage impedance change (Ohms) in response to a range of concentrations of 
NGF antigen (100pg ml
-1
 – 10ng ml-1) on an immunosensor fabricated with anti-psoriasin using the 
BioDot auto-dispensing system. 
 
 
 
Figure 4. 14b: The percentage impedance change (Ohms) in response to a range of concentrations of 
NGF antigen (100pg ml
-1
 – 10ng ml-1) on an immunosensor fabricated with anti-psoriasin using the 
BioDot auto-dispensing system. 
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Figure 4. 15 plots the corrected calibration curves (impedance responses due to 
non-specific interactions on the immunosensor surface) comparing psoriasin targeted 
immunosensor responses to a range of psoriasin concentrations for both immunosensors 
fabricated by hand and using the BioDot auto-dispensing system. 
 
 
 
 
Figure 4. 15:  Corrected calibration curve showing the percentage change in impedance (Ohms) over 
a range of psoriasin antigen concentrations (250pg ml
-1
 – 10ng ml-1).  This immunosensor was 
fabricated using the BioDot auto-dispensing system. The impedimetric response to psoriasin from 
interrogations with a hand fabricated psoriasin immunosensor is shown in pink. 
 
 
 
An R
2
 = 0.89 between 250pg ml
-1
 and 5ng ml
-1
 and small error bars can be observed in 
Figure 4. 15 with the BioDot fabricated sensor showing distinguishable data points.  The 
curve appears to be reaching plateau at antigen concentrations higher than 5ng ml
-1
.  The 
range of detection is 250pg ml
-1
 to 5ng ml
-1
, in comparison to the physiological 
concentrations of psoriasin of 5 – 20ng ml-1. 
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The fabrication of the psoriasin immunosensor using the automatic dispensing system has 
both decreased error bars significantly from a coefficient of variance of 567.79% (hand 
fabricated sensors) to 14.38% (sensors fabricated using the BioDot automated reagent 
dispensing system).  In addition, the linearity of the calibration curve was improved, 
giving an R
2
 = 0.89 between 250pg ml
-1
 – 5ng ml-1.  Therefore, in comparison with the 
immunosensor fabricated by hand, not only does the BioDot auto-dispensing system 
fabricated sensor give a lower significant level of detection, but it also gives a wider 
range of significant detection between 250pg ml
-1
 -1ng ml
-1
 as opposed to between 1 - 
2.5ng ml
-1
.   
 
It is important to note that although the detection range of the BioDot fabricated sensor is 
below the physiological range (250pg ml
-1 – 10ng ml-1 compared to 5 - 20ng ml-1 
respectively), any sample to be tested for psoriasin from a physiological sample can be 
diluted up to 10-fold, which would give the additional benefit of further minimising 
standard error. 
 
It is necessary to validate the specificity with which these impedimetric response profiles 
are being formed, since although it appears that both the NGF and psoriasin 
immunosensors are giving the required responses according to those set out in chapter 1, 
there may be other factors involved that affect the impedimetric response such as, for 
example, the ferri-ferrocyanide ions for the electrolyte media entering the polymer 
matrix, or the phosphate buffered saline solution in which the various antigen 
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concentrations are diluted may exert some effect.  Additionally, the dipping of the 
electrode between solution incubations and interrogations, are investigated for the NGF 
and psoriasin immunosensors in chapters 6 and 7, respectively. 
 
In the interest of concise representation of the results in this project, all subsequent 
impedance interrogation results will not include Nyquist or Bode plots in addition to the 
specific and non-specific impedance responses.  Instead only the corrected calibration 
curves (taking into account the non-specific control sensor responses) will be presented. 
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4.4. Single Shot Immunosensor Interrogation 
4.4.1. Introduction 
The antigen-antibody interaction on these immunosensors is irreversible.  Once each 
immunosensor has been incubated with its target analyte, a certain proportion of the 
available antibody binding sites will be irreversibly occupied, leaving a smaller 
proportion available for binding more antigen at higher concentrations.   
 
To further investigate this issue, instead of measuring a range of antigen concentrations 
using a single immunosensor electrode, which may act to saturate the immunosensors 
binding surface at an early stage, each sensor was interrogated just once per antigen 
concentration.  A baseline measurement was taken with each electrode before any antigen 
incubation and then the impedance change after 30 minutes incubation with a single 
antigen concentration was measured.  A different sensor was then used to measure each 
separate antigen concentration.  
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4.4.2. Results and Discussion 
Nerve Growth Factor (NGF) Immunosensor: 
Figure 4. 16a displays the impedance changes observed across a range of NGF antigen 
concentrations on a specific NGF immunosensor.  Each measurement was taken using a 
separate immunosensor.  Figure 4. 16b shows the identical data set, however the antigen 
concentrations are plotted on a linear scale. 
 
 
Figure 4. 16a: The corrected (impedance changes due to non-specific interactions on the 
immunosensor have been subtracted) percentage change impedimetric response (Ohms) of NGF 
immunosensors between base impedance profiles and the response seen after incubation with a single 
analyte concentration. 
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Figure 4. 16b: The corrected (impedance changes due to non-specific interactions on the 
immunosensor have been subtracted) percentage change impedimetric response (Ohms) of NGF 
immunosensors between base impedance profiles and the response seen after incubation with a single 
analyte concentration. 
 
The impedimetric profiles for the response to a range of concentrations of NGF antigen 
when tested as single use immunosensors rather than with a serial dilution technique (as 
described in chapter 3, section 3.6.5 and results reported in section 4.3.2 of this chapter) 
are completely different.  The plot shown here (Figure 4. 16a) shows changes in 
impedance that are negligible in contrast to the responses shown in Figure 4. 12.  
However, both of these plots show a significantly similar response following exposure to 
10pg ml
-1
 of NGF antigen.   
 
It is postulated that the immunosensor constructs integrity and structure may depreciate, 
due to the stability of the sensor construct in air and at room temperature, during the 
technique used for the single use immunosensors.  Fabricated sensors are stored dry, at 
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room temperature for up to three hours before they are introduced to an antigen sample 
and subsequently interrogated by impedance.  In comparison to sensors interrogated with 
serial dilutions whereby each immunosensor is exposed to antigen immediately after 
fabrication and preparation procedures are complete and remains in wet conditions for the 
remainder of the experiment.  Therefore the first initial measurements, initiated up to 1 
hour after the fabrication procedure is completed (Figure 4. 16a data points for 1, 5 and 
10pg ml
-1
) show a similar response to those observed when sensors are interrogated using 
the serial dilutions interrogation technique.  The response observed for 10pg ml
-1
 is 
similar as the upper-most figure for the error bars shown at this antigen concentration is 
35% (in Figure 4. 16a) and the lowest observed figure from the error bars in Figure 4. 12 
at this same antigen concentration is 33%. 
 
 
Psoriasin Immunosensor: 
The following graph (Figure 4. 17a) illustrates the changes in impedance observed with 
psoriasin targeted immunosensors after incubation with a range of psoriasin 
concentrations.  Again, the effect on impedance of each concentration was measured on a 
separate sensor as opposed to measuring the entire range using a single immunosensor 
electrode (as described in chapter 3, section 3.6.5).  Figure 4. 17b also displays the same 
impedance changes as Figure 4. 17a, but on a linear scale. 
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Figure 4. 17a: The corrected (impedance changes due to non-specific interactions on the 
immunosensor have been subtracted) percentage change impedimetric response (Ohms) of psoriasin 
immunosensors between base impedance profiles and the response seen after incubation with a single 
analyte concentration. 
 
Figure 4. 17b: The corrected (impedance changes due to non-specific interactions on the 
immunosensor have been subtracted) percentage change impedimetric response (Ohms) of psoriasin 
immunosensors between base impedance profiles and the response seen after incubation with a single 
analyte concentration. 
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As described above in section 4.4.2 for the NGF immunosensors, the technique of using 
each immunosensor for the measurement of a single antigen concentration results in the 
storage of immunosensors, in some cases for up to three hours in dry conditions and at 
room temperature prior to incubation with antigen and impedance interrogation.  The plot 
in Figure 4. 17a reflects that sensors are unstable when stored in these conditions and 
their ability to display a large change in impedance after incubation with specific antigen 
is diminished.  However, the responses seen at concentrations of antigen at 25, 50 and 
125pg ml
-1
 are thought to be representative of a working immunosensor.   
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4.5. Fabrication with Higher Antibody Concentrations - 
Centrifugal Filtration (Psoriasin Only) 
4.5.1. Introduction 
Microcon
TM
 centrifugal filter devices can be used to repeatedly spin diluted antibody 
solutions via a standard centrifuge and collecting the retentate several times over until a 
higher satisfactory concentration is reached.  The protocol provided with the Microcon 
Centrifugation Kit was followed in order to produce 100μl of psoriasin at a concentration 
of 2.5mg ml
-1
.   
 
It was postulated that by increasing the concentration to 2.5mg ml
-1
, more antibodies per 
millilitre could possibly be deposited onto the surface of the electrode, so as to provide 
greater electrode surface coverage in terms of specific antibody immobilisation, thereby 
optimising the sensitivity of the device. 
 
4.5.2. Results and Discussion 
Anti-psoriasin, at a starting concentration of 0.5mg ml
-1
, was concentrated using 
centrifuge filtration to 2.5mg ml
-1
.  Psoriasin targeted immunosensors were then 
fabricated, using the BioDot automated reagent dispensing system (as described in 
chapter 3, section 3.5.3), using a higher concentration of anti-psoriasin in an effort to 
enhance electrode surface coverage and effectively enhance the sensors sensitivity 
towards its analyte.  However, after incubation with the target psoriasin analyte and 
subsequent impedance interrogation, it was found that fabrication of the immunosensor 
with higher antibody concentrations (2.5mg ml
-1
 in comparison to the concentration of 
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0.5mg ml
-1
 previously used) resulted in lower changes in impedance relating to each 
antigen concentration (Figure 4. 18).   
 
 
Figure 4. 18: The changes in impedance (Z’ – Ohms) over a range of psoriasin antigen concentrations 
(25pg ml
-1
 – 30ng ml-1).  A comparison is made of this effect between a sensor fabricated with 0.5mg 
ml
-1
 psoriasin antibody (blue line) and 2.5mg ml
-1
 psoriasin antibody (pink line). 
 
 
 
Increasing the antibody concentration lowers the impedimetric response to the specific 
antigen, whilst decreasing the standard error.  This may be due to available specific 
avidin binding sites on the sensor surface being saturated at the lower antibody 
concentrations.  It is possible that a higher antigen concentration may cause a build-up 
effect of non-specifically adsorbed antibody molecules on the sensor surface (Figure 4. 
19), which may dampen any effects the antigen-antibody binding event would have on 
the observed impedance; in this way the increasing concentration of antibody protein may 
effectively behave as an excess amount of blocking agent.   
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Figure 4. 19: Schematic displaying the dampening effect of adding excess antibody to the 
immunosensor surface, which may non-specifically bind on-top of other specifically bound 
antibodies, acting as a dampening layer, preventing increased concentrations of antigen to be 
differentiated from lower ones. 
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4.6. Fabrication with Higher Antibody Concentrations - 
Commercially Harvested IgG Serum (NGF Only) 
4.6.1. Introduction 
Antibodies can be procured in much higher concentrations by commissioning their 
production ‗to order‘, as opposed to purchasing them commercially.  Polyclonal serum 
was produced to order and affinity purified to collect a monoclonal serum with antibodies 
in the concentration range of 10-20mg ml
-1
.  The objective is then to saturate the sensor 
surface with specifically immobilised antibody and therefore obtain an optimal 
immunosensor in terms of both sensitivity and reproducibility. 
 
4.6.2. Results and Discussion 
High concentrations of anti-NGF were procured ‗to order‘ and used to fabricate NGF 
targeted immunosensors with a range of antibody concentrations (1mg ml
-1
, 2.5 mg ml
-1
 
and 5mg ml
-1
).  Sensors were then incubated with a range of NGF antigen concentrations 
and subsequently the change in impedance was interrogated and recorded in Figure 4. 20. 
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Figure 4. 20:  The changes in impedance (Z’ – Ohms) over a range of NGF antigen concentrations 
(1pg ml
-1
 – 500pg ml-1).  A comparison is made of this effect between a sensor fabricated with 1mg ml-
1
 NGF antibody (blue line), 2.5mg
 
ml
-1
 NGF antibody (pink line) and 5mg ml
-1
 NGF antibody (green 
line). 
 
 
 
 
Again, as shown previously in section 4.5, the fabrication of an immunosensor with 
excess layers of antibody deposited onto the surface, results in lower impedance changes 
after incubation with the target analyte, as shown in Figure 4. 20 in the case of an NGF 
targeted immunosensor.   
 
It may only be necessary to cover the immunosensor surface with a single layer of 
antibody in order to achieve a reliable impedance response and therefore by increasing 
the layer thickness by adding antibody concentrations highly in excess of what is needed 
to saturate the surface, it is possible that any increase in layer thickness due to the 
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specific interaction between anti-NGF and NGF protein will be proportionally small 
comparatively to the total thickness of the layer.  As the impedance observed is related to 
the immunosensor layer thickness, it follows that a greater change in layer thickness will 
result in a greater change in impedance.  It is possible that due to a greater total layer 
thickness on the immunosensor surface, as the concentration of antibody used to fabricate 
the sensor increases, the binding of antigen to the surface is lower as a percentage of this 
total layer thickness and therefore the impedance change becomes lower.   
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4.7. Minimising the Effects of Ferri-ferrocyanide Swelling - 
(NGF Only) 
4.7.1. Introduction 
The effects of ferri-ferrocyanide incubation on the electrochemical impedance of NGF 
immunosensors were investigated.  Immunosensors, fabricated as described in chapter 3 
section 3.5.3, were incubated for an extended period in 1 x 10
-6
 M ferri-ferrocyanide 
(concentration of ferri-ferrocyanide used in the impedance interrogation of NGF 
immunosensors) and the impedance measured at 30 minute intervals. 
 
4.7.2. Results and Discussion 
NGF specific immunosensors were developed as described in chapter 3, section 3.5.3, 
and measurements of the change in impedance (Ohms) in response to extended 
incubation in 1 x 10
-6
 M ferri-ferrocyanide (Figure 4. 21). 
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Figure 4. 21: Shows the mean trend in impedance change (Z’ Ohms) over time on a fully fabricated 
NGF sensor.  A 150 minute window is drawn during which the ferri-ferrocyanide effects on 
impedance are minimal. 
 
 
Figure 4. 21 illustrates the mean trend in impedance (Z‘) change in Ohms over time on an 
NGF sensor.  A window of 150 minutes was observed between 200 – 350 minutes during 
which the impedance only fluctuated by 6% as compared with the 240% fluctuation 
between 120 – 500 Ohms overall.  It is within this window that the sensor can be 
interrogated with minimal disruption to the specific impedimetric response created by the 
antibody-antigen interaction.  A hypothesis put forward is that the effect of incubation of 
the sensors with ferri-ferrocyanide on the impedance is due to the ferri-ferrocyanide ions 
(Fe
2+
/Fe
3+
) entering the polyaniline matrix. 
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Therefore in order to minimise the increase in impedance due to this non-specific 
interaction between ferri-ferrocyanide and the sensor during interrogation, sensors are 
incubated for 200 minutes in 1 x 10
-6 
M ferri-ferrocyanide as a standard preparatory step 
after fabrication and prior to impedance interrogation. 
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4.8. Conclusions 
The fabrication of immunosensors specifically targeting NGF and psoriasin were 
fabricated both by hand and with the use of an automatic reagent dispensing system 
(BioDot).  It was found that sensor fabrication using the BioDot resulted in 
immunosensors with far greater reproducibility and with a larger impedance change in 
response to incubation of the sensor with the target antigen, than immunosensors 
fabricated by hand.  This is due to the increased accuracy and precision with which the 
reagents were deposited onto each working electrode surface. 
 
From the investigations presented in section 4.4, testing immunosensors using a single 
shot for each antigen concentration, in addition to the studies reported in chapter 6, 
section 4.6, offers insights into the deterioration of the immunosensor response over time 
being stored in particular conditions.  The storage of sensors dry and at room temperature 
for more than three hours resulted in complete depletion of any change in impedance 
signal in response to antigen incubation.  In comparison, the storage of sensors over a 24 
hour period, in dry conditions at 4°C resulted in a 50% decrease in observed change in 
impedance.  Further studies are necessary to establish optimum storage conditions and 
the suitability of various preservatives (as discussed further in chapter 10, section 10.2). 
 
The exposure of both the NGF and psoriasin targeted immunosensors for prolonged 
periods in ferri-ferrocyanide electrolyte media is shown (section 4.7) to have an effect on 
the impedance response of the immunosensor even in the absence of antigen.  This is 
postulated to be due to the leeching of ferri-ferrocyanide ions into the immunosensor 
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construct and polyaniline matrix, possibly increasing the layer thickness and therefore the 
impedance.  However after approximately five hours incubation with ferri-ferrocyanide, 
there is seen to be a direct decrease in impedance thought to be caused by the 
accumulation of ions in the immunosensor construct, forming conductive pathways 
which effectively increase conductivity, counteracting any increase in impedance caused 
by the specific interaction between antibody and antigen.  Therefore any prolonged 
exposure to ferri-ferrocyanide should be avoided in order to prevent false negative results 
being obtained. 
 
The mechanism by which the interaction between antibody and antigen on an 
immunosensor surface can change the impedance consists of two opposing factors (Tully 
et al., 2008).  The first factor involves the addition of the antigen to the antibody itself.  
This facilitates charge transfer across the construct and therefore decreases impedance.  
The second factor is the formation of a new layer onto the immunosensor construct 
following the binding of antigen.  This increases the layer thickness and therefore the 
distance that charge must travel through the construct, thereby having an effect to 
increase impedance.  The most predominant factor will control the overall impedance 
response observed for an immunosensor subsequent to incubation with its specific 
antigen.  It is hypothesised that larger antigens, such as NGF and psoriasin, add a thick 
layer to the immunosensor construct, thereby creating a significant change in 
immunosensor thickness in comparison to its facilitation of charge transfer.  Smaller 
antigens by contrast will have a greater influence on the facilitation of charge transfer 
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than the thickness of the construct and so this effect will dominate the response with a 
decrease in impedance being observed.  
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5. Fabrication and Verification of Immunosensors 
5.1. Introduction 
Validation for the fabrication of both NGF and psoriasin immunosensors are presented in 
this chapter, along with various characterisation techniques used to provide evidence for 
the successful construction of the sensors in line with the objectives. 
 
The use of a variety of characterisation techniques allows the sensor to be 
cross-examined from several viewpoints, thereby strengthening each method of analysis 
with similar test results confirmed by an alternative method.  Through this, a picture of 
the electrode can be built up and used to support target interrogation results. 
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5.2. Quartz Crystal Microbalance (QCM) 
5.2.1. Introduction 
A (Q-Sense) quartz crystal microbalance (Figure 5. 1) was used to monitor the binding of 
each reagent during the sensor fabrication process.  The gold electrode sensor fabrication 
was monitored at each stage excluding electro-polymerisation (in the case of polyaniline) 
which could not be traced by a QCM without electrochemical function.  Subsequent 
incubation of each reagent individually to the sensor sensor surface, followed by a wash 
stage with de-ionised water, in which any unbound or non-specifically bound reagent is 
removed, is followed by QCM.  Upon the binding of more of each reagent, the change in 
mass on the gold electrode surface alters the resonance frequency of the quartz crystal 
within the QCM device.  In this way, the change in frequency, can be directly related to 
the change in mass.  The specific binding of reagents to the surface in a particular order is 
therefore monitored and can be visualised on the frequency over time plot produced. 
 
Figure 5. 1: A Q-Sense quartz crystal microbalance with pump and control system attached to a PC 
operating system (adapted from Q-Sense.com) 
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This method allows confirmation of the steadfast binding of each reagent onto the sensor 
during fabrication.  These results, in conjugation with alternative characterisation 
methods, can validate the sensor construct as being formed as expected, in addition to 
quantifying how vulnerable the surface of the sensor is to washing steps at each stage of 
fabrication. 
 
A gold electrode with polyaniline (a conductive polymer) electropolymerised on to its 
surface was placed into the QCM device and each reagent in turn was introduced by 
injection through a system of flow tubes controlled by a motor and pump.  Each 
deposition stage was interspersed by a washing step. 
 
5.2.2. Results and Discussion 
Nerve Growth Factor (NGF) Immunosensor 
 
As displayed below, each step of NGF immunosensor fabrication resulted in a change in 
resonance frequency (Hz).  Subsequent washing steps with 0.01M PBS were initiated in 
between each immobilisation step to remove any excess or non-specifically bound 
reagent.  Figure 5. 2 depicts a QCM profile for the molecular fabrication of each stage of 
the NGF immunosensor. 
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Figure 5. 2: QCM Plot displaying the change in resonance frequency (Hz) of the quartz crystal upon 
binding reagents onto the gold electrode surface. 
 
 
As described by the Sauerbrey equation, the change in resonance frequency of a quartz 
crystal is proportional to the mass change on the surface on the crystal according to the 
following equation (Equation 5. 1), whereby Δƒ = Change in resonance frequency (Hz), 
ƒ0
 
= QCM electrode total resonance frequency (Hz), A = QCM crystal area, ρq =  The 
density of quartz (2.648 g cm
-2
) and
 µq = The shear modulus for AT-cut crystals (2.947 x 
10
11
 g cm
-1
 s
-2
) 
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     Δƒ = -   
 
Equation 5. 1: The Sauerbrey Equation – Relating a change in quartz crystal resonance frequency to 
a mass change on the crystal surface.  
 
The following table (Table 5. 1) shows the mass increases on the QCM electrode surface 
after incubation of each reagent in sensor fabrication.  The frequency changes are given 
to show what was plugged into the Sauerbrey equation. 
Reagent + (Total Mass 
Added) 
Change in Resonance 
Frequency (Δƒ) (Hz) 
Mass Change (Δm) 
Biotin (13kDa) (500ng) 12.69 275ng (55%) 
Avidin (66kDa) (40mg) 69.18 0.00158mg (0.004%) 
Biotinylated Anti-NGF 
(153kDa) (4mg) 
11.4 0.000261mg (0.007%) 
BSA (67kDa) (240ng) -6.12 (-140ng)  
Specific NGF Antigen 
(~14kDa) (1µg) 
26.57 0.000609µg (0.06%) 
Table 5. 1: Table showing the frequency changes in Hertz induced by the binding of each reagent in 
the sensor fabrication process and the subsequent relative mass that has therefore bound to the 
surface. 
  
Excluding the frequency change observed after the exposure of BSA to the electrode 
surface, all other frequency changes in line with reagent incubations prove that a certain 
amount of that reagent specifically bound to the electrode surface, effecting a mass 
change.  This provides evidence for the fabrication of the NGF immunosensor as 
described previously in chapter 3.  The loss of mass from the electrode surface after 
incubation with BSA may be due to the loss of other reagents previously deposited on the 
2ƒ0
2 
A√ρqµq 
Δm 
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surface which may have been removed due to a change in viscosity and therefore flow 
rate of the BSA media over the electrode surface.  A faster flow rate over the electrode 
surface would potentially have mechanical effects on the construct to remove previous 
reagents deposited and therefore the drop in mass on the electrode surface after BSA 
incubation is not necessarily due to the loss of BSA alone, which may still have bound to 
the surface of the electrode. 
 
Another phenomenon relevant to this investigation is that as more layers are deposited 
onto the QCM electrode surface, there may be a dampening effect on the change in 
frequency related to the change in mass.  Therefore, although an affect can be observed in 
relation to the addition of each reagent, the thicker or more complex the layer onto which 
the reagent is deposited, the less observable that frequency change becomes (Voinova et 
al., 2002).  This explains why even though antibodies are much larger in molecular 
weight than biotin and avidin, particularly when the antibody is biotinylated, the change 
in resonance frequency of the quartz crystal is not always proportional in comparison to 
the change in mass on the surface (Voinova et al., 2002). 
 
Finally, the QCM results suggest that the association constant for anti-NGF / NGF is 
slow in that the antigen (NGF) continues to bind to the surface an therefore the mass and 
resonance frequency of the quartz crystal keep increasing for up to 3 hours, in contrast to 
the other reagents which take between 10 and 30 minutes to bind the maximum possible 
amount. 
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Psoriasin Immunosensor 
As with QCM investigations in the fabrication of the NGF immunosensor, the fabrication 
of a psoriasin immunosensor on the surface of a gold electrode was also traced via the 
QCM.  A Q-Sense gold electrode was covered with polyaniline by electropolymerisation 
and enclosed inside the QCM device.  The resonance frequency of the quartz crystal on 
which the reagents were deposited was measured and the changes were plotted in Figure 
5. 3. 
 
Figure 5. 3: The changes in resonance frequency (Hz) of the quartz crystal upon binding reagents at 
each stage of psoriasin immunosensor fabrication. 
 
 
The Sauerbrey equation (Equation 5. 1) was then used to relate the change in frequency 
(Hz) to the change in mass (g) on the gold / quartz crystal. The results, including the 
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original mass of each reagent exposed to the surface and the final mass that bound 
specifically to the surface, are shown below in Table 5. 2. 
 
Reagent + (Total Mass 
Added) 
Change in Resonance 
Frequency (Δƒ) (Hz) 
Mass Change (Δm) 
Biotin (13kDa) (500ng) 3.26 71.1ng (14.2%) 
Avidin (66kDa) (40mg) 58.04 0.00126mg (0.003%) 
Biotinylated 
Anti-Psoriasin (153kDa) 
(400µg) 
18.13 0.399µg (9.98%) 
BSA (67kDa) (240ng) 0.83 18.1ng (7.54%) 
Specific Psoriasin Antigen 
(~11kDa) (4µg) 
14.9 0.000325µg (0.008%) 
Table 5. 2: The frequency changes (Hz) induced by the binding of each reagent in the psoriasin 
immunosensor fabrication process and the subsequent relative mass that has therefore bound to the 
surface. 
 
This QCM investigation in order to characterise and validate the fabrication of the 
psoriasin immunosensor successfully showed that all reagents are deposited onto the 
electrode surface as described in detail in chapter 3.   
 
Interesting points to discuss regarding these results first involves the interaction of biotin 
with the polyaniline surface.  There is a sharp change in the quartz resonance frequency 
until a washing step is initiated, removing up to 95% of the biotin layer originally 
deposited.  This may very well be due to biotin molecules aggregating and exerting large 
fluctuations in the frequency change of the quartz crystal and these aggregates are then 
removed during the washing step. 
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Additionally, it is important to note that as more layers are deposited onto the gold / 
quartz electrode, the relative effect on frequency change that a particular mass change 
also is dampened, as seen and explained previously concerning the NGF immunosensor 
QCM investigation. 
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5.3. 125Iodine Radio-Labelling 
5.3.1. Introduction 
Anti-NGF and anti-psoriasin were each conjugated with a radiolabel (
125
Iodine) in order 
to monitor the proportion of total antibody that specifically binds to the surface.  Excess 
antibody was washed off with 2M NaCl buffer which breaks the electrostatic interaction 
that loosely bind antibodies to the polymer surface non-specifically (Figure 5. 4). 
 
Figure 5. 4: Diagram showing the experimental protocol for measuring and subsequently calculation 
the proportional radioactivity on the sensor surface, which is directly related to the proportion of 
antibody initially introduced to the sensor that has specifically bound to the electrode surface. 
 
Conjugation was achieved using a standard radiolabelling kit (Thermo Fischer Scientific) 
which binds 
125
I to the protein via Iodo-bead carriers.  The samples were then run through 
a separation column behind a radioactive resistant shield and 1ml fractions of sample 
were collected ready for measuring the counts per minute (cpm) in a gamma radiation 
counter.  The proportion of anti-NGF and anti-psoriasin that was radioactively labelled 
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was 577.57cpm µg
-1
 and 996.058cpm µg
-1
 respectively as calculated from Figure 5. 5.  
The initial peaks (circled) show the radiolabelled antibody.  The corresponding fractions 
under this initial peak are taken in order to calculate the proportion of antibody 
radiolabelling in comparison to the original antibody concentration. 
 
Figure 5. 5: A plot showing the counts per minute (cpm) of a set of elutant fractions from a column.  
The circled fractions are the fractions containing radiolabelled antibody, which can subsequently be 
deposited onto the working electrode surface. 
 
 
 
The construction of the sensor was performed as described within chapter 3).  The 
radioactivity of the working electrode surface was then monitored before and after the 
washing step with 2M NaCl.  The difference between the before and after measurements 
can be related to the quantity of antibody remaining on the sensor surface compared to 
the initial concentration introduced - thereby giving quantitative evidence of the 
proportion of the antibodies deposited on the surface.  This approach can be validated by 
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comparison commensurate with the radioactivity dermined in the 2M NaCl buffer used to 
wash the sensor surface. 
5.3.2. Results and Discussion 
Radio-labelled antibody was used to observe the proportion of specifically bound 
antibody on the surface of the sensor compared to the total amount of antibody that had 
originally been deposited onto the surface of the sensor.  The level of radiation measured 
could then be related to the concentration of antibody on any particular sample.  It was 
found that on the NGF immunosensor, only 16% of the antibody originally deposited on 
the working electrode surface had specifically bound.  In a similar manner it was found 
that xxx 20% of the psoriasin had specifically bound to sensor surfaces Table 5. 3. 
 
 
 
 
 
Table 5. 3:  This table shows the percentage of radioactivity remaining on the surface of the working 
electrode of both NGF and psoriasin sensors – and therefore the percentage protein specifically 
bound to the electrode, after being washed with 2M NaCl. 
 
 
It is evident from these investigations that up to 84% of the antibody exposed to the 
surface are not specifically bound to the surface. 
 
One explanation for these results is that either there is insufficient availability of 
neutravidin covalent binding sites on the surface to immobilise the biotinylated 
antibodies, or that the concentration of antibody initially deposited onto the 
 % radioactivity remaining 
on sensor after washing 
with 2M NaCl 
NGF sensor 16% 
Psoriasin sensor 20% 
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immunosensor surface is in excess of that required to cover the surface of the 
immunosensor and then occupy all available neutravidin binding sites.  This would result 
in a large percentage of the initially deposited anti-NGF or anti-psoriasin being 
non-specifically bound and removed during a washing step. 
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5.4. Fluorescence Labelling – Confocal Microscopy 
5.4.1. Introduction 
Anti-Fluorescein (anti-FITC) was used in the qualitative measurement to visualise the 
proportion of antibodies that are bound specifically via the biotin-avidin bridge and 
which bind non-specifically to the sensors‘ polymerised surface.  The sensors were 
fabricated according to the protocol (outlined in chapter 3), with the exception of the 
replacement of the NGF and psoriasin antibodies with alternative FITC fluorescently 
labelled antibodies (Figure 5. 6). 
 
Figure 5. 6: A photograph of a confocal microscope with ‘zoom’ view of fluorescently labelled 
antibodies attached to the working electrode surface via the biotin-avidin bridge and polyaniline (as 
used within this project). 
 
 
A contrast and comparison is possible between the behaviour of the fluorescently labelled 
anti-FITC and the NGF or psoriasin antibody.  This is due to the fact that an 
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antibody-antigen binding event is not being interrogated; only the binding of the 
biotinylated constant fragment (Fc) antibody region to the avidin layer on the sensor 
surface is being investigated.  The Fc region is identical on all IgG molecules, regardless 
of the specific target, or analyte. 
 
Fluorescently labelled antibodies on the sensor surface were then visualised via confocal 
microscopy.  This optical imaging technique uses point illuminations to detect and 
construct a three dimensional image of the sample.  The sample fluorescence was 
analysed before and after a washing step with de-ionised water and any remaining, 
specifically bound antibodies visualised as a percentage coverage of the sensor surface.  
This information was then used to ascertain if the sensor can be further optimised by 
increasing the surface coverage of antibody or whether the surface is saturated with 
specifically bound antibody. 
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5.4.2. Results and Discussion 
Immunosensors were fabricated as detailed in chapter 3, section 3.5.3, replacing the 
anti-NGF and anti-psoriasin with anti-FITC pre-bound to FITC.  Fluorescently active 
immunosensors could then be viewed under the confocal microscope and characterised in 
terms of layer homogeneity and layer thickness.  This layer thickness only concerns the 
antibody layer, as only fluorescent artefacts can be seen.  Figure 5.7a shows a confocal 
micrograph at a cross section through the layer to view surface homogeneity, taken under 
an argon laser at a wavelength on 483nm in order to visualise the FITC fluorophores.  
Figure 5.7b shows a 3D side view of the immunosensor construct, after stacking all cross 
sectional images together.   
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Figure 5.7a: Confocal micrograph showing the layer homogeneity of FITC labelled antibodies 
immobilised onto the immunosensor construct. 
 
 
Figure 5.7b: Confocal micrograph showing a stacked side view of the immunosensor, providing 
information about layer thickness. The sensor surface is on the right and the air on the left hand side 
of the image. 
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Confocal micrographs of the immunosensor construct are presented (Figure 5.7a and 
Figure 5.7b) that show both layer thickness of the biotin – avidin bridge and antibody 
layer combined and the homogeneity of the sensor layer.   
 
The thickness of the biological component layer on the immunosensor (~10µm) is around 
500 times that of the theoretical thickness a single layer of antibody immobilised on the 
surface would give, assuming the average height of a 140kDa antibody molecule to be 
20nm.  While the layer thickness is an important component in order to detect impedance 
changes at certain frequencies, this deposition of a concentration of antibodies that far 
exceeds the necessary concentration (1mg ml
-1
) may in fact hinder the sensitivity of the 
sensor, in addition to increasing the cost to fabricate each sensor.   
 
Further research should be done into the consequence of lowering the concentration of 
antibody used in construction of these immunosensors on the sensitivity and ability to 
detect antigen concentration changes with impedance.  It could be possible to thicken the 
layer with a cheaper substitute. 
 
 
 
 
 
 
  
T.R.J. Holford          Cranfield University 
5.5. Scanning Electron Microscopy 
5.5.1. Introduction 
A scanning electron microscope (SEM) was used to monitor topological changes on the 
sensor as reagents where immobilised onto the surface.  Sensors were constructed and at 
each stage, surfaces were visualised under the SEM (Figure 5. 8).  Each scanning electron 
micrograph was taken at 1,000 times magnification and at an operating potential of 15kV. 
 
Figure 5. 8: Diagram a scanning electron microscope. 
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5.5.2. Results and Discussion 
Images of the working electrode were taken in a vacuum at 1,000 times magnification 
and an operating potential of 15kV at each stage of the sensor fabrication (Figure 5. 9 
A-F). 
 
A – B: ‗A‘ displays a blank carbon ink printed electrode.  As can be seen, the surface is 
heterogeneous, with clusters of carbon graphite.  ‗B‘ displays a change in the electrode 
surface topography due to the deposition of polyaniline conductive polymer layer. 
 
 
Figure 5. 9 A: An SEM micrograph of a 
screen printed blank carbon ink electrode.  
Taken at 15kV and 1,000 x magnification. 
Figure 5. 9 B: Micrograph of a conductive 
(poly)aniline layer electrodeposited onto the 
carbon surface.  Taken at 15kV and 1,000 x 
magnification. 
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C – D: Both ‗C‘ and ‗D‘ show a marked change to the electrode face.  To compare and 
contrast ‗B‘ – ‗C‘, it can be seen that the surface topology has changed, in that ‗C‘ 
appears more homogenous due to coverage with the biotin layer. 
 
 
 
 
 
 
 
Figure 5. 9 C: SEM micrograph of the 
biotin layer, deposited onto the (poly)aniline 
forming the first section of the biotin-avidin 
bridge.  Taken at 15kV and 1,000 x 
magnification. 
Figure 5. 9 D: The avidin layer deposited to 
bind onto the biotin-avidin bridge on which 
to dock the biotinylated antibodies.  Taken 
at 15kV and 1,000 x magnification. 
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E – F:  Additional protrusions are now visible on these micrographs, illustrating that the 
surface characteristics have changed after the immobilisation of the specific NGF 
antibody. 
 
 
 
 
 
 
 
 
 
 
It is evident from the SEM micrographs that there is evident change in the surface of the 
working electrode in alignment with the deposition of biological components.  Each 
micrograph was taken after washing of the sensor surface with copious deionised water; 
the observed features are therefore of specifically bound material at the surface and 
Figure 5. 9 E: NGF antibodies immobilised 
onto the sensor construct. Taken at 15kV 
and 1,000 x magnification. 
Figure 5. 9 F: Psoriasin antibodies 
immobilised onto the sensor construct. 
Taken at 15kV and 1,000 x magnification. 
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provide a representation of the surface topology of a working electrode used during 
electrochemical impedimetric interrogation to determine NGF and psoriasin analyte 
concentration in a sample. 
 
Micrographs A – B:  These two micrographs display the topographical changes occurring 
following the electropolymerisation of aniline to the working electrode surface.  There is 
a clear change in the micrograph profile, indicating a layer, or several layers of 
polyaniline have formed on the electrode surface.  The surface is however by no means a 
smooth or flat foundation on which to build the rest of the sensor.  This in support of the 
radiolabelling investigations (section 5.3) presents good grounds on which to hypothesise 
that much of the standard error seen between repeat immunosensor electrodes originated 
from the uneven distribution of polyaniline on the sensor surface, in turn resulting in the 
uneven distribution of each fabrication step including biotin, avidin and ultimately, the 
biotinylated antibodies. 
 
It is also possible that due to the ‗mountainous‘ topography of the polyaniline layer, 
many biotin and avidin binding sites become physically inaccessible to the respective 
antibody, meaning that any increase in antibody concentration added might not result in 
increased sensitivity or performance of the immunosensor. 
 
Micrographs C – F:  These remaining micrographs cannot provide information on 
increasing layer density or depth, as well as any visualisation of individual antibody 
molecules due to the limits of the magnification of this apparatus.  However, these 
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micrographs do give clear indication of a change in topographical properties after 
deposition and a subsequent washing step, which, when paired with QCM and 
fluorescence results (sections 5.2 and 5.4 respectively) provides additional evidence that 
each reagent is being deposited in a correct order as specified by the sponsor of this 
project. 
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5.6. Conclusions 
 
The most important conclusion attained through the validation approaches in this chapter 
is that both the NGF and psoriasin immunosensor constructs, fabricated as described in 
chapter 3, section 3.5, have an excess of non-specifically adsorbes antibody on the 
surface as confirmed through QCM, fluorescence and radiolabelling investigations.   
 
It is possible that an optimal layer thickness must be reached in order for impedance 
changes to be detectable; however, a layer that is too thick (~10µm in this case) can 
dampen the change in impedance caused by the addition of specifically bound antigen 
due to the change being too small in proportion to the total layer thickness.  It is therefore 
hypothesised that a greater sensitivity and further enhanced reproducibility can be 
achieved by depositing an initial lower antibody concentration during immunosensor 
fabrication steps. 
 
In addition, the QCM investigation reveals that the association constant of both 
anti-NGF/NGF and anti-psoriasin/psoriasin displays slow kinetics since binding 
subsequent to introduction of the antigen to the QCM chamber does not reach completion 
until after approximately three hours.  Therefore prior to impedance interrogation, the 
prolonged exposure of the immunosensor to antigen could result in higher responses seen 
for each separate antigen concentration. 
 
 
 
 
 
  
T.R.J. Holford          Cranfield University 
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6. Nerve Growth Factor Immunosensor Validation 
6.1. Introduction 
This chapter aims to present and discuss the validation step of the project, whereby the 
immunosensors targeted towards NGF are subject to various investigations to ensure that 
the impedimetric response profiles observed and presented in chapter 4 are indeed 
specific to the antigen target concentration.   
 
Control experiments are described in the sections below (sections 6.2 – 6.5) which detail 
and investigate the effect of factors that may influence the fabrication, operation and 
impedance profile of the immunosensors.  The sensitivity of the sensors to storage over 
time is then examined and presented in section 6.6. 
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6.2. Statistical Error Associated with Screen Printed Carbon 
Electrodes 
6.2.1. Introduction 
This investigation provides valuable information relating to both the NGF and psoriasin 
immunosensors.  To confirm that the commercially screen-printed carbon working 
electrodes used within this project are not intrinsically responsible for any significant 
effect on the reproducibility of these sensors, the statistical error was experimentally 
calculated by interrogating 30 blank electrodes with ac impedance (under the same 
conditions as a fully fabricated NGF sensor) immersed in a 1 x 10
-6 
M ferri-ferrocyanide 
electrolyte media.  The real impedance (Z‘) (Ohms) at 1Hz of both working electrodes 1 
and 2 was then recorded.  Responses at 1Hz were used because changes in impedance 
(Z‘) were shown to be the most substantial from the Bode plots of the impedimetric data 
(chapter 4, section 4.2.2, Figure 4.2).  These impedance values could then be analysed 
and the statistical error between both working electrodes 1 and 2 on the same electrode 
and between two different electrodes (as shown by the error bars).   
 
6.2.2. Results and Discussion 
It was found that working electrode 1 (WE1) had a statistical error of +/- 6% impedance 
responses at 1Hz (Ohms) across 30 electrodes and working electrode 2 (WE2) had a 
statistical error of +/- 8.6% in impedance responses at 1Hz (Ohms) across 30 electrodes 
(Figure 6. 1).  WE1 also gives a significantly lower impedimetric response (Z‘ (Ohms) at 
1Hz) than that of WE2 on the same electrode, and this must therefore be taken into 
account when analysing results. 
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Figure 6. 1: Plot showing the impedimetric (Z’ – Ohms) statistical error between WE1 and 2 on the 
same and different bare carbon ink printed working electrodes. 
 
 
 
A set of 30 dual commercial ink printed carbon electrodes were investigated to observe 
their response to an applied potential over a range of frequencies measured in terms of 
impedance (Z‘ and Z‘‘ Ohms).  It was found that a reasonably small standard error 
existed between WE1 and 2 on different electrodes at +/- 6% and +/- 8.6% respectively.  
A slightly higher difference was seen between WE1 and 2 on the same electrode, which 
must be considered in any impedimetric investigation that utilises both electrodes.  The 
process by which these electrodes are printed is highly standardised and reproducible, 
which explains the relatively low standard error between two separate electrodes.  The 
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larger differences of up to 500 Ohms between WE1 and 2 on the same sensor electrode 
can be explained by the location of each WE (see Figure 6. 2).  
 
 
 
 
Figure 6. 2:  Picture of the dual sensor commercially screen-printed carbon electrodes used to 
fabricate the NGF and psoriasin immunosensors in this project. 
 
 
 
 
Observing the electrode structure in Figure 6. 2, WE1 is clearly surrounded on both the 
left and right sides and underneath by the electrical conduction strip connecting the 
central Ag/AgCl reference electrode to the electrical contacts at the top.  The presence of 
this strip acts as a further separation that may affect the flow of ions between the counter 
electrode and WE1.  This may in turn affect the bare carbon WE1 impedimetric response 
at 1Hz in a different way to WE2.    
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6.3. Control without Biotinylation 
6.3.1. Introduction 
The presence of the biotin-avidin bridge in the sensor construct is put in place in order to 
enhance the uniformity of the sensing layer, in addition to aiding the orientation of each 
antibody molecule for optimal sensing.  It is however, theoretically possible to attach the 
anti-NGF to the polyaniline conductive polymer and still detect antibody-antigen binding 
events.  This electrostatic interaction can occur because antibodies are anionic in nature, 
owing to COO
-
 groups, and the polyaniline surface is cationic, due to its NH3
+
 groups.  
These oppositely charged groups then form electrostatic interactions, acting to 
immobilise the antibodies onto the polymer surface without the use of the biotin-avidin 
bridge. 
6.3.2. Results and Discussion 
Figure 6. 3a displays a corrected calibration curve for the NGF immunosensor fabricated 
without the biotin-avidin bridge.  Although the R
2 
value (R
2
 = 0.90 as compared to 0.92) 
seems to be comparable to the results observed for the BioDot automated dispensing 
system fabricated NGF immunosensors (fabricated as described in chapter 3, section 
3.5.3 and interrogated in chapter 4, section 4.3.2), the error bars are significantly higher 
(with a coefficient of variance of 52.21% as compared to 38.56%) meaning that one data 
point cannot be distinguished from another.  Figure 6. 3b displays the same results but on 
a linear scale. 
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Figure 6. 3a: Impedimetric response of an NGF sensor to NGF antigen when fabricated without the 
biotin-avidin bridge. 
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Figure 6. 3b: Impedimetric response of an NGF sensor to NGF antigen when fabricated without the 
biotin-avidin bridge.  Plotted on a linear scale. 
 
 
NGF immunosensors were fabricated without the biotin-avidin bridge as shown in the 
schematic in Figure 6. 4, whereby the COO
-
 charges on the antibody Fc tail region 
electrostatically bind to the NH3
+
 charge on the oxidised amine groups exposed at the 
polyaniline surface.  These sensors were then interrogated for impedimetric responses 
towards NGF as normal (see chapter 3.6.5). 
 
 
 
Figure 6. 4: Schematic diagram of an NGF immunosensor fabricated without the biotin-avidin 
bridge. 
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Results, displayed as a corrected calibration curve showed a similar impedance response 
profile to the optimised NGF immunosensor in section 6.3, but with significantly larger 
error bars on each data point (i.e. measured concentration).  This can be explained, as the 
lack of control over the orientation of each antibody molecule without the biotin-avidin 
moiety means that many antibodies are positioned with the variable, antigen binding sites 
facing towards the electrode rather than the solution.  This stearic hindrance results in 
significant differences in the number of antibody-antigen binding events that can be 
observed and therefore a lower change in impedance is measured at any particular 
antigen concentration.   
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6.4.  Immunosensor Impedance Interrogation within the 
Electrochemical Cell 
6.4.1. Introduction 
The aim of this control experiment is to attempt to minimise any unknown effects that 
electrode dipping and rinsing procedures may have on the impedimetric performance of 
the NGF immunosensor.  Therefore, sensors were tested for their response to NGF 
antigen of increasing concentrations directly within the electrochemical cell, making 
washing and incubation steps redundant.  Antigen from a stock solution was added to the 
ferri-ferrocyanide media to increase the concentration, via calculated volume 
adjustments.  
 
6.4.2. Results and Discussion 
Immunosensors (fabricated as described in chapter 3, section 3.5.3) targeted to NGF were 
tested whereby the immunosensors were not removed from the ferri-ferrocyanide 
electrolyte media during exposure to varying antigen concentrations.  Instead, increasing 
concentrations of antigen were added to the ferri-ferrocyanide media and the immersed 
immunosensor was then interrogated by impedance after an incubation time of 30 
minutes.  Responses are displayed in Figure 6. 5a on a logarithmic scale and in Figure 6. 
5b on a linear scale for clarity. 
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Figure 6. 5a: Calibration plot showing the change in impedance (Z’ – Ohms) in response to a range of 
NGF antigen concentrations.  The sensor was incubated with antigen within the ferri-ferrocyanide 
media to prevent any effects from physical dipping and moving of sensor. 
 
 
Figure 6. 5b: Calibration plot showing the change in impedance (Z’ – Ohms) in response to a range 
of NGF antigen concentrations.  The sensor was incubated with antigen within the ferri-ferrocyanide 
media to prevent any effects from physical dipping and moving of sensor. 
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The results displayed in Figure 6. 5a and Figure 6. 5b show a trend of decreasing 
impedance as antigen concentrations are increased.  This is in stark contrast to the 
observed increases in impedance in chapter 4, section 4.3.2 which shows an increase in 
the change in impedance after exposure of the immunosensor to higher concentrations of 
NGF.  The difference between the two results mentioned is that the procedures used in 
chapter 4 involve the incubation of the immunosensor with its antigen outside of the 
ferri-ferrocyanide electrolyte media, whereby the results presented here in this chapter 
(Figure 6. 5a and Figure 6. 5b) were obtained from immunosensors following exposure to 
NGF antigen while remaining immersed in the ferri-ferrocyanide electrolyte media. 
 
It is possible that two opposing phenomena are working on this sensor to influence the 
impedance.  While increasing concentrations of antigen may be binding to the 
immunosensor specifically, thereby increasing layer thickness and therefore increasing 
the impedance responses, there is a counteracting influence from the introduction of 
conductive ions to the sensor construct from the ferri-ferrocyanide electrolyte media. 
 
As observed in chapter 4, section 4.7, the incubation of a fabricated sensor construct for 
up to five hours in ferri-ferrocyanide results in the increase in impedance, after which 
point, the impedance begins to drop significantly.  One explanation put forward for this 
phenomenon is that ferri-ferrocyanide ions can bind and become incorporated into the 
polyaniline layer and possibly the construct as a whole, creating conductive pathways 
through the immunosensor and thereby lowering the impedance rather than increasing it.   
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The immunosensors used in this investigation were incubated for over three hours in 
ferri-ferrocyanide prior to interrogation and therefore, it is expected when considering the 
results in chapter 4, section 4.7, that when immunosensors remained for extended periods 
in the ferri-ferrocyanide electrolyte media, that the ions from the media began to form 
conductive channels through the construct, effectively lowering impedance.  
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6.5. Control:  Incubation in Phosphate Buffered Saline 
6.5.1. Introduction 
A necessary control investigation was carried out in order to observe any changes in 
impedimetric response to 0.01M phosphate buffered saline (PBS) (pH 7.4) – in which 
NGF antigen is diluted prior to exposure to the immunosensor surface.  Sensors were 
fabricated as normal and interrogated in the same way as described in chapter 3, however, 
as opposed to increasing NGF concentrations, the incubations were simply done in 0.01M 
PBS and the sensors interrogated at 30 minute intervals. 
 
6.5.2. Results and Discussion 
A change in impedance was observed with incubation of the sensors in 0.01M PBS over 
time, however, this response is consistently 10-fold lower than the responses seen with 
the specific antigen present at any particular concentration (Figure 6. 6). 
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Figure 6. 6:  Impedance plot displaying the change in impedance (Z’ – Ohms) in response to 
prolonged exposure to phosphate buffer solution (PBS).  Measurements were taken every 30mins in 
order to be comparable to the specific sensor interrogations.  A comparison is made with the 
impedance profile in response to a range of NGF antigen concentrations – labelled above each data 
point. 
 
 
 
Similarly to the effect of ferri-ferrocyanide on impedance of a sensor, 0.01M PBS 
contains ions that over time can form electrostatic interactions within the sensors‘ 
polymer matrix, that might cause possible swelling of the polymer, thus increasing the 
impedance.  PBS at 0.01M was used for consistency and it was the same buffer used for 
dilution of all reagents in sensor fabrication (chapter 3, section 3.5.3).  In future work it is 
therefore possible to attempt to minimise this effect of increase in impedance on the 
immunosensor that the PBS 0.01M buffer has by either using a lower, 0.001M PBS 
concentration or even using de-ionised water to dilute the NGF antigen samples prior to 
incubation with the sensor electrodes. 
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6.6. Sensor Longevity 
6.6.1. Introduction 
The shelf life of fully fabricated NGF immunosensors was investigated after dry storage 
at 4ºC at 0 hours, 24 hours and 48 hours.  Each sensor was interrogated after a known 
storage period, measuring the change in impedance in response to a range of NGF 
concentrations.  The corrected calibration curves (taking the non-specific sensor response 
into account) are displayed in the results section below (section 6.6.2). 
 
6.6.2. Results and Discussion 
The gradient and the overall sensor impedimetric responses diminish by roughly 50% 
after 24hours and remain at this lower level for up to 48 hours after fabrication.  Slightly 
larger error bars in conjunction with a lower impedance change following exposure to a 
particular antigen concentration dictates that points plotted on the graph are no longer 
significantly distinguishable from the next concentration value after a period of 24 hours 
following sensor fabrication (Figure 6. 7). 
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Figure 6. 7:  The percentage change in impedance (Z’ – Ohms) calibration curves in response to a 
range of NGF antigen concentrations, displaying the diminishing effects of dry storage on sensor 
performance and sensitivity. 
 
 
 
 
The NGF immunosensor, while being able to provide a significant response upon 
detection of the NGF antibody-antigen binding event immediately following fabrication, 
exhibits significantly smaller impedimetric responses (up to 50%) after 24 hours.  This is, 
at least in part, due to the denaturation of anti-NGF at temperatures higher than freezing 
(0°C).   
 
Although it is feasible that the sensors can be made-to-order in preparation for sample 
testing, it would mean that the benefits of rapid testing would be minimised in 
comparison to having the choice to fabricate many sensors in bulk and store them for up 
to 12 months (anti-NGF shelf life at -20°C or lower).  This may be achievable via dry 
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storage at lower temperatures, storage in a neutral buffer or with the use of a trehalose 
sugar (depicted below - Figure 6. 8), which is a food preservative, maintaining form and 
texture of the sensor construct while still preserving the proteins used to build it (Lai et 
al., 2006).  The use of Trehalose sugars (Figure 6. 8) for this purpose is described in more 
detail in chapter 10.  Further approaches could involve freeze drying techniques 
(Bjerketorp et al., 2006). 
 
 
 
Figure 6. 8: Diagram of a trehalose sugar molecule. 
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6.7. Conclusions 
Control and validation steps were carried out in this chapter to substantiate impedance 
interrogation responses of immunosensors specifically targeted towards NGF.  The 
responses shown give clear indications about certain factors of the immunosensor 
fabrication procedure that influence the impedance characteristics of the NGF 
immunosensors. 
 
The statistical standard error between blank screen printed carbon electrodes 1 and 2 was 
investigated on the same electrode chip and between two different electrode chips.  It was 
found that there is a standard error of the impedance response of working electrode 1 
between electrode chips was +\- 6% and that of working electrode 2 was +\-8.6%.  It was 
also observed that working electrodes 1 and 2 on the same electrode chip have a 
difference in impedance of up to 300 Ohms.  Although the standard error between two 
separate working electrode 1 impedance responses is small, the difference between 
working electrode 1 and 2 must be accounted for when using both for the comparison of 
impedance responses between a sample of NGF and a control measurements. 
 
Through examining the change in impedimetric responses of NGF immunosensors over 
time whilst immersed in a 0.01M PBS solution, a small but significant change in 
impedance responses was observed.  This response may be due to the diffusion of ions 
from the 0.01M PBS buffer solution into the polyaniline matrix, thereby possibly 
increasing the thickness of the entire immunosensor construct.  It is possible that this 
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would then increase the impedance of the immunosensor.  This effect must be taken into 
consideration when carrying out further impedimetric investigations on NGF 
immunosensors subsequent to immunosensor incubation in NGF antigen dilute in 0.01M 
PBS. 
 
Interesting impedance response dynamics are observed with prolonged incubation of 
NGF immunosensors in 1 x 10
-6
 M ferri-ferrocyanide.  Up to five hours incubation of an 
NGF immunosensor in ferri-ferrocyanide resulted in an increase in impedance, 
hypothesised to be due to ingress of ferri-ferrocyanide ions into the polyaniline polymer 
matrix and increasing immunosensor construct layer thickness.  Subsequently, this effect 
is reversed and longer durations of incubation of NGF immunosensors in 
ferri-ferrocyanide result in a decrease in impedance.  It is postulated that this effect is due 
to conductive channels through the polymer layer forming from high concentration 
‗sinks‘ of ferri-ferrocyanide ions.  Future protocol for impedance interrogations for the 
response of NGF immunosensors towards their specific antigen should therefore avoid 
the prolonged exposure of the immunosensor to ferri-ferrocyanide electrolyte solution to 
prevent interference. 
 
NGF immunosensors were fabricated without the biotin-avidin moiety and the impedance 
responses to a range of NGF antigen concentrations were investigated in comparison to 
NGF immunosensors fabricated as described in chapter 3, section 3.5 with the 
biotin-avidin bridge present.  It was found that although a specific impedance response 
was observed after incubation with a range of antigen concentrations, this response was 
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lower than that achieved when the biotin-avidin bridge is present in addition to the level 
of standard error being larger.  This observation leads to the conclusion that the presence 
of the biotin-avidin bridge and the subsequent orientation of the anti-NGF molecules in a 
particular way means that both the specificity and reproducibility of the response is 
enhanced. 
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7. Psoriasin Immunosensor Validation 
7.1. Introduction 
Control and validation investigations were carried out to substantiate the results obtained 
for psoriasin sensors developed in chapter 4, providing supporting data that impedimetric 
responses observed can be related to increased specific psoriasin antigen concentrations. 
In particular interrogations were performed to ensure responses were not indirectly 
related to to an increased layer thickness or insulative property caused by another factor 
related to the fabrication method, impedance interrogation methods or the interference of 
the system by another moiety present in the system other than the specific antigen. 
 
Factors affecting the fabrication and impedance interrogation procedures for the psoriasin 
immunosensor are scrutinised to determine their influence on the ability of the sensor to 
provide an accurate and specific and reliable measurement of the psoriasin antigen it is 
made to target. 
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7.2. Control without Biotinylation 
7.2.1. Introduction 
Anti-psoriasin is immobilised onto the electrode surface via a biotin-avidin bridge, the 
purpose of which is to create a uniform layer of antibody with each molecule optimally 
orientated, thereby maximising the number of possible antibody-antigen binding events 
occurring and hence increasing the sensitivity of the sensor.  To validate this point, 
immunosensors were fabricated without the biotin-avidin bridge, with all other factors 
(i.e. impedance measurement regimes and analysis procedures to determine the 
impedance change in response to incubation of the psoriasin targeted immunosensor with 
psoriasin) remaining the same.  Sensors were then used to evaluate impedance changes in 
response to a range of psoriasin antigen concentrations.  Non-specific immunosensors 
used as a control also did not contain the biotin-avidin bridge. 
 
 
 
7.2.2. Results and Discussion 
Immunosensors were fabricated as described in chapter 3, section 3.5.3 but without the 
biotin-avidin bridge as depicted in chapter 6, section 6.3.2, Figure 6.4.  Figure 7. 1a 
shows the corrected impedance calibration curve (taking non-specific interactions into 
account) of immunosensors fabricated with anti-psoriasin in response to a range of 
psoriasin antigen concentrations.  Figure 7. 1b shows the same data but presented on a 
linear scale.  The linearity and range of the immunosensors impedimetric response 
towards certain concentrations of the specific antigen (psoriasin) is significantly lower 
when constructed without the biotin-avidin bridge (R
2
 = 0.82 without the biotin-avidin 
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bridge compared to 0.89 with it; and a range of 50 – 500pg ml-1 without the biotin-avidin 
bridge in comparison to 250pg ml
-1 – 5ng ml-1 with it).  However, the standard error 
observed in Figure 7. 1a is high, meaning the impedimetric response from one psoriasin 
concentration on the plot cannot be significantly distinguished from the next in most 
cases, hence a specific measurement can only be made with a low level of certainty.  
 
 
 
Figure 7. 1a: Calibration curve illustrating the change in impedance (Z’ – Ohms) of a psoriasin 
specific sensor, fabricated without the biotin-avidin bridge, in response to a range of psoriasin 
antigen concentrations.  Presented on a logarithmic scale. 
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Figure 7. 1b: Calibration curve illustrating the change in impedance (Z’ – Ohms) of a psoriasin 
specific sensor, fabricated without the biotin-avidin bridge, in response to a range of psoriasin 
antigen concentrations.  Presented on a linear scale. 
 
 
The larger error bars (representing the standard error between impedance measurements 
taken from replicate immunosensors) seen in this investigation can be accounted for only 
by the absence of the biotin-avidin moiety, which served to orientate each antibody 
molecule in the optimal way (90° perpendicular from the polyaniline polymer surface, 
with the antigen binding domain facing the solution containing the psoriasin antigen) so 
as to maximise the number of antibody-antigen binding events per immunosensor, since 
more antibody-antigen binding domains will be available for interaction with the antigen 
molecules in the antigen sample solution.  It is clear that without this structural frame put 
in place during immunosensor fabrication (as described in chapter 3, section 3.5.3), it was 
not possible to control the number of antibody molecules optimally oriented between 
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each sensor, hence the number of antigen-antibody interactions during incubation of the 
immunosensor with any given psoriasin concentration was lower, directly decreasing the 
standard error between replicate immunosensors.  A similar conclusion was reached by 
Vareiro et al (2005) when they used biotinylated antibodies immobilised onto a 
self-assembled monolayer (SAM) using streptavidin to determine that a greater number 
of biotinylated thiol molecules on a gold electrode surface led to enhanced human 
chorionic gonadotrophin limits of detection in a surface plasmon resonance based 
immunosensor.  This result is similar to that achieved when NGF sensors were also 
fabricated and interrogated with exclusion of the biotin-avidin bridge (chapter 6, section 
6.3) 
 
 
 
 
 
 
 
 
 
 
 
 
  
T.R.J. Holford          Cranfield University 
7.3. Immunosensor Impedance Interrogation within the 
Electrochemical Cell 
7.3.1. Introduction 
The testing protocol of the immunosensors can also have an influence on their 
performance.  The previously described protocol (chapter 3, section 3.6.5) dictates that 
each sensor undergoes standard rinsing steps in de-ionised water in between immersion 
and subsequent psoriasin antigen incubation or impedance interrogation steps.  There is a 
possibility that this sequence of physical agitation exerts some effect on the 
immunosensors impedimetric response to a particular psoriasin antigen concentration.  
This investigation was designed to remove these rinsing steps and initiate each incubation 
and interrogation of a given antigen concentration in the same electrochemical cell and 
ferri-ferrocyanide media, adding increasing concentrations of psoriasin to this test 
solution. 
 
7.3.2. Results and Discussion 
Immunosensors targeted towards psoriasin were fabricated as described in chapter 3, 
section 3.5.3.  These were then incubated for 200 minutes in ferri-ferrocyanide solution 
as a preparatory step, the necessity for which was observed in chapter 4, section 4.7.  
Immunosensors were then interrogated for changes in impedance after exposure to a 
range of psoriasin antigen concentrations, by increasing the concentration of psoriasin 
within the ferri-ferrocyanide electrolyte media, as opposed to separate incubation with 
antigen outside the electrochemical chamber.  The results are displayed in Figure 7. 2a 
and Figure 7. 2b in both a logarithmic and linear scale respectively. 
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Figure 7. 2a: Calibration plot showing the change in impedance (Z’ – Ohms) in response to a range of 
psoriasin antigen concentrations. The sensor was incubated with antigen within the 
ferri-ferrocyanide media to prevent any effects from physical dipping and moving of sensor. 
 
 
Figure 7. 2b: Calibration plot showing the change in impedance (Z’ – Ohms) in response to a range 
of psoriasin antigen concentrations. The sensor was incubated with antigen within the 
ferri-ferrocyanide media to prevent any effects from physical dipping and moving of sensor. 
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It is known from the investigations presented in this thesis in chapter 4, section 4.7, that 
the extended exposure of an immunosensor (fabricated as described in chapter 3, section 
3.5.3) to ferri-ferrocyanide electrolyte media, leads to an increase in impedance over a 
period of up to 200 minutes, after which a plateau is observed for approximately 120 
minutes, during which it is intended that all impedance interrogations will be completed.  
After 320 minutes (approximately five hours) of exposure to ferri-ferrocyanide, the 
impedance trends downwards, meaning there is in effect, an increase in conductance.  It 
is possible that ferri-ferrocyanide ions are integrating into the polyaniline (and other 
layers making up the immunosensor construct) causing an increase in layer thickness, and 
therefore impedance.  However after a certain period (roughly five hours) it is postulated 
that there is a sufficient density of ions saturating the immunosensor construct that could 
form conductive pathways through the sensor and thereby start to decrease the observed 
impedance (increase conductance). 
 
It can therefore be postulated that because in this investigation the immunosensors are 
exposed to ferri-ferrocyanide for an extended period, compared to the investigations 
described and reported in chapter 4, section 4.3 that ingress of ions leads to an increase in 
conductivity influencing the impedance.  Therefore is is possible that there is a decrease 
in impedance over time, which counteracts the increase in impedance (i.e. drop in 
conductivity) previously observed with increasing antigen concentrations. 
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7.4. Control: Incubation in Phosphate Buffered Saline 
7.4.1. Introduction 
Each different concentration of psoriasin antigen is diluted with 0.01M PBS (pH 7.4) 
prior to being exposed to the psoriasin immunosensor for 30 minutes.  This testing 
regime is as described in chapter 3, section 3.6.5.  It is therefore an important validative 
step to test for the affect on impedance change PBS alone has on the immunosensors.  A 
batch of immunosensors were fabricated (as described in chapter 3, section 3.5.3) and the 
impedance taken at a frequency of 1Hz after every 30 minutes of incubation in 0.01M 
PBS.  The largest apparent changes in total impedance in response to incubation of the 
psoriasin immunosensor with psoriasin antigen occur at a frequency of 1Hz, as 
determined using Bode plots (chapter 4, section 4.2.2, Figure 4.2).  Therefore impedance 
changes at 1Hz were used to plot the impedance calibration curves. 
 
7.4.2. Results and Discussion 
Figure 7. 3 shows changes in impedance in response to incubation with 0.01M PBS over 
a period of time.  These changes are compared to impedance changes observed in 
response to incubation of the immunosensor with a range of psoriasin antigen 
concentrations, as reported in chapter 4, section 4.3.2.  Although immunosensors 
incubated in 0.01M PBS alone as opposed to a particular psoriasin antigen concentration 
diluted in the 0.01M PBS did show a change in impedance upon interrogation, it is 20 
times lower than that observed with the antigen present. Additionally, impedance 
responses observed with immunosensors incubated with 0.01M PBS alone show a higher 
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level of standard error in comparison to those seen when immunosensors are incubated 
with psoriasin prior to impedance interrogation. 
 
 
 
Figure 7. 3:  Impedance plot displaying the change in impedance (Z’ – Ohms) in response to 
prolonged exposure to phosphate buffer solution (PBS).  Measurements were taken every 30mins in 
order to be comparable to the specific sensor interrogations.  A comparison is made with the 
impedance profile in response to a range of psoriasin antigen concentrations – labelled above each 
data point. 
 
It is hypothesised that, as in the case of ferri-ferrocyanide swelling (chapter 4, section 
4.7) and incubation of the NGF immunosensor in PBS, the dilution buffer may also exert 
a possible swelling effect on the psoriasin immunosensor construct.  This will increase 
the layer thickness of the immunosensor and hence result in a slight increase in the 
impedance over time.  Therefore, in future experiments that involved the incubation of 
these immunosensor constructs (described in more detain in chapter 3, section 3.5.3) in 
0.01M PBS, the slight increase in impedance due to increased layer thickness must be 
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subtracted in order to counteract any affects on impedance of this non-antibody-antigen 
binding event. 
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7.5. Conclusions 
Validation investigations revealed some key characteristics relating to the fabrication and 
impedance interrogation of the psoriasin immunosensors developed within this EngD 
project.   
 
The incubation of immunosensors in PBS (the buffer used to dilute the antigen 
concentrations) without antigen present results in a minimal yet significant increase in 
impedance.  It is postulated this is due to the possible swelling of the psoriasin 
immunosensor construct with ions from the PBS gives rise to an increased layer thickness 
and subsequently an increased impedance response.  It is therefore necessary to subtract 
the responses as a standard from each impedance increase observed after incubation for a 
given length of time in PBS buffer, either with or without the presence of psoriasin 
antigen. 
 
Similarly, as discussed in chapter 4, section 4.8, prolonged exposure of the 
immunosensor construct to ferri-ferrocyanide (the electrolyte media used for impedance 
interrogations) leads to an increase in impedance up to five hours after initial exposure 
and a subsequent decrease in impedance either due to the depletion of the immunosensor 
construct due to storage in adverse conditions or due to the formation of conductive 
pathways by the accumulation of conductive ions across the immunosensor construct.  
This is substantiated in the investigations reported in chapter 6, section 6.4 and section 
7.3, whereby impedance interrogation was carried out within the impedance chamber 
with ferri-ferrocyanide.  Antigen concentrations were added to the ferri-ferrocyanide 
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media to prevent the need for dipping or rinsing of the immunosensor construct.  Due to 
the immunosensor already being exposed to ferri-ferrocyanide for 200 minutes prior to 
the impedance interrogations as part of the preparatory process, further exposure time to 
ferri-ferrocyanide during antigen incubation periods led to a decrease in impedance for 
subsequent antigen concentrations.   
 
While the investigations into the effect of incubation of psoriasin immunosensors in 
0.01M PBS over time show that there is a change in impedance, further studies must be 
carried out to establish the effect of incubation of each immunosensor in a single antigen 
concentration over time, as opposed to a range of antigen concentrations.  This will 
provide impedance responses that can be directly compared to the responses observed in 
response to 0.01M PBS alone. 
 
A final conclusion concerns investigations into the fabrication of immunosensors for 
psoriasin without the biotin-avidin bridge (section 7.2).  Immunosensors were fabricated 
as described in chapter 3, section 3.5 but without the biotin-avidin bridge, they were then 
incubated with their target antigen and interrogated via electrochemical impedance 
spectroscopy.  An observed specific response was achieved, however the level of 
standard error between repeat measurements is significantly higher and the percentage 
change in impedance significantly lower than observed with sensors fabricated with the 
biotin-avidin bridge.  This confirms that the biotin-avidin bridge serves to orientate a 
higher proportion of antibody molecules in an optimal way so as to increase the 
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occurrence of specific antibody-antigen binding events in comparison to immunosensors 
constructed without the biotin-avidin bridge. 
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8.  The Management of Strategic Networks, Outsourcing             
Innovation and Competitive Advantage 
 
8.1. Introduction, Scope and Objectives 
 
This Engineering Doctorate (EngD) requires research into fields of industry and 
management relevant to the project.  The electrochemical sensors developed in this 
project are not built for commercial use; instead they are intended to aid in product 
development within clinical trials at Unilever.  This study builds on previous research, 
establishing and describing current methods of managing inter-firm integration and how 
it relates to competitive advantage. 
 
The strategic network in place between Unilever and Cranfield University set up to 
undertake this project acts as a foundation on which to build a discussion surrounding 
various types of strategic network.  The chapter describes how these networks are 
beneficial and how they should be managed to obtain value from them.  The chapter 
closes with a discussion regarding the specific benefits of this particular project and 
therefore why Unilever Plc has opted to undertake such a venture. 
 
A framework for the implementation of management on strategic networks is described, 
providing strategic information of how to manage and maintain a relationship between 
institutions such as the relationship directly involved in this project, and the benefits and 
limitations it can encompass. 
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8.2. Background to the Problem 
 
Strategic networks are formed by organisations in order to gain or borrow resources and 
or knowledge that are otherwise unavailable to them, to create value and gain competitive 
advantage (Porter, 1987).  Organisations are limited in that they cannot in general, 
specialise in all facets of their industry.  It is unlikely for example, that Tesco can provide 
all its products and services to a competitive standard unless it outsourced their 
manufacture.  Firms tend to have a few core competencies that make them unique, but 
any other competency that they do not specialise in yet still try to undertake, reduces their 
ability to survive in a competitive market.  A core competency is a part of the business 
for example, manufacture, sales or finance in which that particular firm excels i.e. they 
can provide value in.  Therefore any resources spent on any other task can minimise 
focus on the core competencies therefore reducing the firms‘ capability to create value.  
Henceforth, the outsourcing of non-core tasks to specialist providers can enhance the 
quality of service or product they can provide as well as offering many benefits to the 
outsourcing firm.   
 
Although Unilever possess an extensive global research and development department, 
they have employed the services and expertise of our research group in the field of 
biosensor and immunosensor development and fabrication.  This means they access the 
tacit knowledge we possess concerning electrochemical diagnostics, are not required to 
sink costs into specialist equipment and additionally to our benefit we gain the 
remunerative benefits from networking with a high profile firm. 
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8.3. The Benefits of Strategic Networks 
This section aims to provide an insight into the existence of different types of strategic 
integration and give a comprehensive account of their structure and the management of 
such networks in order to create competitive value. 
 
Innovation networks are not beneficial in all cases and only chosen as a strategic action if 
it is mutually beneficial to each firm involved (Tidd et al., 2005).  There are various ways 
in which firms can integrate, and a particular type of integration chosen by each firm will 
depend on their competitive environment, what they are able to offer each other, what 
they hope to achieve and how compatible their modes of operation and organisational 
cultures are.  Below is a diagram illustrating a general overview of the different types of 
strategic integration in existence (Figure 8. 1). 
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Figure 8. 1: The influence of supply market and objectives on supplier relationships (adapted from 
Tidd et al, 2005). 
 
 
Outsourcing is highly beneficial in that it provides access to specialised skills that would 
otherwise be unavailable within the firm itself.  Additionally it can provide a reduced 
time to market because many service providers can operate in parallel, more 
productively, to finish a product or service much faster.  Outsourcing effectively allows 
the efficient expansion of the workforce, completing tasks to a high tier quality, in a 
faster time, with reduced costs owing to economies of scale within the outsourced 
specialist company. In addition, once non-core competencies have been outsourced, it 
gives the firm freedom to strengthen and focus on its core competencies.  This 
combination of benefits provides a platform for competitive advantage. 
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8.3.1. Managing Outsourced Services and Products 
Although outsourcing non-core competencies can be an overall beneficial venture, there 
are many pitfalls and limitations that can render the exercise damaging to the company, 
without appropriate management. 
 
If too many tasks are outsourced, there is a danger of ‗hollowing out‘ the company 
(Langfield-Smith, 2000) whereby too few workers are operating with and monitoring a 
vast array of contractors; the company will therefore loose its technical and human skill 
competencies.  This can in turn lead to a loss of competitive advantage as the company is 
no longer a strong central hub, but a small central shell with too many spokes, with 
nothing new, innovative or unique to offer, just a central operation controlling contractors 
to carry out high quality yet largely standardised jobs.  Additionally, with extensive 
networks of suppliers, it can become difficult to control the various operations taking 
place.  Without proper consideration of legal and cultural aspects of the business 
relationships, it will be difficult to maintain a good connection to control and monitor the 
outsourced operation. 
 
To expand on this, if objectives are not made clear, particularly in a research setting and 
management controls are not appropriately put in place, a conflict of interests could arise.  
For example the outsourcer may be interested purely in research targeted towards the 
commercial value it provides, whereas the outsourced contractor may be more focused on 
research for research sake and branch off down many different, although related, research 
avenues, even though they do not have particular commercial or cost saving viability.  
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Therefore, as with the undertaking of all product and service development, proper 
controls in the form of clear goals and objectives regularly monitored and discussed as 
the project progresses are necessary to provide control by the outsourcing company and 
prevent increased expenses and wastage of time.  Below shows a model of how, in 
general, a firm can manage its outsourced non-core competencies (numbered 1, 2 and 3) 
in order to minimise issues with knowledge and objective transfer and to demonstrate 
distinct targets for each firm to adhere to (Figure 8. 2). 
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Figure 8. 2: A schematic diagram illustrating a basic framework for the management of outsourcing 
products or services. 
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8.4. An Analysis of Competitive Environment 
Unilever describe themselves as a multi-local multinational company thereby staying 
global whilst integrating tightly into each local community in which they operate or sell 
their brands.  Unilever invested €928 million into R&D in strategic collaborations in 
2010 with a turnover of €44.3 billion (Unilever Annual Reports and Accounts, 2010). 
 
They have one of the largest customer bases in the world with an estimated 2 billion 
consumers using a Unilever product per day, a little less than a third of the global 
population, over 180 countries (Unilever Annual Reports and Accounts, 2010). 
 
Their highest revenue is achieved in Asia with €17.7bn (40% of total sales), closely 
followed by the Americas with €14.6bn (33% of total sales) and €12.0bn (27% of total 
sales) in Western Europe. 
 
They display competitive edge in that 80% of their brands, including Knorr and Walls are 
world number one and number two products.  Their global environment friendly 
objectives are achieved by alliances with other consumer programmes focusing on this, 
for example, the ―rainforest alliance‖ and Unilever brand Lipton, as well as collaborating 
with ―Tesco Greener Living‖, ―Carrefour Bio‖ and ―Fairtrade‖, therefore associating their 
products with sustainable ‗green‘ ideology and creating brand loyalty with those 
customers who are committed to this ideology. 
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Recently Unilever plan to reduce their environmental impact whilst doubling in size as 
depicted in the diagram below (Figure 8. 3): 
 
 
 
 
 
 
 
 
Figure 8. 3: Schematic depicting Unilevers plan to minimise environmental impact whilst still 
doubling in size 
 
In order to achieve this they have recently enhanced their portfolio through mergers and 
acquisitions of several companies including TIGI hair care, Sara Lee, Alberto Culver 
(who piloted the Tresemme hair care range), Toni&Guy, ice cream brands in Greece and 
frozen goods and tomatoes brands in Italy and Brazil respectively. 
 
8.4.1. Methods of Analysis 
Two main models since 1980 give the structure on which to analyse the competitive 
environment.  The first to consider is Porters five forces (section 8.4.2.) which analyses 
the firms‘ competitive environment and uses this to form appropriate strategies for 
gaining competitive advantage.  The second is the ‗resource based view‘ (RBV) of the 
environment put forward by Wernerfelt (1984).  This model details the position of 
€40bn 
€44bn 
€80bn 
Environmental 
Impact 
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intra-firm resources and networks as an important road towards competitive advantage 
(section 8.4.3). 
 
8.4.2. Porters Five Forces 
Before the benefits Unilever will gain from this and similar projects can be established, it 
is important to form an understanding of their present position within the consumer goods 
industry.  The Porter‘s five forces analysis is a management tool created to assess the 
business environment that surrounds a particular business with regards to ‗rivalry‘ or 
‗competition‘ (Porter, 2008).  The five forces that are considered to have an effect on 
rivalry are the supplier power, the buyer power, the barriers to market entry, the threat of 
substitutes and the degree of rivalry that currently exists in that market (Figure 8. 4). 
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Figure 8. 4: Porters 5 forces (adapted from Porter, 2008). 
 
Force 1 - Bargaining Power of Suppliers 
Suppliers of products, parts or services to any company have a certain level of power 
over the business partnership; the level of power depends on certain factors.  For 
example, Unilever sources products, like plastic containers for sun tan lotions and 
moisturisers, in bulk, from a supplier.  Unilever has the option to source simple plastic 
packaging from any source, thereby, in a competitive market, the plastic bottle suppliers 
have little bargaining power and are most likely to be selected because of price, quality 
and service provided.  At the other end of the spectrum, many of Unilever‘s cosmetic 
care products contain constituent chemicals that may not be easily available.  The 
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suppliers of these chemicals will have a certain level of power over price and certain 
terms and conditions of the contract; they have a high bargaining leverage. 
 
Switching cost is also an important factor in establishing which party has leverage.  If it 
costs the supplier more money to switch to another client, then Unilever would have an 
advantage over negotiations, however if it costs Unilever more to change suppliers; due 
to costs of renegotiating, altering logistics strategy or simply lost time during the 
changeover, the suppliers would have some bargaining leverage (supplier power).  Due to 
the specialist nature of the work our lab is employed by Unilever to do, once the contract 
is signed, it would be costly for them to switch to another lab as they may lose our unique 
research capability and time spent drawing up new contracts, building new innovation 
networks, and realigning aims and objectives with the new contractors. 
 
 
Force 2 - Bargaining Power of Buyers 
This describes the power buyers (of Unilevers product) have to place pressure on a 
company and in-particular, to renegotiate prices, or quality of the products or services 
provided, should they be unsatisfied.  Buyer power includes a dependency on switching 
costs for each party and how unique the product or service is.  In Unilevers‘ case, the 
buyers are the traders that sell their products (pharmacies and supermarkets) and 
eventually the general public.  So if there are a large number of competitors selling 
similar products, then the buyers have the power to choose whichever product is more 
economically beneficial to them, better quality, and perhaps meets their moral, ethical 
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and environmental values in terms of production waste and disposal of the product.  
Unilever, and other similar firms, must therefore cater for these needs within their target 
market in order to be competitive.   
 
Some examples of Unilever buyers are on one end of the scale, Carrefour, Tesco and Wal 
Mart, all of which provide a large proportion of Unilevers buyers.  These large retailers 
have huge bargaining power.  In contrast, smaller retailers also buy products from 
Unilever and they would have very little bargaining power as the existence of their 
custom, while being important to Unilever, only influences their annual profits at a very 
low percentage. 
 
Force 3 - Threat From New Entrants 
The consumer goods industry is competitive due to its size and so it constantly attracts 
new entrants.  Unilever are in an advantageous position in most cases since although 
there may be a high level of competition for consumer goods, the barriers to new entrants 
in this market are high since many customers buy products based on familiarity, brand 
loyalty and perceived quality, which only a few firms have achieved to such extent as 
Unilever, including their major rival Proctor & Gamble.  Pricing is also a factor to 
entering a new market, and companies who are new to the market will not have set up 
efficient logistical networks and so will not have the capital to charge lower prices if they 
wish to make a return and compete.  Therefore due to the nature of the consumer market, 
providing Unilever remain competitive and innovative, they run little risk from newly 
entering companies. 
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Force 4 - Threat of Substitute Products or Services 
This describes when consumers switch to using a non-brand or novel alternative product 
or service.  Within Unilever for example, products that are used to moisturise skin may 
be threatened by the invention of a new type of product other than a standard 
moisturising cream to do the same task, like a hygienic face mask for example.  The 
threat will depend on the customers switching costs to the alternative product, the 
performance of the substitute compared to its price, the customers perceived level of 
product differentiation i.e. how different the cheaper alternative is to the existing 
Unilever product and how open minded the consumer is to trying something new. 
 
Force 5 - Threat From Existing Competitors 
Unilever have a number of existing rivalries with well established companies such as 
Proctor & Gamble, Sara Lee and Johnson & Johnson (see section (market analysis) for 
more details).  Competitive advantage in this oligopoly in the consumer goods market is 
generally based on a company‘s ability to keep up-to-date with new technologies for 
making new products or improving existing products.  For this reason they invest 
considerable resources into front-line research projects such as the one described in this 
thesis. 
 
Porters‘ five forces however is a limited technique in terms of depth of analysis regarding 
complexities of inter-organisational interaction and does not consider the internal 
environment of the firm, only its environment (Igel and Ramanathan, 2002). 
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8.4.3. The Resource Based View 
The resource based view (RBV) is an alternative method used for analysis of industrial 
competitive environment and successively form strategies for gaining competitive 
superiority.  According to the RBV, a firm is defined as the set of resources it owns (Das 
and Teng, 2000).  Resources include both tangible and intangible assets belonging to or 
utilised by the firm.  The degree of competitive edge a firm or alliance has in its industry 
depends on their unique resource alignment and combinatory value. 
 
The advantage of using this view of the firm to assess competitive vantage point is that it 
takes into account the resources that define the firm and often determine its capabilities.  
In these terms, resources can be firm specific and not imitable and therefore more 
representative of the competitive capabilities available to them.  This approach therefore 
focuses on the internal capabilities of a firm (strengths and weaknesses) as opposed to its 
external environment, providing a viewpoint on competitive advantage from a less 
utilised aspect, therein providing a more complete analysis of potential competitive 
advantage in a firm. 
 
The RBV links seamlessly with the formation of alliances in that any integration between 
firms allows access to another firms‘ valuable resources and hence strengthen their 
resource base and sustain competitive advantage.  Eisenhardt and Schoonhoven (1996) 
found that in general, firms in weak competitive positions are looking to gain resources 
and advantage and firms in strong positions are looking to share their treasured resources 
in order to gain remunerative advantage or monopolise a particular area of an industry. 
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Das and Teng (2000) describe a RBV model of analysis with regards to strategic alliance 
formation whereby four stages are set forth (Figure 8. 5): 
 
 
 
 
Figure 8. 5: Schematic of four stages of a RBV based strategic alliance (adapted from Das and Teng 
(2000)). 
 
 
Resource based rationale 
Considering that for a firm to have a particular product or service they have three options: 
internalisation (make it themselves), market exchange (buy it from another firm) or 
through a strategic alliance.  When considering transaction cost economics, which links 
to the resource based view of the firm (McIvor, 2009) the choice between the above three 
options will basically be based on which one is most economical for the firm (Coase, 
1937; Williamson, 1975).  This means that transaction costs (costs of market exchange) 
must be analysed against production costs (costs of internalisation).  Therefore, when 
transaction costs are high, internalisation is key to minimise expenses, and vis-a- vis if 
production costs are high. 
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An alliance is essentially a market exchange which is internalised to some degree, 
whereby the costs of transaction are not high enough so as to substantiate vertical 
integration (Gulati, 1995) 
 
When determining the rationale for alliance formation from the resource based view as 
opposed to the cost minimisation view as explained above, and then the value of the 
resources gained from alliance formation takes precedence over transaction and 
production costs.  Because many valuable resources are imperfectly imitable and without 
efficient substitutes, providing the resources are additionally unavailable through market 
exchange, then the formation of strategic networks and alliances to gain access to 
valuable resources is preferred (Das and Teng, 2000); The reason being that the 
possession of valuable, non-imitable resources, both tangible and intangible can create 
sustainable competitive advantage, as long as the above characteristics are maintained. 
 
Furthermore, the case for alliance formation over mergers and acquisitions in certain 
situations can be argued in the case that unnecessary resources will be acquired in 
mergers and acquisitions and as some exhibit particular specific functions, they may be 
difficult to sell, in contrast, alliances mean only the valuable resources are shared, thereby 
minimising short-term and long-term costs while maximising valuable resource 
procurement. 
 
In 1998, Kugut defined two motivations for a firm to enter an alliance.  The first being to 
obtain the other firms knowledge or technological resources for example, in order to enter 
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a foreign market they may acquire or collaborate with a local company and develop a 
strategic network with other local businesses to gain relevant and valuable resources 
within that local market.  Alternatively, firms may enter an alliance in order to combine 
their resources with another firm whilst maintaining their own expertise, thereby gaining 
value and conserving unique aspect in order to perpetuate sustainable competitive edge. 
 
An example of this could be that a firm possesses an excess of manufacture machinery 
yet not enough demand to maximise the use of each machine.  Therefore they could 
initiate an alliance in which they are then able to use another company‘s clientele to 
maximise efficiency and revenue from the sunk costs within their manufacturing and 
production systems, whilst still retaining their own resource. 
 
Regardless of how the resources are shared in an alliance, an alliance should only be 
beneficial if a higher degree of long-term value can be gained as compared to internal use 
or sale of the resource (Das and Teng, 2000). 
 
Alliance Formation 
For strategic alliances to be formed, each partners‘ resources must be imperfectly mobile, 
imperfectly imitable and imperfectly substitutable.  These attributes mean that in order to 
gain access to the firms‘ valuable resources, a formation of a strategic alliance is 
necessary, otherwise without these; competitive firms could simply imitate or create a 
substitute for this resource and deem an alliance unnecessary.  Therefore the formation of 
alliances depends on those three characteristics. 
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Structural Preferences 
There are several typologies used to describe resources of a firm wither in or out of a 
strategic alliance.  The resources can be divided into financial, physical, managerial, 
human, organisational and technological resources according to Hofer and Schendel 
(1978).  More simply, Grant (2001) splits the firms resources into tangible (codifiable) 
and intangible (non-codifiable).  Furthermore, in an effort to classify resources into a 
more RBV founded theory, Miller and Shamsie (1996) distinguished two forms, being 
property-based and knowledge-based resources. 
 
Property-based resources tend to be non-replicable due to patents, contracts, copyrights 
and trademarks, thereby the exchange of these resources between firms in alliance is 
commonplace; no other firm can easily copy.  Additionally, property-based resources are 
imperfectly substitutable, for example, the location of a business being convenient within 
a supply chain and for logistics purposes is difficult if not impossible to substitute.  
 
Das and Teng (2000) describe four main typologies of inter-firm integration: 
 
Equity Joint Ventures – Separate entities work together as one.  It is limited by 
opportunistic behaviour from either side of the partnership.  Ideal for acquiring another 
firms tacit knowledge as partners have high exposure time with each other. 
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Minority Equity Alliances – Whereby each partner buys into an equity position with the 
others.  This primarily is used when one partner has resource-based resources to offer and 
the other has knowledge-based resources to share.  This kind of alliance can reduce 
opportunistic behaviour because equity buy-ins demand longer term investment and is 
generally difficult to elude from. 
 
Bilateral Contract-Based Alliances – A joint effort resource-wise generally preferred for 
knowledge-based resource partitioning. 
 
Unilateral Contract-Based Alliances – A clear transfer of property rights.  Contracts are 
made clear and specific.  This is the preferred format in property-based resource 
alliances. 
 
Essentially, the structural format chosen will be based on what is necessary to obtain the 
valuable resources from another firm whilst maintaining control of your own resources. 
 
 
Alliance Performance 
Some scholars hypothesise that performance will be an output directly related to the firms 
resource ‗fit‘ i.e. how well one firms resources provide for the other firms needs 
(Seabright et al., 1992).  However, those resources not supplying adequate value should 
also be taken into account and not just how the resources match in terms of size and 
quantity for example, but their compliance with each other should be taken into account. 
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The fact that two firms integrate and share resources means that their strengths are 
combined and allow the firm a greater chance of gaining competitive advantage together 
opposed to operating individually.  There are however conflicts which can arise within 
inter-firm alliances due to control issues, objective disagreements, resource distribution 
and each firm possibly seeking advantage over the other opportunistically (Das and Teng, 
2000).  Conflicts may also arise due to dissimilar managerial practices and organisational 
culture. 
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8.5. Gaining Competitive Advantage – A Framework 
As this project aims to allow Unilever to gain and maintain a competitive edge on its 
rivals, it is necessary to carry out an analysis of how else firms can gain competitive 
advantage in relation to creating innovation through strategic networks. 
 
Sources for obtaining inter-organisational competitive advantage can be divided into 
shared assets, knowledge sharing, complimentary resources and capabilities and the 
effective management of these (Dyer and Singh, 1998).  These make up the relational 
view of the firm, which in contrast to the structural view (Porters‘ five forces) and the 
resource based view (RBV) describes how a network of sustained relationships between 
two cooperating firms can bring competitive advantage. 
 
All firms have a competitive strategy.  This can be purposefully set out from the 
beginning with clear goals and methods to achieve them.  Competitive plans can also 
develop over time through everyday operation within the firm (Porter, 1980).  This 
implicitly grown strategy may therefore differ between departmental sectors of a 
company, creating a misalignment resulting in the company being ineffective as a whole, 
hence an analysis of the companies competitive environment, and its capabilities in order 
to develop relevant strategies to that particular entity in that particular industry. 
 
Porter (1987) describes three steps to formulate a competitive strategy.  The firm must 
first identify what the business is doing presently in terms of strategy.  They must 
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subsequently assess their environment (using Porters‘ five forces) and finally couple the 
findings from the previous two steps to develop a new strategy.  
 
8.5.1. Cost Savings Leading to Increased Revenue 
The use of hub-and-spoke networks (Nero et al, 1999) allows two main cost saving 
benefits, the first being a reduction in expenditure on sunk costs due to the contractor 
already having research and manufacture or office space utilities set up.  Secondly cost 
can be minimised, in addition to an advantage from economies of scale, due to a higher 
production rate than what could be achieved by the hiring company i.e. many specialist 
‗spokes‘ can simultaneously do more work than a ‗hub‘, and with greater capability to 
provide quality products and service.  Therefore unit costs are reduced, whether it is the 
cost of transporting a customer on an aeroplane or undertaking research.  This in turn 
allows growth of the company through increased revenue and therefore a gain of 
competitive advantage. 
 
Cost leadership basically consists of taking an aggressive position to lower production 
costs and maximise operational efficiency, whilst still providing quality service and 
product.  Lower costs provide a buffer to defend the company against buyers and 
suppliers and its direct rivals due to earning greater profit margins. 
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8.5.2. Differentiation and Focus 
Differentiation defines the firms‘ products or services that are perceived as unique and 
inimitable throughout the industry.  Differentiation can lead to competitive advantage 
through creating brand loyalty, for example, it also forms entry barriers to the market.  
Additionally, a firm can focus on a particular niche within a market and apply their 
resources to that target; the assumption being that the product or service provided will be 
of greater quality, differentiating the firm from other more scopically competing rivals. 
 
Competitive advantage gained through cost leadership, differentiation and focus is 
displayed in the diagram below to illustrate how the strategies link to advantages (Figure 
8. 6). 
 
Figure 8. 6: How cost leadership, differentiation and focus strategies relate to competitive advantage 
(adapted from Porter, 1987). 
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8.5.3. Unique Knowledge Transfer and Management 
The main problem when outsourcing is that suppliers are, with little cost and within a 
short time frame, able to replicate the knowledge they share with one firm and use it with 
competitors.  Therefore the competitive advantage is gained from the manner in which 
the strategic relationship is managed.  Specifically, to create the competitive advantage 
by operating a transparent knowledge share with them, and sharing production and 
manufacture details with the supplier, who will therein have an increased capability to 
enhance productivity and quality, at lower cost to the employing firm. 
 
It is important to understand that all rival companies have the same or similar 
collaborative networks available to them, meaning that knowledge can be freely cloned to 
counteract competitive advantage, hence, in order to gain competitive advantage from 
these networks, proper management of the knowledge transfer and the development of 
firm specific inter-firm processes will eradicate effects from knowledge imitation as any 
replicated knowledge will be irrelevant to another competing firm.   
 
A study on how knowledge networks were kept between U.S. automotive suppliers and 
automakers including Toyota, G.M, Ford and Chrysler had far greater performance in 
reduction of defects by 50% in Toyota as opposed to 26% in U.S. based firms.  This is 
due to the nature of Toyota‘s knowledge transfer network with the suppliers and gives 
evidence that ‗network resources have a significant influence on firm performance‘ (Dyer 
and Hatch, 2006).  In 1998, Dyer and Singh describe how a consistent system of contact 
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and interaction between firms ultimately leads to the transfer, recombination and creation 
of specialised knowledge. 
 
In addition, the unique core competencies and tacit knowledge held within the firm must 
then be focused on with extra resources and available time gained from outsourcing 
non-core competencies, to gain competitive advantage through focus on core 
competencies. 
 
The tacit knowledge shared between two collaborating companies cannot be easily 
replicated compared with codifiable data which can easily be templated and replicated to 
a rival firm.  Therefore tacit knowledge interactions with supplier firms‘ gains sustainable 
competitive advantage, whereby the knowledge shared is specific to that particular 
relationship.  The model below (Figure 8. 7) illustrates the barriers to intra and inter-firm 
knowledge transfer as reported by Dyer and Hatch (2006) in relation to forming 
competitive alliances with suppliers that are sustainable.  In order to create that, these 
barriers must be addressed. 
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Figure 8. 7: A diagram illustrating the barriers to effective knowledge transfer (adapted from Dyer 
and Hatch (2006)). 
 
 
 
8.5.4. Effective Management of Strategic Networks for Competitive 
Value Creation 
The management factors which can precipitate effective management of integration with 
another firm can be clearly defined and undertaken consciously by managerial staff in 
order to create successful supplier-buyer collaboration. The model of factors critical to 
management success of a strategic partnership is displayed below (Figure 8. 8), whereby 
‗Collaborative Innovation‘ describes factors that allow the knowledge share between 
partners to reap innovative solutions and products, ‗Partnership Quality‘ denotes 
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 Casual ambiguity / 
complexity 
Attribute of the Source 
 Lack of motivation 
 Lack of credibility 
Attributes of the Recipient 
 Lack of motivation 
 Lack of absorptive capacity 
Attributes of the Recipients Existing 
Process 
 Internal process rigidities 
Attributes of the Recipients Network / 
External Environment 
 Network constraints 
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commitment and trust between members of both factions and ‗Value Creation‘ is the 
focus on the parts of the partnership that brings value to each partner. 
 
 
 
Commitment 
Trust 
 
Conflict 
Management 
Synergy 
Value Creation 
Process 
Efficiency 
 
Figure 8. 8: A Schematic representation of the critical management factors involved in obtaining 
innovation and competitive advantage from strategic alliances (adapted from Gibbs and Humphries 
(2009)). 
 
Below depicts an adaptation of Grant‘s (2001) resource based, five-stage procedure to 
generate a strategy for the firm and operate competitively within their industry (Figure 8. 
9): 
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Figure 8. 9: The resource based approach framework for strategy formulation. 
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8.5.5. Management of Innovation Networks 
The steady creation and development of new, innovative products and services provides a 
strong front for a firm working to sustain long-term advantage, consistently capturing 
more and more of the market, thereby enhancing profitability. 
 
Informal parts of a network, due to their implicit nature, require a careful balance of 
management.  There must be enough control over this phenomenon in order to profit 
from its competitive value yet excessive management may lead to the destruction of its 
informal and hence creative nature.  This is otherwise known as the Daphne-dilemma 
(Van Aken and Weggeman, 2000).  Informal innovation networks are valuable as they 
provide a foundation for knowledge based competitive advantage, which in the current 
industry is a more precious asset than physical resources (Prahalad and Hamel, 1990; 
Tidd et al, 2005). 
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8.6. The Business Benefits of This Project –The Product and the 
Relationship 
At present, the successful integration of new technology into any industry in terms of 
process, marketing, supply chain or the product itself can have an impact on the 
competitive environment.  Due to this fact, many firms gain competitive advantage by 
remaining flexible enough in their resource structure so as to match the dynamic nature of 
the technological industry.  Without this crucial quality, companies who were once large 
and successful are surpassed by more innovative and flexible companies. 
 
8.6.1. Trend in Industry Towards R&D Outsourcing 
Owing to increasing market needs to develop specialist products, and reduce the 
accompanying costs, many industrial organisations are asking how they can be more cost 
effective with R&D and how to measure and improve R&D.  A common conclusion is 
the decision to collaborate with partners and form strategic research alliances such as the 
one put together to implement this project between Cranfield University and Unilever 
Plc. 
 
There is evident growth in R&D outsourcing worldwide and it is fast becoming a 
preferred method of new product development, which research shows is enhanced when 
R&D is outsourced to a centre of excellence (Hsuan and Mahnke, 2011).  Due to this 
trend, many Universities and other tertiary level educational and research institutions 
offer R&D contracts, as in this project, as a way of creating synergistic relationships with 
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the buyers benefiting from reduced sunk costs into facilities and equipment along with 
gaining the specialist and tacit knowledge of a dedicated academic lab.  The supplier (in 
this case, our group at Cranfield University) in turn benefits from extra funding resources 
and more opportunities to develop students through industrially linked projects. 
 
Although there is a limit to this relationship in that industry often assumes University 
student research to lack quality, delivery and confidentiality in comparison to an 
industrial lab contractor, however this is reflected in the cost.  Additionally a limitation to 
this partnership is that Universities must use government funding appropriately to avoid 
economic inefficiency and wasted public funds.  Alternative providers include 
government research facilities, which are perceived to provide state-of-the-art research, 
however, likewise their prices are made to match.  Industrial companies can also 
cooperate with each other, forming a strategic alliance for R&D but this type of 
partnership is generally formed between non-competitive companies that use similar 
technologies. 
 
The nature of the partnership chosen will depend upon the particular project and the size 
of the firm.  A firm developing a new product or technology may, due to confidentiality 
reasons, chose a private contractor; whereas small to medium enterprises (SME‘s) or 
firms researching into a common problem it may be more beneficial, and for SME‘s 
perhaps the only viable option to cooperate research with a similar firm. 
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Having considered Unilevers‘ competitive environment and the benefits outsourcing and 
innovation networks can bring to a firm, the following section details how analysis of 
those things in specific terms relating to what Unilever will gain from a project such as 
this one, will lead to competitive advantage. 
 
8.6.2. Saving Time 
A major setback for any firm trying to gain or maintain competitive advantage is to be the 
first of its rivals to reach the finish line in terms of innovating and developing new 
products or improving quality of existing products.  During research and development of 
a product, Unilever must undertake various quality control and product safety tests.  
Presently, they use a process called ELISA (enzyme linked immunosorbent assay) 
(Engvall and Perlmann, 1971) which requires an overnight incubation procedure before 
this quality control and safety analysis can be completed. 
 
The amount of time that could be saved with this project is estimated to be between 7-20 
hours per batch of sample analysis per day (depending on the analyte in question).  The 
present testing method involves tape stripping skin cells and then solubilising the target 
molecule in buffer, which typically takes up to 3 hours (this part remains the same with 
the new sensors).  ELISA tests must then be undertaken (taking around 2 hours) to 
measure the concentration of psoriasin protein present in the sample, which involves an 
overnight incubation making a total of up to 24 hours for a single set of samples to be 
tested. 
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Pre-constructed sensors, which could potentially be stored for up to 12 months (as 
described in chapter 10, section 10.2) would enable the sample to be interrogated without 
the need for incubation with antibodies and horse radish peroxidise (HRP) prior to 
measurement, the total time for testing could therefore be minimised to 3 hours 35 
minutes (see Figure 8. 10), less than half of the total testing time with the presently used 
ELISA protocol.  This includes sample extraction and re-suspension into buffer, a 30 
minute incubation of sensor with the sample and a five minute impedance interrogation 
of the immunosensor.  This allows Unilever to considerably improve the time to market 
and maintain a competitive edge over its rivals. 
 
Figure 8. 10: Comparison and contrast between the time taken to complete sample interrogation 
using the existing method and the method described in this project. 
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8.6.3. Cost Savings 
ELISA kits for nerve growth factor and psoriasin can typically cost on average of £350 
and upwards from commercial companies such as USCN, Abcam, AbFrontier and 
Abnova.  The use of screen-printed carbon electrodes, which are inexpensive to 
manufacture, along with the small volumes of reagents applied to the electrodes to form a 
sensor and offer promise for providing tests with lower unit costs.  Since these sensors 
are still being produced in the lab and not in bulk in a factory, the cost savings cannot be 
predicted at the present time although as a benchmark, glucose sensors are presently 
being produced for approximately 5 cents (US) per unit, meaning to directly compare 
with ELISA, 96 electrodes (as in a 96 well ELISA plate) could potentially cost around $5 
USD, which is 70 times less than ELISA. 
 
8.6.4. Benefits within the Market 
The consumer goods industry is highly competitive, with technology leading the way to 
new anti-wrinkle creams, improved moisturising soaps, novel bath oils and many other 
new personal care products.  Research projects such as this one gives companies at the 
forefront of consumer goods technology the ability to keep that competitive advantage 
due to the access we provide to new knowledge and research specialisation in the field of 
electrochemical diagnostics. 
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8.7. Discussion and Conclusions 
With proper consideration for both the impact on the external competitive environment 
and the resources subsequently available to each allying firm, and the apt management of 
the network within the context of each firms‘ competitive position, the formation of a 
strategic network can equip a firm to hold a strong competitive edge within their industry. 
 
It is evident that there is no one type of strategic network that fits others, it is dependant 
on the firms competitive environment and whether they operate in an intensive, fast 
moving industry such as technology or a more consistent industry such as a firm that 
produces cardboard boxes.  Because all firms will have different ‗survival‘ strategies 
depending on their environment and what they wish to achieve, whether it is a product or 
service they provide, the format of network or alliance formed will directly affect their 
performance within their chosen industry.  Rycroft and Kash (2002) stated that due to 
changing competitive environments, network structures can evolve. 
 
Unilever Plc, being a power-house of R&D within its industrial sector, currently does 
consider strategic networks as an important and in fact critical facet of their competitive 
strategy, and because they create unilateral alliances with several centres of research 
excellence outside their own R&D facility, they enjoy a large competitive reward by 
remaining at the forefront of innovation.  Strategic alliance formation pushes forwards 
their reputation with the consumer as well as allowing them to focus on their core 
expertise and deliver high quality service and products for all of their brands.  
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A final note concerns the balance between academic and commercial value.  Strategic 
networks between commercial companies and centres of education, such as a University 
research group, presents a management challenge for finding an appropriate balance 
between furthering knowledge and creating competitive value.  An appropriate 
framework should therefore be put in place to allow each partner in such alliances to 
acquire and internalise value through the project thereby maintaining a creative, 
innovative yet commercially focused R&D network.  
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9. General Conclusions 
9.1. Introduction 
Two separate electrochemical immunosensors have been developed for the detection of 
nerve growth factor (NGF) and psoriasin (S100A7) to within physiological 
concentrations of 50 – 200pg ml-1 and 5 – 20ng ml-1 respectively via impedimetric 
interrogation.  These immunosensors are intended for use in the development of personal 
care products belonging to Unilever plc. 
 
Several investigations were carried out in which these immunosensors were 
characterised, enhanced in terms of sensitivity and reproducibility and then validated to 
confirm specificity and examine the shelf-life of fabricated sensors.  The general 
conclusions gathered from each of these research stages are presented in this chapter. 
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9.2. Immunosensor Characterisation 
Investigations concerning the fabrication of NGF and psoriasin immunosensors within a 
quartz crystal microbalance resulted in confirmation that the immunosensors are 
constructed in a specific manner with each increase in quartz crystal resonance frequency 
corresponding to the exposure and immobilisation of each reagent to the electrode.  It can 
be concluded that each reagent is bound specifically to the sensor surface in the order 
specified in chapter 3, section 3.5. 
 
Additionally, QCM investigations provide an initial piece of evidence that the 
concentration of anti-NGF and anti-psoriasin being deposited onto the immunosensor 
construct surface is excessive, forming a thick layer of antibody.  This is suggested by the 
fact that subsequent to antibody immobilisation onto the surface in the QCM chamber, 
the injection of BSA does not result in any apparent binding of BSA to the sensor 
surface.  This can be explained by the large excess of antibody already on the electrode 
surface, preventing any further reagent binding, except for specific antigen which can 
bind to the antibody binding sites. 
 
It can also be concluded that the association constant of anti-NGF/NGF and 
anti-psoriasin/psoriasin are slow.  This is due to the QCM plots, displayed in chapter 4, 
section 4.2, showing that antigen takes up to three hours to fully bind after incubation is 
initiated.  This suggests that in future impedance interrogation investigations, the 
immunosensors could be incubated in the target sample for an extended period to further 
enhance antibody-antigen binding and hence the response. 
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Iodine radiolabelled anti-NGF and anti –psoriasin were used to fabricate 
immunosensors and through washing steps and measurements of initial and subsequent 
levels of radiation, around 82% of the antibody initially deposited during immunosensor 
construction was seen to be removed.  This adds to the theory that an excess of antibody 
is being immobilised on the sensor surface.  Initial interpretations of these results led to 
the hypothesis that too little anti-NGF and anti-psoriasin was specifically immobilised on 
the sensor surface, and subsequent increases in antibody concentration and perhaps 
multiple immobilisation steps were necessary to bind a higher percentage of antibody.  
However, later investigations, whereby immunosensors were fabricate with higher 
antibody concentrations led to lower impedance response curves in addition to confocal 
microscopy experiments which exposed an excessively thick sensor construct (10µm) 
which confirmed the conclusion that a lower antibody concentration than 1mg ml
-1
 may 
lead to greater immunosensor sensitivity towards its target analyte, in addition to a 
possible improved reproducibility of results. 
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9.3. Immunosensor Enhancement and Impedance Interrogation 
A major conclusion to this research was established from the fabrication of 
immunosensors using the BioDot automatic reagent dispensing system.  It was found that 
by using an automated BioDot microdeposition approach greatly enhanced the 
reproducibility of measurements as seen with the tightening of error bars (standard error) 
in all responses shown in chapter 4, section 4.3. 
 
From investigations in chapter 4, section 4.4 regarding single shot analyte detection, it 
can be concluded that sensor performance is significantly lower and the immunosensor 
layer integrity may therefore have been compromised during storage of the sensors in dry 
conditions at room temperature.  Research in chapter 4, section 4.7 suggests that 
immunosensors should be stored at 4°C and can be used up to 24 hours after fabrication, 
at which point impedance responses are minimised by up to 50%.  Further studies are 
necessary to determine the optimum storage conditions of these immunosensors with the 
possible use of freeze drying techniques or of trehalose sugars - or another preservative as 
discussed in chapter 10, section 10.2. 
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9.4. Immunosensor Validation 
Both ferri-ferrocyanide electrolyte media and dilution buffer PBS exert false positive 
effects on immunosensor impedance due to possible leeching of ions into the 
immunosensor construct, resulting in increased layer thickness, thereby increasing 
impedance to a certain degree as reported in chapter 4, section 4.7 for ferri-ferrocyanide 
and chapter 6, section 6.5 for PBS. 
 
Chapter 4, section 4.7 and chapter 6, section 6.4 reveal that prolonged exposure of the 
immunosensor constructs to ferri-ferrocyanide media at 1 x 10
-6
 M results in an increase 
in impedance for up to five hours.  A subsequent drop in impedance after this point is 
observed, with this being postulated to be due to the possible accumulation of 
ferri-ferrocyanide ions forming conductive channels through the immunosensor 
construct. 
 
Investigations into the fabrication of NGF and psoriasin electrochemical immunosensors 
without the use of the biotin-avidin bridge (described in chapter 3, section 3.5) result in 
an observed specific response, however the error is significantly higher and the 
percentage change in impedance for any particular antigen concentration is lower.  It can 
be concluded that the biotin-avidin bridge serves to orientate a higher proportion of 
antibody to the immunosensor surface in an optimal way so as to maximise the 
occurrence of antibody-antigen binding events per exposure to any particular antigen 
concentration. 
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9.5. Strategic Networks and Business Related Conclusions 
Research was carried out into the business implications of the formation of strategic 
alliances such as the one formed between Unilever plc and Cranfield Health for this 
EngD project. 
 
It was concluded that such alliances and networks and the subsequent suitable 
management of them can lead to the gain of competitive edge in the personal care 
product industry.  This competitive edge can be materialised through the utilisation of 
tacit knowledge and unique resources gained through the alliance.  The success of the 
alliance is then reliant upon its management including clear transparency of goals and a 
focus on value creation as well as the encouragement of creativity and innovation while 
remaining commercially orientated. 
 
The development of the electrochemical immunosensors targeting NGF and psoriasin 
through this EngD project, in alliance with Unilever plc can create a competitive 
advantage in the personal care industry.  Although at present these immunosensors do not 
provide a sensitivity or time duration advantage over presently used ELISA protocols, 
they do represent a method of NGF and psoriasin detection at lower cost ($3 as opposed 
to $6) which can serve to significantly minimise Unilever R&D expenditure in a larger 
scale.  This cost margin can be further widened through the mass production of these 
sensors which would result in a lower unit cost than presently estimated, with the 
majority of fabrication cost being attributable to the purchase of anti-NGF and 
anti-psoriasin antibodies. 
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10. Suggestions for Further Work 
10.1. Introduction 
Throughout the course of this EngD project, significant results have been observed 
regarding the development, characterisation, interrogation and validation of 
electrochemical immunosensors specifically targeted towards the inflammation markers 
nerve growth factor (NGF) and psoriasin.   
 
This chapter describes the future focus of the project and suggests various avenues of 
approach with which these immunosensor designs could be further enhanced and 
validated towards the aim of ultimately using sensors to test human samples for NGF and 
psoriasin presence and concentration.  
 
This project has shown promise towards the development of human NGF and psoriasin 
impedance based immunosensors.  A significant change in real impedance (Z`) was 
observed with increasing NGF or psoriasin antigen.  However, a number of factors such 
as, for example, the optimal concentration of antibody to immobilise on the 
immunosensor surface, the binding of antibodies in a specific orientation so as to gain 
and the question of immunosensor storage and longevity all would benefit from further 
investigation. 
 
A final future plan is set out involving the interrogation of real human skin scrapping 
samples containing unknown concentrations of NGF and psoriasin.  A discussion is made 
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into the various new issues arising, such as, for example, the presence of a high 
concentration of other unknown proteins. 
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10.2. Longevity Trials Using Trehalose Sugars 
Two α-glucose molecules joined via a α,α,1,1-glucoside bond, form a disaccharide 
trehalose sugar (Figure 10. 1).  This compound, as well as being non-reducing, is stable at 
high temperatures and in acidic conditions.  Trehalose is commonly as a food 
preservative due to its ability to preserve proteins and carbohydrates and retain water, 
whilst having a minimal effect on the texture and integrity of the surface it covers.  Lai et 
al., (2006) used trehalose sugars to preserve their DNA sensor, resulting in a 7 – 9% 
degradation of the sensor after 30 days. 
 
Figure 10. 1: Representation of a trehalose sugar molecule, which could be used to preserve 
fabricated immunosensor constructs during prolonged periods of storage. 
 
 
It is speculated that, the coverage of the NGF and psoriasin immunosensor surfaces with 
trehalose sugars could potentially allow for prolonged storage of the immunosensors 
following fabrication.  Small volumes could be deposited onto the immunosensor surface 
using the BioDot auto-dispensing system (described in detail in chapter 3, section 3.5.3) 
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and the sensors stored dry at -20°C after bulk production.  Many sensors could therefore 
be stored for a prolonged period, yet to be ascertained, and used when appropriate. 
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10.3. Amine Capping with Acetic Anhydride 
Antibodies exhibit anionic properties which can lead to the formation of multiple 
electrostatic interactions with the cationic polyaniline surface (Figure 10. 2) therefore 
meaning that antibodies bind in an unintended orientation, not via the biotin-avidin 
bridge (as described in chapter 3, section 3.5.3), in a non-optimal fashion.   
 
 
Figure 10. 2: Illustration depicting the occurrence of multiple electrostatic interactions between the 
overall negatively charged antibodies and positively charged un-reacted amine groups 
 
 
Acetic anhydride (Figure 10. 3) can be used to acetylate un-reacted amine groups on the 
conducting polymer surface after biotinylation (otherwise there would be no amine 
groups for biotin to bind to), thereby capping un-reacted amine groups and minimising 
the multiple electrostatic interactions between the antibody and amine groups (Figure 10. 
4). 
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Figure 10. 3: Acetic anhydride, used to cap amine groups and prevent immobilisation of antibody 
directly to the immunosensor surface rather than via the biotin-avidin bridge. 
 
 
Figure 10. 4: The mechanism by which un-reacted (after biotin exposure) amine groups on the 
polyaniline sensor surface are capped by acetic anhydride. 
 
 
The purpose of blocking these un-reacted amine groups to prevent antibody molecules 
binding directly to the polyaniline surface would be to maximise the number of 
antibodies that are attached to the immunosensor surface in the optimal orientation so as 
to expose the specific region of the antibody to the antigen media.  This in turn could 
allow an in creased number of specific binding reactions between antibody and antigen, 
resulting in a greater sensitivity of the immunosensors towards any particular antigen 
concentration. 
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10.4. Site Specific Biotin Conjugation onto Mono-Valent 
Antibody Fragments 
During the conjugation of biotin onto antibodies, the biotin can bind to any available 
amine group.  This coupling is not necessarily site specific to the antibody Fc region and 
the biotin can theoretically be placed at various different sites around the antibody 
depending on the antibody being used and the exposed amino-acid residues it presents.  
This translates to an issue with the uniform construction of the sensor and means that 
many of the antibodies may not be bound in the optimal orientation for enhanced sensor 
sensitivity as described in chapter 3, section 3.5. 
 
Both NGF and psoriasin are bivalent antibodies (i.e. they have two binding sites).  It is 
therefore possible to use 2-mercaptoethylamine (2-MEA) to cleave the disulphide bond 
of the antibody to form two monovalent antibody fragments, each with a free thiol (SH) 
group on the tail end.  Sulfo-SMCC (Maleimide – spacer – biotin) can then be conjugated 
to the antibody fragment (Figure 10. 5).  This in addition to the capping of un-reacted 
amine groups will theoretically could result in antibodies being bound in an optimal and 
uniform orientation and provide a highly sensitive and more reproducible surface for 
specific antigen detection. 
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Figure 10. 5: Schematic to illustrate the cleavage of a bivalent antibody to form a monovalent 
antibody with a free thiol group, and the site specific conjugation of an antibody with biotin via 
maleimide and a spacer molecule (sulfo-SMCC) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
T.R.J. Holford          Cranfield University 
10.5. Alternative Conducting Polymers 
10.5.1. Poly–2–aminobenzylamine (Poly-2-aba) 
Polyaniline contains free amine groups which forms interactions with biotin as part of the 
sensor construction phase.  Each aniline molecule at the tail end of the polymer chain has 
a single free amine group, allowing for only one biotin molecule to bind.  An alternative 
conducting polymer can be mixed with polyaniline in order to provide a greater 
occurrence of amine groups per polymer tail (Figure 10. 6) and allow for a greater 
concentration of antibody to be immobilised to the surface via the biotin-avidin link. 
 
In this way a conclusion could then be reached as to whether the proportion of 
biotinylation on the electrode surface is dictating the proportion of avidin and hence of 
total antibody that can bind to the surface specifically via the biotin-avidin bridge.                     
 
Figure 10. 6: Schematic diagrams comparing the available amine groups for biotin binding on the 
tail end of polyaniline and poly-2-aminobenzylamine. 
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10.6. Testing Human Samples 
Due to a delay in the supply of clinical samples from Unilever the following investigation 
has been commissioned to occur after thesis submission but prior to the viva examination 
for this EngD project. 
 
The immunosensors targeting NGF and psoriasin as reported in this thesis are ultimately 
aimed for testing for the presence of NGF and psoriasin in human samples from buffer 
washings containing human skin particles previously exposed to the topical application of 
personal care products.   
 
The immunosensors developed in this project are capable of specifically detecting NGF 
and psoriasin to within their physiological concentrations (NGF: 50 – 200pg ml-1 and 
psoriasin: 5 – 20ng ml-1 as stipulated by the sponsor (Unilever plc)) from commercially 
purchased antigen samples.  These are ready to be used within an initial testing phase 
with human samples whereby immunosensors for both NGF and psoriasin will be 
fabricated, as described in chapter 3, section 3.5, and incubated with centrifuged buffer 
washings of human skin scrapings after exposure to topical application of personal care 
products. 
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ABSTRACT 
This review details recent advances in the fields of immunosensors and closely related 
immunoassays in the past decade, together with a discussion of possible future trends. 
Immunosensors can be classified by the way in which they transduce the signal 
produced upon the formation of an antibody antigen complex. Recent advancements to 
these methods of detection and transduction are discussed in detail, with particular focus 
on electrochemical, optical, piezoelectric and magnetic based sensors. The varying 
applications of these sensors are also discussed. 
Some of the most significant advances include development of immunosensors 
for the continuous monitoring of analytes, point of care (PoC) devices, with lower unit 
costs, automation, reusability and ease of use. Immunosensor technology has advanced at 
a prolific rate since its conception and has grown into a diverse area of ongoing research.  
Keywords: Immunosensor; Point of care; Lab on a Chip; Reusable; Continuous 
Monitoring 
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1. Introduction to Immunosensors 
The concept of using immunological components as sensing agents was first described 
within an immunoassay for plasma insulin in human subjects (Yalow and Berson 1959). 
The high dissociation constants (Kd) with which antibodies bind to their target antigen 
has continued to be exploited, with the most well-known immunoassay being the enzyme 
linked immunosorbent assay (ELISA) (Engvall and Perlmann 1971). The ELISA test has 
since been seen as a ‗gold-standard‘ for immunoassays for comparison against all newly 
developed immunoassays and immunosensors. Briefly, ELISAs involve the 
immobilisation of a reactant (an antibody or antigen) onto a solid surface - with enzymes 
being used as markers for the presence and abundance of a specific antibody-antigen 
(Ab/Ag) interaction (Butler 2000). 
Immunoassays make specific and sensitive measurements of target analytes by 
harnessing the high specificity of the Ab/Ag interaction - and this phenomena was used to 
develop what led to the first commercially available immunoassay – the home pregnancy 
test (measuring human chorionic gonadotrophin (hCG). Immunoassays for detecting hCG 
were first described in the 1960s, with radioimmunoassays following in the 1970s, 
however these lacked specificity towards hCG until the first lateral-flow immunoassay 
measuring the hCG-β subunit was developed which could distinguish between hCG and 
luteinising hormone (LH) (Vaitukaitis et al., 1972).  
In the late 1980‘s the first pregnancy tests were made available to the public for 
home use, and ever since, the technology has been applied to a diverse range of uses. 
Other workers (Clark and Lyons 1962) described the development of the first biosensor, 
which coupled the biological specificity of enzymes with an electrode and transducer. 
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Immunosensors, by definition, also incorporate this transduction stage to link the specific 
Ab/Ag interaction with the signal generation. Early work on immunosensors has been 
reviewed (Hock 1997) and there are more recent reviews (Cosnier 2005, Diaz-Gonzalez 
et al., 2006, Rodriguez-Mozaz et al., 2006, Centi et al., 2009). 
Several methods exist to transduce a signal created by the binding of antibody and 
analyte, each with associated advantages and disadvantages, leading to a wealth of 
research into fabrication of working immunosensors and immunoassays. Recent research 
is focussed towards point of care (PoC) systems, reusable and portable devices, 
miniaturisation, fabrication of more reliable platforms and the use of aptamers, 
molecularly imprinted polymers, nanoparticles and other relevant species. It is now 
possible to produce antibody fragments with a high specificity for their target analyte and 
for a much wider range of uses than available with naturally formed antibodies (Nassef et 
al., 2009, Lu et al., 2007). 
The future of this area of research seems set towards developing more sensors 
with the characteristics described above, with particular emphasis towards PoC 
applications and greater capabilities for simultaneous multiple analyte analysis 
(multiplexing) and high-throughput screening. 
 
 
1.1. Immunosensors: Present day status 
The home pregnancy test was first established as a lateral flow-cell immunoassay to 
measure levels of hCG in urine (Vaitukaitis et al., 1972). Lateral-flow immunoassays 
generally consist of an absorbent strip along which sample flows on a single axis from 
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the sampling pad until the analyte reaches its specific antibody which is conjugated to a 
coloured marker (Marino et al., 2009). The target (hCG), bound to its coloured antibody 
continues to a capture site where further anti-hCG immobilised along a line binds the 
Ab/Ag complex. If hCG is present in the urine, the Ab/Ag complex will bind at the 
capture site, forming a visible line to indicate the presence of hCG. Urine continues to 
flow up the strip to a pH sensitive control area in which a second line becomes visible to 
indicate that the sample has progressed all the way along the test strip. The appearance 
therefore of two solid lines on the strip indicates a positive result, one line a negative 
result. Today many lateral-flow tests determining the intensity of the coloured Ab/Ag 
complex to generate a digital readout of binding (Johnson et al., 2011) (figure 1). 
PoC testing is an ‗on site‘ test, detailed within a large proportion of contemporary 
front-line research, with numerous devices, diverse in terms of analytical targets. 
However, none offer a complete set of the necessary characteristics for a good PoC 
sensor including full automation, portability, precision, accuracy and sensitivity, low cost 
and ease of use (Von Lode 2005, Warsinke 2009). In recent years some PoC devices have 
become available for the detection and monitoring of cancer development (Rusling et al., 
2009, Mani et al., 2009, Yu et al., 2006). There has been a continued, sustained effort 
towards lowering the limits of detection on presently existing immunosensors and 
developing new immunoassays for other targets of clinical significance. 
Non-invasiveness is another important characteristic when considering PoC sensor 
design, preferably samples such as urine, sweat or saliva are used. Minimising the pain 
associated with blood sampling, as in blood glucose detection, is possible by reducing 
sample size; with devices utilising samples of 0.3 µl blood now on the market (Warsinke 
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2009) although when sampling for proteins, larger sample sizes of 1 µl are typically 
needed. Miniaturisation of devices could help produce lowered sample sizes, they operate 
on a smaller scale, can minimise pain upon sample collection and reduce unit costs.  
 
2. Principles of Immunosensors 
2.1. Definition of Immunosensors 
The journal Biosensors and Bioelectronics in the abstracts of the Fifth World Confernce 
on Biosensors defines a biosensor as an: ‘…analytical device incorporating a biological 
material, a biologically derived material, or a biomimic, intimately associated with or 
integrated within a physicochemical transducer or transducing microsystem…’. 
Biosensors can incorporate many different biological sensing agents e.g. enzymes, cell 
receptors, nucleic acids, microorganisms and, in the case of immunosensors, antibodies 
or antibody fragments. Immunosensors employ the high Ab/Ag specificity to detect the 
presence of its analyte as shown schematically (figure 2). 
Immunosensors can be either direct or indirect, meaning that the detection 
mechanism operates either directly via the Ab/Ag interaction, or a further label, such as 
an enzyme or fluorescent molecule, is used in order to detect whether a binding event has 
occurred. 
 
2.2 Electrochemical immunosensors 
Electrochemical sensors can be based on potentiometric, amperometric or impedimetric 
transduction principles. Inherent benefits of electrochemical sensors include selectivity, 
ease of use, low limits of detection and scope for miniaturisation. 
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2.2.1. Potentiometric immunosensors 
Devices based on this principle use potential changes which are logarithmically 
proportional to a particular ion activity and reactants are neither destroyed nor consumed 
during the measurement process. Therefore no concentration gradients are formed and 
stir independent responses are observed, facilitating ease of use. A sensor design which 
transduces the potential across a membrane into a digitised signal - or field effect 
transistors (FETs) whose semi-conductive surface potential changes upon a change in 
analyte concentration (Luppa et al., 2001) are examples of potentiometric sensors.  
A FET consists of a ‗source‘ and a ‗drain‘ of electrical current flowing through a 
silicon channel, which can be controlled by a transverse electric field created by a 
charged metallic gate controlling the flow of charge. ISFETs (Ion-Sensitive Field-Effect 
Transistor) are similar to metal oxide silicon field effect transistors (MOSFET) whereby 
there is a substitution of the gate electrode with a chemically sensitive membrane, 
solution and a reference electrode (Yuqing et al., 2003). ISFETs are micrometer sized 
integrated circuits which have led towards the ‗lab on a chip‘ (LoC) concept being 
introduced into a patient, offering for instance, continuous monitoring of blood glucose 
levels or a cardiac marker in patients at risk of heart attack (McKinley 2008). ISFETs are 
utilised as potentiometric immunosensors due to their high sensitivity, potential for 
miniaturisation and multichannel testing as well as short sample times and low sample 
volumes (making them useful for PoC and forensic applications) (Yuqing et al., 2003).  
When antibodies are bound to the surface of the gate on an ISFET, the 
conductivity at the electrode surface can be higher than in the surrounding buffer. This 
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change in local conductivity to the gate metal can be monitored utilising alternating 
current (AC) impedance and may be related to the concentration of the analyte in the 
sample (Bergveld 1986, Schasfoort et al., 1990). Other workers (Estrela et al., 2010) 
immobilised peptide aptamers on a MOSFET gate which recognise CDK2 
(cyclin-dependant kinase 2) with an LLD of 5pg ml
-1
, a clinically significant 
concentration. Very low analyte concentrations can be reliably detected (Selvanayagam 
et al., 2002) and background noise significantly minimised. Other workers reported using 
two monolithically integrated sensors connected in a serial flow configuration, the 
streaming potential was measured with low noise due to a differential sensor arrangement 
(Koch et al., 1999). 
Other immunopotentiometric sensors include enzyme labelled antibody sensors 
(indirect) which utilise a shift in potential upon activation of the enzyme reaction as a 
measurement of the analyte (Ghindilis et al., 1992, Purvis et al., 2003), the principle 
advantage being that measurements can be taken in real-time. Sensitivity and 
reproducibility of these potentiometric sensors can be improved by modifying the layers 
supporting the sensor construct. For example (Purvis et al., 2003) electrodeposition of 
polypyrrole onto electrodes for sensing hepatitis B surface antigen, troponin 1, digoxin 
and tumor necrosis factor, could be improved by increasing the potential range to a more 
anodic (positive) range, thereby increasing the sensitivity and stability of the sensor. 
Other workers (Tang et al., 2005) reported development of a potentiometric sensor 
containing layer-by-layer assembled polymers to produce a stable and ordered platform 
on which to immobilise antibodies.  
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Stable three dimensional sol-gels or chitosan membranes were found (Tang et al., 
2006, Liang et al., 2008) to improve reaction efficiency and offer the possibility of 
creating template polymer layers for immunosensorss with improved measurement of a 
wide range of analytes (Liang et al., 2008). Challenges to the use of these devices are 
lack of sensitivity to distinguish between concentrations within the same order of 
magnitude (i.e. within a small concentration range) and often a high occurrence of non-
specific binding effects in comparison to their amperometric counterparts, due to their 
logarithmic signal response characteristics. 
 
2.2.2. Amperometric immunosensors 
Amperometric immunosensor designs measure changes in current in response to an 
electrochemical reaction at a set voltage and are generally favoured over potentiometric 
designs in research and sensor development. They consume a small percentage of 
analytes during measurement, which means that either the analyte must be redox active or 
use of a redox active label will be necessary. Consumption of the analyte creates 
concentration gradients, thereby rendering responses stir-dependant. 
Workers successfully increased the sensitivity of amperometric immunosensors, 
including using a layer-by-layer construction approach utilising gold nanoparticles 
(AuNPs) and methylene blue to form a uniform and stable base for a hCG sensor. 
Increasing the surface area onto which capture agents were immobilised increased 
binding events and sensitivity (Chai et al., 2008). A multi-enzyme immunosensor 
targeting prostate specific antigen (PSA) was fabricated with carbon nanotubes (CNTs), 
enhancing sensitivity by decreasing particle size and increasing the number of labels in 
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the system (Jensen et al., 2009). Other workers used AuNPs to enhance the surface area 
and sensitivity of sensors (Chai et al., 2008, Zhuo et al., 2008, Liang et al., 2009, Kim et 
al., 2009) and platinum nanoparticles have been used in an operational design for the 
detection of H2O2 electroreduction (Fu et al., 2009).  
Stabilisation of sensor constructs was achieved by using polylysine films into 
which anti-biotin molecules were immobilised (Cataldo et al., 2008). Cross-linking 
prevents conformational change and unfolding of the antibodies allowing markedly 
enhanced sensitivity when compared with similar constructs, longer storage times and 
higher resistance to extremes of pH and temperature.  
Usually amperometric sensors require a redox reagent to allow electron flow. 
However a miniaturised, reagentless immunosensor design for the cancer marker 
carcinoembryonic antigen (CEA) has been constructed (Zhuo et al., 2008), incorporating 
AuNPs and a ferrocenyl substituted 3,4,9,10-perylenetetracarboxylic dianhydride 
derivative to give a nanostructured material which forms a stable redox-active film. 
Another reagentless amperometric immunosensor incorporated AuNPs in a α-fetoprotein 
immunoassay displaying long term maintenance of bioactivity and heightened sensitivity 
(Liang et al., 2009). 
An amperometric reversible immunosensor has been developed (Gooding et al., 
2004) incorporating rabbit IgG antibodies in an electrodeposited polypyrrole layer on an 
electrode. Reversibility of the immunoreaction is attributed to a 200ms pulse at each 
potential during measurement through a flow cell, which is too short to allow the stronger 
hydrogen bonds and hydrophobic forces to take effect in the binding event, but long 
enough to allow for a specific binding event to occur and a measurement to be made 
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(Gooding et al., 2004). However; if sensors can be produced at low cost, there is little 
need for reversibility, since sensitivity may dissipate upon each use (Piehler et al., 1997). 
The main advantage of reusable systems is the ability to continuously monitor analytes in 
real-time, allowing prompt counter-action to be taken. However Ab/Ag interactions have 
high affinities (Kd‘s generally lie between 105 – 1011 M), making reversing this strong 
interaction without rendering the device unusable by removing or denaturing the 
biological recognition element challenging. 
 
2.2.3 Impedimetric immunosensors 
The use of impedance/capacitance to detect Ab/Ag complex formation was first reported 
when upon formation of this complex on the surface of the electrode, the increase in 
dielectric layer thickness caused changes in capacitance proportional to the size and the 
concentration of antibodies (Bataillard et al., 1988). This was one of the first capacitive 
biosensors and others were to follow, for example gold electrodes could be coated with 
thiols and then these surfaces used to chemically immobilise antibodies to human serum 
albumin (HSA). Binding of the antigen led to a drop in capacitance, giving 
immunosensors with detection limits of 1 mg l
-1
 (Mirsky et al., 1997). Further work by 
the same group demonstrated that the use of longer chain thiols led to much more stable 
immunosensors and also enhanced their sensitivity by use of a sandwich type assay with 
both mono- and polyclonal anti-HSA (Riepl et al., 1999). 
Pulsed potential waveforms were used to measure current transients during 
electrical relaxation of conducting polymer surfaces incorporating anti-HSA antibodies 
(Sadik and Wallace 1993). Pulses were applied and current transients measured after 
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520ms using a Dionex-PAD II. Another group utilised a repeating polarising waveform 
and by recording the current transient using computerised software, produced a labeless, 
reversible immunosensor for bovine serum albumin (BSA) with a range of 0-50 mg l
-1 
(Grant et al., 2003). Further work (Grant et al., 2005) used AC impedance for continual 
perturbation of the polymer, as opposed to exciting the surface and recording the 
relaxation profile for the current transient. The current with respect to the polarising 
potential was monitored with the capacitive (imaginary (Z‘‘)) and faradaic (real (Z‘)) 
components of impedance being identified, quantified and displayed as Nyquist plots. 
Impedance changes between electrode surfaces and a surrounding solution upon a 
binding event can be transduced into an electrical signal using a frequency response 
analyser. There are several theories as to how this binding event affects changes in real 
and imaginary components of the system, although it is difficult to identify the origin of 
these changes. One theory hypothesises that binding of larger antigens forms a resistive 
barrier, causing the impedance to increase whilst binding of smaller antigens can 
facilitate a charge transfer and lower impedance (Tully et al., 2008). Another theory is 
that when the Ab/Ag complex is formed, the binding events between the hyper-variable 
loop regions mean that conformational changes occur and potential changes are 
introduced into the system. Future work must establish the origin of this impedance 
change, whether from increases in surface density or conformational changes that modify 
charge transfer across the sensor interface. 
Some groups (Balkenhold and Lisdat 2007, Vig et al., 2009, Escamilla-Gomez et 
al., 2009) have reported determining charge transfer resistance (CTR) as opposed to the 
real or imaginary components of impedance. CTR is a direct measurement of the ability 
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for charge transfer to occur between electrodes and surrounding electrolyte and is directly 
affected by the concentration of reaction products in the system, allowing their 
determination. Impedimetric immunosensors can be used as reagentless alternatives to 
indirect sensors, for example  electrochemical impedance spectroscopy (EIS) was used in 
an immunoassay for the detection of luteinising hormone (LH) entrapped within a 
conductive polypyrrole polymer matrix (Farace et al., 2002). Responses were observed in 
phase angle after exposure to LH, demonstrating that immunosensors can undertake 
reagentless transduction of specific signals related to the Ab/Ag complex formation. 
Recent examples include capacitative immunosensors for measurement of 
transglutaminase in human serum (Balkenhold and Lisfat 2007) which amplify the signal 
using secondary antibodies; direct sensors for Salmonella typhimurium in milk without 
sample pre-treatment (Pournaras et al., 2008); direct, labeless sensors for Escherichia coli 
in river and tap water with thiolated antibodies immobilised to a gold screen printed 
electrode (Escamilla-Gomez et al., 2009); another label-free sensor for the detection of 
the antibiotic enrofloxacin (Wu et al., 2009); a highly sensitive (LLD down to pg ml
-1
) 
labeless sensor for digoxin based on microarrays, sonochemically ablated into an 
insulating poly(1,2-diaminobenzene) polymer into which conducting polymer (containing 
the specific antibody) is deposited (Barton et al., 2009); and labeless sensors that directly 
detect atrazine in wine, to limits significantly lower than the EU maximum residue level 
of 50 µg l
-1
  (Ramon-Azcon et al., 2007). 
 
2.3. Optical immunosensors 
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Optical immunosensors operate under the principle that the manner and extent to which 
the sensor responce to light is modified upon binding of a specific antigen. As with other 
immunosensors, optical sensor research has seen a trend towards development of label-
free, simple to construct and use, inexpensive and highly sensitive devices (González-
Martínez et al., 2007).  
An optical sensor uses light as a stimulus and is able to detect alterations in the 
intensity of light as it passes through or refracts from a sampling system in relation to 
Ab/Ag binding. Popular examples of optical immunosensors include surface plasmon 
resonance (SPR) based sensors, fibre-optic sensors (FOS) and various fluorescence based 
sensors. 
Several papers have reported the benefits of using nanoparticles in their 
immunosensor design to improve performance (Seydack 2005). Nanoparticles have in 
general lowered detection limits, allowed for multiplexing and signal amplification due to 
increased surface areas and enhanced ability to control the system they provide, such as, 
for example through the use of magnetic nanoparticles, which can be electromagnetically 
manipulated, allowing higher levels of control. Measuring samples in a label-free manner 
means that the device can operate on a real-time basis; examples include an 
immunosensor based on Reflective Interferometric Fourier Transform Spectroscopy  to 
detect BSA via a self-correcting double layer of porous silicon (Pacholski et al., 2006); 
the detection of antinuclear antibodies using an optical immunosensor modified with 
colloidal gold (Lai et al., 2007); and the use of optical waveguide light-mode 
spectroscopy for environmental monitoring of trifluralin (a herbicide), a Fursarium 
mycotoxin zearalenone and vitellogenin, an egg yolk protein. (Szekacs et al., 2008). 
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2.3.1. SPR immunosensors 
SPR harnesses refractive index changes caused by the formation of the Ab/Ag complex 
on a metal surface being related to the concentration of the antigen in the sample being 
measured (González-Martínez et al., 2007). A typical SPR system uses microfluidics to 
pass controlled amounts of analyte across the sensor surface to which the antibody is 
immobilised. Measurements are made by reflecting a beam of polarised light off of the 
back surface of the metal film, through a prism. When the beam of light passes through 
the glass prism and hits the noble metal surface, not all the light is reflected. Some of the 
energy from the light photons is absorbed into the metal, exciting surface plasmons 
(electron oscillations at an interface of two materials) on the other side of the surface. 
Binding events cause changes in refractive index close to the surface which affect the 
reflected light intensity, angle and wavelength, measured as resonance units (RU). 1 RU 
is generally equal to a concentration of 1 pg mm
-2
 of analyte (Varki 1999). Passing 
antigen and then washing solutions over the sensor surface, allows the analyte 
concentration and association and dissociation constants of Ab/Ag complexes to be 
determined. 
Recent developments utilise the high specificity and real-time measuring abilities 
that SPR offers. For example (Prieto-Simon et al., 2009) the theoretical lowest limit of 
detection for a analyte when considering the affinity of the antibody – anti- Okadaic acid 
(IC70 = 0.03 ug l
-1
), was achieved using a flow-based kinetic exclusion assay (KinExA), a 
fluorimetric method which provides rapid and continuous screening. The added precision 
and reliability this method brings in comparison to an indirect assay, is most likely 
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accredited to the absence of the non-specific adsorption of avidin. Other work described 
successful operation of reusable and portable devices, for example, an ‗all-in-one‘ 
multi-microchannel sensor, designed to detect low molecular weight analytes (Kim et al., 
2007). The use of biotin-avidin interactions enhance the sensor signal, allowed 
miniaturisation and increased storage times. Additionally the ‗all-in-one‘ sensor is a 
multichannel device and able to make many highly sensitive measurements (LLD ~ 8ppt) 
enough to produce a calibration curve every 4 minutes (Kim et al., 2007). Other 
examples that have utilised and enhanced the high sensitivity and adaptability of SPR 
include a sensor for the trace (1 ppt - 1 ppb) detection of 2,4-dinitrophenol (Aizawa et al., 
2007), the combination of Fourier Transform – Surface Plasmon Resonance (FT-SPR) in 
a sensor targeted to rabbit IgG (Boujday et al., 2009), a sensor for the labeless, 
multiplexed detection of antibiotics in milk (Rebe Raz et al., 2009), the detection of 
dengue virus in serum (Kumbhat et al., 2010) and low density lipoprotein (LDL) 
detection (Matharu et al., 2009). 
 
2.3.2. Fibre-optic immunosensors 
The use of fibre-optics for use in sensors started in the late 1970s (Lubbers et al., 
1977, Lubbers and Opitz 1975, Peterson et al., 1980, Goldstein et al., 1980). Due to their 
reliability and small size they are easily integrated into other technologies. Chemical and 
immunochemical reagents can be immobilised at or close to the tip of an optical fibre 
with measurements being taken of absorbance and or fluorescence. In adsorbance 
fibre-optic sensors (FOS), binding of antigen leads to a colorimetric change (McKinley 
2008). Fluorescence based FOS relyon the quenching or build-up of fluorescence 
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(measured as fluorescence intensity) in a fluorescent molecule which can then be related 
to the amount of antigen present. Absorbance/fluorescence of the antigen can be either 
inherent or due to a suitable label. 
Benefits inherent to FOS are adaptability to operating over long distances and the 
potential for less common forms of interrogation to be performed, such as evanescent 
wave spectroscopy. Additionally they are easy to manufacture, and are unaffected by 
electrostatic or electromagnetic interference. They have good stability in most sample 
matrices and the promise for targeting multiple analytes (Lubbers 1995). 
Recent research has improved the sensitivity, reproducibility, simplicity of 
manufacture, operation and maintenance and many fibre-optic immunosensors have been 
developed for a variety of applications due to their small size and therefore simple 
integration into sensor devices. One example is an optical fibre covered with a 
photoactivatable poly(pyrrole-benzophenone) polymer film upon which specific binding 
reagents are immobilized through ultra-violet  light stimulation of the polymer (Konry et 
al., 2005) (see figure 4). The immunosensor targets antibodies to viral antigens (which 
are covalently bound to the conductive polymer surface) in order to detect the presence of 
hepatitis C virus (HCV) and could replace the present immunoassay for HCV which can 
give false negatives in patients under dialysis (Konry et al., 2005). 
A fibre-optic based fluorescence immunosensor which targets autoantibodies to 
ovarian and breast cancer associated antigens (Salama et al., 2007) was developed for 
early detection of cancer biomarkers in ovarian and breast serum and increase the 
chances of early and successful patient treatment. The sensor was a reliable and sensitive 
device with a limit of detection for 27.B1 IgM (an antibody against the G-protein 
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GIPC-1), of 30 pg ml
-1
 (50 times lower than chemiluminescent ELISA, 500 times lower 
than colorimetric ELISA) with lowered detection time and smaller sample volumes. 
A portable, reusable immunosensor was developed (Long et al., 2009) with an 
optical fibre based sensor targeted towards microcystin-LR (MC-LR) in water samples, a 
source of contamination from cyanobacteria which can be responsible for conditions such 
as liver cancer. MC-LR-ovalbumin was covalently immobilized to the fibre-optic surface, 
to give a highly sensitive sensor, with a LLD of 0.03 µg l
-1
, resistant to non-specific 
interactions and response times <8 minutes (Long et al., 2009).  
 
2.3.3. Fluorescence based immunosensors 
Fluorescence is a phenomenon by which certain molecules emit light energy of certain 
wavelengths. Fluorescence based immunosensors utilise fluorescent molecules which 
bind either directly to the target molecule or as an indirect label to measure, via 
spectrometry, the fluorescence intensity and therefore the concentration of the analyte to 
which the molecule is bound. 
Recent advances include capillary waveguide fluoroimmunosensors which 
utilised poly(dimethylsiloxane) coated glass capillaries to improve reproducibility, 
sensitivity and rapidity of measurement of detection of rabbit IgG (Niotis et al., 2009). 
Black drawing ink was used to block bulk fluorescence in capillary waveguide 
fluoroimmunosensor  to improve detection of the analyte in these devices (Mastichiadis 
et al., 2009).  
Fluorescence spectroscopy has also been used in unison with SPR (Wang et al., 
2009) with excitation of surface plasmons inducing an increase in the fluorescence signal 
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and an enhanced intensity of electromagnetic field, allowing quantification of down to 
0.6 pg ml
-1
 aflatoxin M1 in milk, much lower than the maximum residue level quoted by 
EC legislation. 
Chemiluminescence has also been utilised as a detection method for 
immunosensing due to its high signal to background ratios. Some of the earlier work on 
utilising chemiluminesence methods for the detection of bactgeria has been reviewed 
here (Ivnitski et al., 1999). Improving the immobilisation of Brucella-killed organisms to 
the surface of a chemiluminescent sensor with silane-benzophenone derivatives improved 
performance compared to other methods (Liebes et al., 2009). Also recently a 
chemiluminescence based technique for the point of care detection of cancer markers in 
blood serum has been developed (Grosso et al., 2010), utilising inexpensive ―off the 
shelf‖ compounds such as luminol, by way of a sandwich-type immunoassay. 
Fluorescent nanocrystals (quantum dots (QD‘s)) are inorganic fluorophores (Zhou 
et al., 2010) usually containing a 2-10 nm diameter crystalline core of CdSe or CdTe. 
They are generally fabricated in >200ºC temperatures using toxic and costly organic 
solvents and then bound to a biological linker. A more efficient and less toxic ‗single-pot‘ 
synthesis has been developed using dually functional fusion proteins as nanocrystal 
mineralisers to make ZnSe immuno-quantum dots linked to an IgG antibody (Zhou et al., 
2010). QDs are highly sensitive and specific when paired with a biological ligand and 
often aid in the reducing detection time (Wang et al., 2009). They have photophysical 
properties including broad absorption and narrow emission spectra, long fluorescence 
lifetimes and size-tuneable emissions. Improvements in QD design include minimisation, 
stability enhancement and adressing long and short-term toxicity issues (Sukhanova and 
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Nabiev 2008) - the optimisation of QD ‗anatomy‘. Using multiple QDs could allow 
development of multi-analyte detection systems to allow higher throughput of samples at 
lower cost. 
 
2.4. Piezoelectric immunosensors 
Piezoelectric devices convert a physical or mechanical change into electrical 
energy and visa versa. The commonest piezoelectric sensor is the quartz crystal 
microbalance (QCM), which exploits the change in the resonance of quartz crystals upon 
changes in their mass, allowing binding of antigen to antibody (when one of these is 
immobilised on the crystal surface) to be measured electrically. Recently multiple QCMs 
were immersed in a flow channel and connected by two line-antenna wires which are 
used to both generate and detect vibrations (Ogi et al., 2010) to give a multichannel, 
wireless and electrode-less QCM immunosensor. Various IgGs were used to confirm the 
specific operation of the immunosensor. Another group (Ghosh et al., 2010) utilised the 
anharmonic interactions of polystyrene microbeads on a quartz crystal platform. 
Anharmonics are based on how different interactions on the surface of the sensor affect 
the harmonic resonance frequencies in different manners, thereby allowing identification 
of an analyte. 
 
Microcantilever based devices were developed utilising rotating resonance 
microcantilevers which measured the frequency-shift of the microcantilever motion with 
respect to the specific-adsorbed mass, to give sensors capable of measuring α-fetoprotein 
to less than 2 ng ml
-1
 for the label-free, PoC early detection of heptocellular carcinoma 
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(Liu et al., 2009). Also a microring resonator immunosensor has been recently described 
which can detect multiple analytes (PSA, α-fetoprotein, CEA, tumour necrosis factor-α 
and interleukin-8) concurrently, without loss of sensitivity or measurement precision 
when compared to single-parameter analysis (Washburn et al., 2010). 
 
2.5. Magnetic immunosensors 
There has been a recent ssurge of interest in the use of magnetic particles within 
biosensors as detailed in this recent review (Haun et al., 2010). Incorporating magnetic 
beads into immunosensors allows a higher level of control. Electromagnets can pull 
immunosubstituted beads towards a binding site and then weakly bound species can be 
removed by an oppositely located electromagnet. An optomagnetic immunosensor for 
detection of cardiac markers (Bruls et al., 2009) utilises antibody-bound super-
paramagnetic nanoparticles and two separately operated electromagnets, on either side of 
a plastic casing. One electromagnet pulls the substituted nanoparticles through the media 
to the optical sensor surface, then the upper electromagnet is switched on to remove 
loosely bound or unbound particles from the sensor surface. An optical determination of 
binding can be taken. There are no extra wash stages, giving a simple one-step 
measurement once the sample fluid has been added, allowing. simplicity and rapid 
procurement of results necessary for PoC. 
Immunomolecular-magnetic beads have been incorporated into a technique which 
both separates and then tests for, particular analytes; for example, the separation of 
Staphylococcus aureas and Group G Streptococcus to allow both detection and 
quantification (Xiao et al., 2007). Other workers developed a magnetic relaxation 
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switching device that can detect different enantiomeric molecules, similar in structure but 
pharmacologically different (Tsourkas et al., 2004). The principle is that magnetic 
nanoparticles affect the magnetic resonance of the different enantiomers; this can be 
detected by the immunosensor as the nanoparticles compete for the active site of the 
antibody. 
The embodiment of magnetic beads produces stable devices that are inexpensive 
to fabricate, easy to operate and rapidly measure their specific analytes. The greatest 
challenge is constructing the device, although once fabricated operation is simple 
(Palecek and Fojta 2007). 
 
3. Immunosensor Components and their benefits / characteristics 
3.1. Carbon nanotubes 
CNT's, first reported in 1991 (IIjima 1991) which can be single-walled (SWNT‘s) 
and multi-walled (MWNT‘s), offer promise for immunochemical devices. The benefits of 
using CNTs are that they display enhanced detection sensitivity compared to sensors 
incorporating other carbon platforms (possibly due to increased surface area, they have 
electrocatalytic effects, benefit from lower levels of fouling, are mechanically strong and 
flexible and have excellent electrical and thermal conductivity (Dumitrescu et al., 2009, 
Huang et al., 2010). An early example of the use of CNTs in immunosensors involved 
their incorporation into polyanisidine to form composite working electrodes with 
improved characteristics when utilised within impedimetric biosensors compared to just 
the polymer or composites with carbon black or TiO2 (Carrara et al., 2005). 
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CNTs can be incorporated into screen printed electrodes (as well as almost any 
other format of electrode) allowing large scale, cost effective production of these sensors. 
For example, polysulphone screen printed sensors containing CNTs could be integrated 
with microfluidics in a continuous flow format to measure Botrytis cinerea in apple 
tissues for food (Pumera et al., 2007) or environmental monitoring purposes (Fernandez-
Baldo et al., 2009). A nanohybrid system of CNTs and AuNPs doped into chitosan films 
containing antigen were utilised in the development of an immunosensor for 
α-fetoprotein synergising the benefits of both nanostructures (Lin et al., 2009). 
Alternatively carbon nanohorns could be utilised within an immunosensor for quantifying 
microcystin-LR in the range 0.05 to 20 ng ml
-1
.  
 
 
3.2. Nanoparticles 
The inherent benefit that the use of nanoparticles, in particularly AuNPs, brings is their 
ability to significantly enhance sensitivity and lower detection limits of sensors, possibly 
due to the increased surface area onto which antibodies can be immobilised, or affecting 
the refraction of light in an SPR based sensor. Recent work includes an immunosensor 
based on organic semiconductors with nanogold-labelled antibodies (Li et al., 2008); a 
sensor with anti-CEA-modified magnetic nanoparticles to detect CEA down to 0.5 ng 
ml
-1
 (Chen and Tang 2007)); a sensor which utilises AuNPs for the detection of 
interleukin-6 (Liang and Mu 2006); SPR and EIS based immunosensors using AuNPs for 
the detection of Salmonella spp. (Ko et al., 2009, Yang et al., 2009) and an 
electrochemical immunosensor for the detection of α-fetoprotein with improved 
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sensitivity over previously developed immunosensors for clinical use (Liang et al., 2009). 
There is a natural limit of detection depending on the antibodies used simply because 
they each have their own cross-reactivities and non-specific binding, meaning eventually 
the difference cannot be established between specific and non-specific interactions 
(Seydack 2005). 
Gold nanoshells have been synthesised consisting of a dielectric core surrounded 
by a metal shell, where the optical resonance is related to the relative size of their 
constituents and were utilised to detect analytes in whole blood. Antibody conjugated 
nanoshells aggregate upon binding the analyte and the resonance spectra measured, 
giving a simple, purification free measurement system applicable to PoC usage (Hirsch et 
al., 2003). 
Other metal and inorganic nanoparticles have been incorporated into biosensors of 
different types as reviewed here (Guo and Dong 2009). Recent examples of the use of 
metals other than gold in immunosensors include the development of an immunosensor 
utilising antibodies to PSA immobilised on a gold electrode. After binding of target, 
secondary antibodies conjugated with platinum nanoparticles were then bound and 
utilised to catalyse an electrochemical hydrogen evolution reaction (Zhang et al., 2010). 
Other workers used platinum nanoparticle modified electrodes as the base for an 
immunosensor for human immunoglobulin G, where binding of the target was followed 
by development with a secondary antibody labelled with alkaline phospatase. This 
enzyme could be used to catalyse deposition of copper onto the electrode, thereby 
inhibiting its hydrogen evolution reaction and allowing detection of the target as low as 2 
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pg ml
-1
 (Huang et al., 2008). Other platinum modified electrodes have been used in the 
detection of E. Coli (Cheng et al., 2008).  
 Silver nanoparticle modified electrodes have also been used, for example in the 
recent construction of immunosensors for HSA, microcystin-LR and penicillin G (Dawan 
et al., 2011). Other nanoparticles include species such as streptavidin labelled iron 
oxide/dextran nanobeads which could be utilised within a sandwich-type immunoassay. 
Antibodies to brain natriuretic peptide were immobilised onto an SPR chip and then 
exposed to their antigen (Teramura et al., 2006). A secondary biotin-labelled antibody 
was then added followed by the nanobeads to enhance the SPR signal. Increased 
enhancements could be obtained by then adding cycles of biotin-labelled anti-strepavidin 
followed by further addition of the nanobeads.  
 
 
3.3. Microelectrodes 
Microelectrode arrays offer many advantages over standard planar electrodes. 
Microelectrodes provide stir independence sensor responses and although each separate 
microelectrode environment is far smaller than that of a planar electrode as a whole, 
collectively in an array, they frequently permit lower limits of detection for an analyte 
(Barton et al., 2008a, b, 2009, 2010).  
 
3.4 Monolayers 
For any sensor, major challenges can be the speed and extent of response and potential 
reversibility. Solid-state sensors can be limited by diffusion of analyte molecules to react 
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with the active sensing component. It therefore follows that the thinner the sensing layer 
is, the less time diffusion will take, thereby improving speed and reversibility of sensor 
response, as well as potentially improving signal to noise ratio because effects due to any 
immobilisation matrix are minimised. A number of techniques including Langmuir-
Blodgett, polyelectrolyte deposition and gold-thiol monolayers have been utilised in 
attempts to produce improved biosensors as reviewed here (Davis and Higson 2005). 
 The use of suitable monolayers in electrochemical sensors has been widely 
investigated, in part because most of the materials used in these systems are organic 
therefore the thinner any precursor monolayer, the less its insulating effect. We have 
already discussed several examples of the utilisation of gold-thiol monolayers in 
capacitive immunosensors (Mirsky et al., 1997, Riepl et al., 1999). Challenges for many 
immunosensors are those of drift, stability and biofouling and monolayers have been used 
to mitigate these problems. One of the most popular is the use of oligo-ethylene glycol 
thiol monolayers because of their regular structure, minimal desorption and high 
biocompatibility, for example they could be used to modify gold electrodes to give 
substrates onto which antibodies to Hepatocarcinoma marker or DNA probes could be 
immobilised, resulting in impedimetric/capacitive sensors for DNA or proteins (Carrara 
et al., 2009). 
 Monolayers are often widely utilised in SPR systems, since in SPR the intensity 
of the evanescent wave falls off with distance from the metal surface, therefore the 
thinner the immobilizing layer, the closer the biological recognition species are to the 
surface and the greater the effect of any recognition event.. Some of the earliest work 
used carbohydrate monolayers to selectively bind lectin proteins to SPR chips (Horan et 
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al., 1999). Specificity and reduced non-selective binding can also be improved by the 
presence of such monolayers, for example a variety of disulphide ligands could be 
deposited as imprinted monolayers with a morphine template and used to detect morphine 
by SPR (Tappura et al., 2007). Similarly binary monolayers can be constructed 
containing substituted thiols and oligonucleotides and shown to bind the counterstrand 
with improved complementary and reduced non-complementary binding (Vikholm-
Lundin and Piskonen 2008). 
 
3.5. Antibody Fragments 
Antibodies can be lysed into different constitutive fragments using the proteolytic 
enzymes pepsin or papain. They can be split into the Fab region which is the specific 
binding part of the molecule targeted to the antigen and the Fc region, which is 
unnecessary for immunosensors. It can be necessary to reduce the disulphide bridge in 
the Fab region and using dithiothreitol to prevent any non-specific interactions (Lee et 
al., 2005). It is possible to digest the Fab regions further into single chain variable 
fragments (scFv) in which the variable regions of the heavy and light chains are fused 
together, they are smaller than the Fab fragment, yet display similar specificity (Torrance 
et al., 2006). An extensive library of antibody fragments targeted towards a diverse array 
of antigen targets has been created (Nissim et al., 1994, Vaughan et al., 1996,. Toth et al., 
1999, Charlton et al., 2001).  
Immunoglobulin macromolecules are prone to asymmetrical binding to sensor 
platforms on which they operate, meaning many of the macromolecules are in an 
unsuitable binding orientation, lowering the specificity and reproducibility of a sensor 
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(Lee et al., 2005). Antibody fragments still retain the required biological specificity but 
are small and symmetrical in shape, allowing for reliable immobilisation and higher 
specificity towards the analyte due to lower steric hindrance. For example a 
immunosensor was fabricated utilising the Fab fragment from a monoclonal antibody 
against bovine insulin on a gold surface as the basis of an SPR sensor which displays a 
working concentration range of between 100 ng ml
-1
 – 10 µg ml-1 insulin (Lee et al., 
2005).  Another group used scFv selection and cloning techniques to fuse the scFv 
section of an antibody to the light chain cysteine residue on the C-terminal to aid uniform 
immobilisation of the fragments to the surface of an SPR chip to give an immunosensor 
(Torrance et al., 2006). Labeless EIS immunosensors were developed incorporating 
antibodies and antibody fragments immobilised onto a polyaniline surface (Tully et al., 
2008). By relating the redox state of the polymer to the charge transfers occurring upon 
Ab/Ag complex formation via impedance changes, antigen concentrations with a LLD for 
Internalin B (as a marker for Listeria monocytogenes, a food pathogen) of 4.1 pg ml
-1
 
could be determined. 
 
4. Immunosensor applications 
4.1. Commercially viable sensors 
The first commercially available immunoassay was the hCG hormone pregnancy test, a 
breakthrough for PoC sensing as it was used in the home, by the patient, without any 
need for specialised training; this meant the sensor had to be robust, inexpensive and 
simple to both operate and interpret. Later immunosensors which give an indication of 
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the duration of the pregnancy on a digital display by means of a transducer can be 
classified as true immunosensors. 
Immunoassays are presently available for a more diverse range of analytes than 
immunosensors. These immunoassays, for example ELISA, can be highly labour 
intensive, time consuming and expensive. Development of immunosensors for analytical 
applications, particularly in commercial markets, is important for cost minimisation. Also 
immunoassay development is paramount for integrating analytical capabilities into a 
portable, disposable and robust device, useful in many scenarios such as hospitals, 
general practitioners, airport, roadside police control and environmental measuerments 
(Ruano-Lopez et al., 2009). 
Recent work developed template platforms that can be used and fabricated as 
immunosensors for many targets where antibody can be immobilised onto an 
immunostrip with a reading being taken very specifically and rapidly and with 
sensitivities superior to equivalent ELISA tests. Sensors were developed capable of 
labelfree electrochemical detection of myelin basic protein (Tsekenis et al., 2008) and 
ciprofloxacin (Garifallou et al., 2007), non-specific binding effects were minimised using 
a dual electrode system.  
The Philips SmartBioPhone
TM
 is a portable, disposable LoC device developed 
with objectives of low cost and simplicity of operation and interpretation by being able, 
owing to its dry film lamination, of being integrated with any smartphone by either 
connecting with a USB or SDIO. The optical fluorescence device ‗LABONFOIL‘ is fully 
automated and deals with the whole process from sample preparation to interpretation of 
the results. LABONFOIL has been used for the measurement of a): marine algae to study 
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climate change, CO2 sequestration and toxic blooms b): Salmonella spp. and 
Campylobacter spp. c): biomarkers for colorectal cancer and d): detection of cocaine in 
professional drivers (Ruano-Lopez et al., 2009). Other workers (Hoegger et al., 2007) 
developed a disposable microfluidic ELISA device capable of measuring of folic acid in 
infant formula in five minutes with eight simultaneously operated microchannels in a 
highly automated microfluidic system. Commercial immunosensors must be robust and 
suitable for use by un-skilled operators. Due to these requirements, they pose a challenge 
in design and fabrication. 
The major research drive in the development of implantable sensors comprises 
research into implantable glucose sensors (Ghindlilis et al., 1996) to help treat diabetes 
without the trauma of taking drops of blood for glucose measurement. Challenges to this 
approach exist such as the risks associated with tissue destruction and infection or 
toxicological effects of new nanotechnologies such as QDs and CNTs, for example 
because of their long, straight shape, CNTs are thought to be possibly as dangerous as 
asbestos and capable of causing cancer in cells lining the lungs (Poland et al., 2008).  
The 2007-2009 recession has had an impact on PoC in all sectors, which is 
particularly evident in blood glucose testing; however, not considering the blood glucose 
sensors, the rest of the PoC market is predicted to grow by 8 – 9% between the time of 
writing and 2015 with many companies developing some innovative PoC technologies 
(Stephans et al., 2009). For commercial viability, sensors must operate under various 
conditions or measure multiple targets, be inexpensive and be stable for more than one 
month‘s shelf-life (Luong et al., 2008). Commercial sensors are being developed at lower 
rates than those made for research purposes, mainly due to additional stringent 
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requirements such as damage resitance, lower cost and being non-invasive. Successful 
biosensor designs must also incorporate characteristics such as biorecognition agent 
interchangeability, the prospect for miniaturisation and ideally be comparable to existing 
protocols to facilitate approval by relevant regulatory agencies. These objectives are 
difficult to achieve concurrently, making it difficult to enter the market without a 
reasonable volume niche product as a market driver. For example, within the food 
production industry, the market potential for the detection of bacterial and viral 
pathogens in food has been estimated to be $150 million (worldwide) (Alocijia and 
Radke 2003). Another significant market driver has been for detection of biological 
weapons following the increased perceived risk of terrorist activity. 
  
4.2. Medical diagnostics 
Medical applications for immunosensors include for example hCG-β (Kassanos et al., 
2008), Escherichia coli (Lin et al., 2004), myoglobin related to post-myocardial 
infarction (Billah et al., 2008), anti-cholera toxin antibody (Haddour et al., 2006) and 
fatty acid-binding proteins related to tissue injury (Chan et al., 2005).  
Detection, diagnosis and subsequent treatment of cancer is challenging medical 
diagnostics and much research has been conducted into sensors capable of detecting 
exceptionally low quantities of cancer markers, with the requirement of operating with 
the small sample sizes available from tissue or bone when concerning cancer diagnosis. 
With small sample sizes, particularly at the early stages of development, it is far more 
likely that the cancer can be detected if multiple cancer biomarkers are tested for (Rusling 
et al., 2009). A variety of cancer marker immunosensors such as for prostate, breast, 
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ovarian and colorectal cancer have been discussed in this paper. Recent work has 
developed electrochemical devices capable of recognizing species such as the 
Hepatocarcinoma marker SCCA from the IgM fraction from patients serum. A micro-
fabricated biochip was developed with antibodies to the marker immobilised on a gold-
thiol surface and had an estimated detection limit of 2.43 μg ml-1 (Carrara et al., 2008). 
Benefits from such devices are early detection of serious diseases and increased 
possibility of successful treatment. Contrarily, so much is to be expected of these devices 
that they are often complex to fabricate compared to existing techniques and devices, 
such as, for example liquid chromatography-mass spectrometry (LC-MS) which can 
provide reliable results in the diagnosis of diseases such as cancer (Stevens et al., 2003). 
However, although presently difficult to fabricate, immunosensors offer a financial 
advantage over techniques such as LC-MS and are far more suitable for PoC applications 
due to their operational simplicity. 
 
4.3. Sensors for environmental applications 
Sampling large areas such as fields, rivers or lakes requires high sample throughputs to 
cover the entire sample area. This requires portable equipment capable of rapid 
measurement at low cost with great sensitivity. Precision and accuracy are important 
since, for environmental and public safety purposes, routine sampling is commonplace, 
so the reliability of any results is highly important if contamination is slowly increasing. 
A fluorescent reporter yeast biosensor was fabricated that could both detect and 
biodegrade organophosphate pesticide paraoxon(Schofield et al., 2007). This self-
sustaining detection and solution system represents a significant advance because it 
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allows a continuous and toxic contamination minimisation solution to the environmental 
damage that chemical and biological agents can exert. A challenge however is acquiring 
all the necessary, specific antibodies towards the diverse range of toxins which can affect 
the environment (Goryacheva et al., 2007).  
 
4.4. Public health and safety applications 
Following recent terrorist attacks, significant efforts have been focused towards 
homeland security for example, the detection of explosives and other agents that might 
pose a public. Other uses include de-mining, forensics, monitoring of health risks posed 
to military personnel and the demilitarisation of weapons. This had led to development of 
new and improved ways of detecting materials used for terror (Singh 2007). Examples 
include a TNT sensor with multiplexed liquid arrays with aid of a flow-cytometer 
(Anderson et al., 2006); the detection of 2,4-dinitrotoluene (2,4-DNT) and TNT using 
oligo(ethylene-glycol) based immunosensors (Nagamoto et al., 2009, Minuta et al., 
2008); a sensor capable of detecting trace amounts of TNT in aquatic environments 
(Bromage et al., 2007) and an SPR based immunosensor comparing polyclonal and 
monoclonal antibodies for the detection of TNT (Shankaran et al., 2006). These examples 
mostly target TNT and there is a marked lack of research into the detection of other 
explosive devices. Nitroaromatic explosives have low vapour pressures and 
concentrations in air at ambient temperatures making detection of these vapours more 
problematic (Singh 2007) especially since the window within which to detect a suspect 
explosive or dangerous material is a few seconds as the carrier walks by the detector, 
unless they have been selected for individual screening. Presently, ELISA, GC-MS, 
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HPLC and electrochemical sensing are used for the detecting explosives and dangerous 
materials, but they can be time consuming and laborious, leaving a gap for 
immunosensors with increased speed and simplicity of detection (Anderson et al., 2006). 
Analytical performance in these sensors is, at the moment, insufficient. One 
challenge for the use of immunosensors in airport security is they use antibodies which, 
once bound to their constituent antigen, are generally not reusable. There are many 
working immunosensors available being used for the detection of explosives in situations 
such as contamination in the environment and on military personnel (Singh 2007).  
 
5. Conclusions and future prospects 
Immunosensor research is focussed towards development of PoC devices to allow prompt 
management of a particular issue whether commercial, medical, environmental or 
security by non-trained personnel. The future will see more of these devices being 
developed with these improved characteristics. Immunosensing devices are becoming 
miniaturised into LoCs to carry out all testing in one device in one place, thereby 
improving their suitability as PoC tools. Micro-fluidics aid this characteristic and allow 
for continuous sampling.  
One major challenge for many of these immunosensors is that so far they have 
only been developed in laboratory environments. For any commercial application to be 
successful there must exist a technology that allows rapid production of large numbers of 
sensors, to high quality specifications and relatively inexpensively. One potential 
technology is that of screen printed electrodes which can be produced relatively cheaply 
using existing technology. An alternative technique is that of complementary metal oxide 
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semiconductor technology (CMOS) which is widely used for constructing integrated 
circuits. As an example of the potential for miniaturisation using this approach, a CMOS 
chip has been developed just 6.4 x 4.5 mm in size on which are located 128 electrodes 
capable of individual detection of DNA hybridisation by capacitance changes (Stagni et 
al., 2006). The ability to detect multiple analytes within one device is dependent on the 
development of such technology to give arrays of multiple immunosensing elements. The 
use of such small sensing electrodes is of interest since recent research described earlier 
into microelectrode technology has led the way to obtaining stable, stir independent 
responses using a variety of robust platforms for immobilisation of various sensing 
elements. 
CMOS technology has also been used to develop optical sensors, for example a 8 
x 16 photodetector array can be constructed capable of detecting bioluminescence; the 
resultant chip can be connected by fibre-optics to give a system capable of very low light 
detection due to directly coupling the chemistry to the CMOS chip (Eltoukhy et al., 
2006). Surface acoustic wave technology is also a potential approach for utilisation in 
immunosensing since, similar to QCM, it is capable of detecting mass changes upon 
binding. CMOS was utilised to construct a surface acoustic wave device on an integrated 
circuit to give a chip about a millimetre in length. This can be functionalised with 
antibodies and has been shown to be capable of detection of a cancer biomarker (Tigli 
and Zaghloul 2008). 
The use of magnetic nanoparticles has already been described within this work 
and incorporation of this technology into lab-on-a-chip devices is being undertaken. It is 
possible to combine magnetic nanoparticles with NMR detection methods such as 
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magnetic resonance imaging. Chip based NMR detection systems formulated using 
CMOS have been developed which will allow the measurement of small (μl) samples at 
low cost making them suitable for PoC devices as reviewed here (Huan et al., 2010). The 
potential of combining immunosensor specificity with the sensitivity and versatility of 
NMR will allow the detection of a wide range of biological interactions in real time. 
Immunoassays developed in the 1950s demonstrated the exquisite specificity and 
specificity of these biological interactions. When they are combined with the potential 
interrogation techniques made possible by the advances in electronic, optical and 
fabrication technology, it seems that a whole new range of PoC tests will become 
commercially available, allowing for mass-screening programs and detection and early 
remediation of many health and environmental challenges. 
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